Compressible adjunct with crossing spacer fibers

Information

  • Patent Grant
  • 11890015
  • Patent Number
    11,890,015
  • Date Filed
    Thursday, September 9, 2021
    2 years ago
  • Date Issued
    Tuesday, February 6, 2024
    24 days ago
Abstract
A staple cartridge assembly for use with a surgical stapling instrument includes a staple cartridge including a plurality of staples and a cartridge deck. The staple cartridge assembly also includes a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises a first biocompatible layer comprising a first portion, a second biocompatible layer comprising a second portion, and crossed spacer fibers extending between the first portion and the second portion.
Description
BACKGROUND

The present invention relates to surgical instruments and, in various arrangements, to surgical stapling and cutting instruments and staple cartridges for use therewith that are designed to staple and cut tissue.





BRIEF DESCRIPTION OF THE DRAWINGS

The features of the various embodiments are set forth with particularity in the appended claims. The various embodiments, however, both as to organization and methods of operation, together with advantages thereof, may best be understood by reference to the following description, taken in conjunction with the accompanying drawings as follows:



FIG. 1 is a perspective view of a surgical stapling and severing instrument comprising a handle, a shaft extending from the handle, and an end effector extending including an anvil and a staple cartridge;



FIG. 2 is a perspective view of a wedge sled of a staple cartridge of the surgical stapling and severing instrument of FIG. 1;



FIG. 3 is a perspective view of a two-piece knife and firing bar (“E-beam”) of the surgical stapling and severing instrument of FIG. 1;



FIG. 4 is a longitudinal cross-sectional view of an anvil in a closed position, a staple cartridge comprising a rigid support portion, and a compressible adjunct illustrated with staples being moved from an unfired position to a fired position during a firing sequence;



FIG. 5 is another cross-sectional view of the anvil and the staple cartridge of FIG. 4 illustrating the anvil in an open position after the firing sequence has been completed;



FIG. 6 is a partial perspective view of a staple cartridge assembly comprising a compressible adjunct in accordance with at least one embodiment;



FIG. 6A is a partial perspective view of the adjunct of FIG. 6 implanted against tissue by at least one staple;



FIG. 6B is a partial perspective view of an alternative compressible adjunct implanted against tissue by at least one staple in accordance with at least one embodiment;



FIG. 7 is a partial perspective view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 8 is a partial perspective view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 9 is a partial perspective view of an alternative compressible adjunct implanted against tissue by at least one staple in accordance with at least one embodiment;



FIG. 10 is a partial cross-sectional view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 11 is a partial cross-sectional view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 12 is a partial cross-sectional view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 13 is a partial perspective view of an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 14 is a perspective view of the compressible adjunct of FIG. 13 positioned against a cartridge deck of a staple cartridge;



FIG. 15 is a perspective view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 16 is a partial perspective view of an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 17 is a partial perspective view of a compressible adjunct in accordance with at least one embodiment;



FIG. 18 is a cross-sectional view of the compressible adjunct of FIG. 17;



FIG. 19 is a detailed view of the cross-sectional view of FIG. 18;



FIG. 20 is a perspective view of a staple cartridge assembly comprising a compressible adjunct in accordance with at least one embodiment;



FIG. 21 is a different perspective view of the staple cartridge assembly of FIG. 20;



FIG. 22 is a different perspective view of the staple cartridge assembly of FIG. 20;



FIG. 23 is a partial perspective view of a compressible adjunct in accordance with at least one embodiment;



FIG. 24 is a partial cross-sectional view of a staple cartridge assembly in accordance with at least one embodiment;



FIG. 25 is a partial cross-sectional view of a securing member inserted into a staple cavity of a staple cartridge in accordance with at least one embodiment;



FIG. 26 is a partial cross-sectional view of a compressible adjunct in accordance with at least one embodiment;



FIG. 27 is a partial cross-sectional view of a compressible adjunct in accordance with at least one embodiment;



FIG. 28 is a partial perspective view of an alternative compressible adjunct implanted against tissue by at least one staple in accordance with at least one embodiment;



FIG. 29 is a partial cross-sectional view of the compressible adjunct of FIG. 28 without compression;



FIG. 30 is the partial cross-sectional view of FIG. 29 under compression;



FIG. 31 is a perspective view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 32 is a perspective view of a staple cartridge assembly comprising an alternative compressible adjunct in accordance with at least one embodiment;



FIG. 33 is a partial perspective view of a staple cartridge assembly comprising an implantable adjunct in accordance with at least one embodiment;



FIG. 34 is a partial perspective view of the adjunct of FIG. 33 implanted against tissue by at least one staple;



FIG. 35 is a partial perspective view of an implantable adjunct in accordance with at least one embodiment;



FIG. 36 is a partial perspective view of an implantable adjunct in accordance with at least one alternative embodiment;



FIG. 37 is a partial elevational view of the implantable adjunct of FIG. 36;



FIG. 38A is a detail view of a loop knot in accordance with at least one embodiment;



FIG. 38B is a detail view of a loop knot utilized by the adjunct of FIG. 35 in accordance with at least one embodiment;



FIG. 39 is a partial elevational view of the implantable adjunct of FIG. 35;



FIG. 40 is a partial cross-sectional view of a compressible adjunct including a plurality of standing fibers in accordance with at least one embodiment described herein;



FIG. 41 is a partial cross-sectional view of a compressible adjunct including a plurality of standing fibers in accordance with at least one embodiment described herein;



FIG. 42 is a partial perspective view of a compressible adjunct implanted against tissue by at least one staple in accordance with at least one embodiment described herein;



FIG. 43 is a partial perspective view of a fiber in accordance with at least one embodiment described herein;



FIG. 44 is a partial perspective view of a fiber in accordance with at least one embodiment described herein; and



FIG. 45 is a partial perspective view of a compressible adjunct in accordance with at least one embodiment described herein.





Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate various embodiments of the invention, in one form, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.


DETAILED DESCRIPTION

The Applicant of the present application owns the following U.S. patent applications that were filed on Sep. 30, 2015 and which are each herein incorporated by reference in their respective entireties:

    • U.S. patent application Ser. No. 14/871,036, entitled IMPLANTABLE LAYER COMPRISING PLASTICALLY DEFORMED FIBERS, now U.S. Pat. No. 10,327,777;
    • U.S. patent application Ser. No. 14/871,056, entitled IMPLANTABLE LAYER COMPRISING A CONSTRICTED CONFIGURATION, now U.S. Pat. No. 10,478,188;
    • U.S. patent application Ser. No. 14/871,078, entitled TUBULAR ABSORBABLE CONSTRUCTS, now U.S. Pat. No. 10,561,420;
    • U.S. patent application Ser. No. 14/871,087, entitled IMPLANTABLE ADJUNCT COMPRISING BONDED LAYERS, now U.S. Patent Application Publication No. 2017/0086838;
    • U.S. patent application Ser. No. 14/871,107, entitled COMPRESSIBLE ADJUNCTS WITH BONDING NODES, now U.S. Pat. No. 10,172,620;
    • U.S. patent application Ser. No. 14/871,057, entitled COMPRESSIBLE ADJUNCT WITH INTERMEDIATE SUPPORTING STRUCTURES, now U.S. Patent Application Publication No. 2017/0086829;
    • U.S. patent application Ser. No. 14/871,083, entitled COMPRESSIBLE ADJUNCT WITH LOOPING MEMBERS, now U.S. Pat. No. 10,736,633;
    • U.S. patent application Ser. No. 14/871,089, entitled WOVEN CONSTRUCTS WITH INTERLOCKED STANDING FIBERS, now U.S. Pat. No. 10,271,849;
    • U.S. patent application Ser. No. 14/871,119, entitled COMPRESSIBLE ADJUNCT AND METHODS FOR MAKING THE SAME, now U.S. Pat. No. 10,285,699;
    • U.S. patent application Ser. No. 14/871,131, entitled METHOD FOR APPLYING AN IMPLANTABLE LAYER TO A FASTENER CARTRIDGE, now U.S. Patent Application Publication No. 2017/0086842;
    • U.S. patent application Ser. No. 14/871,153, entitled COMPRESSIBLE ADJUNCT WITH ATTACHMENT REGIONS, now U.S. Pat. No. 10,524,788;
    • U.S. patent application Ser. No. 14/871,176, entitled PROGRESSIVELY RELEASABLE IMPLANTABLE ADJUNCT FOR USE WITH A SURGICAL STAPLING INSTRUMENT, now U.S. Pat. No. 10,603,039; and
    • U.S. patent application Ser. No. 14/871,195, entitled COMPRESSIBLE ADJUNCT ASSEMBLIES WITH ATTACHMENT LAYERS, now U.S. Pat. No. 10,307,160.


The Applicant of the present application also owns the U.S. patent applications identified below which are each herein incorporated by reference in their respective entireties:

    • U.S. patent application Ser. No. 12/894,311, entitled SURGICAL INSTRUMENTS WITH RECONFIGURABLE SHAFT SEGMENTS, now U.S. Pat. No. 8,763,877;
    • U.S. patent application Ser. No. 12/894,340, entitled SURGICAL STAPLE CARTRIDGES SUPPORTING NON-LINEARLY ARRANGED STAPLES AND SURGICAL STAPLING INSTRUMENTS WITH COMMON STAPLE-FORMING POCKETS, now U.S. Pat. No. 8,899,463;
    • U.S. patent application Ser. No. 12/894,327, entitled JAW CLOSURE ARRANGEMENTS FOR SURGICAL INSTRUMENTS, now U.S. Pat. No. 8,978,956;
    • U.S. patent application Ser. No. 12/894,351, entitled SURGICAL CUTTING AND FASTENING INSTRUMENTS WITH SEPARATE AND DISTINCT FASTENER DEPLOYMENT AND TISSUE CUTTING SYSTEMS, now U.S. Pat. No. 9,113,864;
    • U.S. patent application Ser. No. 12/894,338, entitled IMPLANTABLE FASTENER CARTRIDGE HAVING A NON-UNIFORM ARRANGEMENT, now U.S. Pat. No. 8,864,007;
    • U.S. patent application Ser. No. 12/894,369, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING A SUPPORT RETAINER, now U.S. Patent Application Publication No. 2012/0080344;
    • U.S. patent application Ser. No. 12/894,312, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING MULTIPLE LAYERS, now U.S. Pat. No. 8,925,782;
    • U.S. patent application Ser. No. 12/894,377, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE, now U.S. Pat. No. 8,393,514;
    • U.S. patent application Ser. No. 12/894,339, entitled SURGICAL STAPLING INSTRUMENT WITH COMPACT ARTICULATION CONTROL ARRANGEMENT, now U.S. Pat. No. 8,840,003;
    • U.S. patent application Ser. No. 12/894,360, entitled SURGICAL STAPLING INSTRUMENT WITH A VARIABLE STAPLE FORMING SYSTEM, now U.S. Pat. No. 9,113,862;
    • U.S. patent application Ser. No. 12/894,322, entitled SURGICAL STAPLING INSTRUMENT WITH INTERCHANGEABLE STAPLE CARTRIDGE ARRANGEMENTS, now U.S. Pat. No. 8,740,034;
    • U.S. patent application Ser. No. 12/894,350, entitled SURGICAL STAPLE CARTRIDGES WITH DETACHABLE SUPPORT STRUCTURES, now U.S. Patent Application Publication No. 2012/0080478;
    • U.S. patent application Ser. No. 12/894,383, entitled IMPLANTABLE FASTENER CARTRIDGE COMPRISING BIOABSORBABLE LAYERS, now U.S. Pat. No. 8,752,699;
    • U.S. patent application Ser. No. 12/894,389, entitled COMPRESSIBLE FASTENER CARTRIDGE, now U.S. Pat. No. 8,740,037;
    • U.S. patent application Ser. No. 12/894,345, entitled FASTENERS SUPPORTED BY A FASTENER CARTRIDGE SUPPORT, now U.S. Pat. No. 8,783,542;
    • U.S. patent application Ser. No. 12/894,306, entitled COLLAPSIBLE FASTENER CARTRIDGE, now U.S. Pat. No. 9,044,227;
    • U.S. patent application Ser. No. 12/894,318, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF CONNECTED RETENTION MATRIX ELEMENTS, now U.S. Pat. No. 8,814,024;
    • U.S. patent application Ser. No. 12/894,330, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND AN ALIGNMENT MATRIX, now U.S. Pat. No. 8,757,465;
    • U.S. patent application Ser. No. 12/894,361, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX, now U.S. Pat. No. 8,529,600;
    • U.S. patent application Ser. No. 12/894,367, entitled FASTENING INSTRUMENT FOR DEPLOYING A FASTENER SYSTEM COMPRISING A RETENTION MATRIX, now U.S. Pat. No. 9,033,203;
    • U.S. patent application Ser. No. 12/894,388, entitled FASTENER SYSTEM COMPRISING A RETENTION MATRIX AND A COVER, now U.S. Pat. No. 8,474,677;
    • U.S. patent application Ser. No. 12/894,376, entitled FASTENER SYSTEM COMPRISING A PLURALITY OF FASTENER CARTRIDGES, now U.S. Pat. No. 9,044,228;
    • U.S. patent application Ser. No. 13/097,865, entitled SURGICAL STAPLER ANVIL COMPRISING A PLURALITY OF FORMING POCKETS, now U.S. Pat. No. 9,295,464;
    • U.S. patent application Ser. No. 13/097,936, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER, now U.S. Pat. No. 8,657,176;
    • U.S. patent application Ser. No. 13/097,954, entitled STAPLE CARTRIDGE COMPRISING A VARIABLE THICKNESS COMPRESSIBLE PORTION, now U.S. Pat. No. 10,136,890;
    • U.S. patent application Ser. No. 13/097,856, entitled STAPLE CARTRIDGE COMPRISING STAPLES POSITIONED WITHIN A COMPRESSIBLE PORTION THEREOF, now U.S. Patent Application Publication No. 2012/0080336;
    • U.S. patent application Ser. No. 13/097,928, entitled TISSUE THICKNESS COMPENSATOR COMPRISING DETACHABLE PORTIONS, now U.S. Pat. No. 8,746,535;
    • U.S. patent application Ser. No. 13/097,891, entitled TISSUE THICKNESS COMPENSATOR FOR A SURGICAL STAPLER COMPRISING AN ADJUSTABLE ANVIL, now U.S. Pat. No. 8,864,009;
    • U.S. patent application Ser. No. 13/097,948, entitled STAPLE CARTRIDGE COMPRISING AN ADJUSTABLE DISTAL PORTION, now U.S. Pat. No. 8,978,954;
    • U.S. patent application Ser. No. 13/097,907, entitled COMPRESSIBLE STAPLE CARTRIDGE ASSEMBLY, now U.S. Pat. No. 9,301,755;
    • U.S. patent application Ser. No. 13/097,861, entitled TISSUE THICKNESS COMPENSATOR COMPRISING PORTIONS HAVING DIFFERENT PROPERTIES, now U.S. Pat. No. 9,113,865;
    • U.S. patent application Ser. No. 13/097,869, entitled STAPLE CARTRIDGE LOADING ASSEMBLY, now U.S. Pat. No. 8,857,694;
    • U.S. patent application Ser. No. 13/097,917, entitled COMPRESSIBLE STAPLE CARTRIDGE COMPRISING ALIGNMENT MEMBERS, now U.S. Pat. No. 8,777,004;
    • U.S. patent application Ser. No. 13/097,873, entitled STAPLE CARTRIDGE COMPRISING A RELEASABLE PORTION, now U.S. Pat. No. 8,740,038;
    • U.S. patent application Ser. No. 13/097,938, entitled STAPLE CARTRIDGE COMPRISING COMPRESSIBLE DISTORTION RESISTANT COMPONENTS, now U.S. Pat. No. 9,016,542;
    • U.S. patent application Ser. No. 13/097,924, entitled STAPLE CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,168,038;
    • U.S. patent application Ser. No. 13/242,029, entitled SURGICAL STAPLER WITH FLOATING ANVIL, now U.S. Pat. No. 8,893,949;
    • U.S. patent application Ser. No. 13/242,066, entitled CURVED END EFFECTOR FOR A STAPLING INSTRUMENT, now U.S. Patent Application Publication No. 2012/0080498;
    • U.S. patent application Ser. No. 13/242,086, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK, now U.S. Pat. No. 9,055,941;
    • U.S. patent application Ser. No. 13/241,912, entitled STAPLE CARTRIDGE INCLUDING COLLAPSIBLE DECK ARRANGEMENT, now U.S. Pat. No. 9,050,084;
    • U.S. patent application Ser. No. 13/241,922, entitled SURGICAL STAPLER WITH STATIONARY STAPLE DRIVERS, now U.S. Pat. No. 9,216,019;
    • U.S. patent application Ser. No. 13/241,637, entitled SURGICAL INSTRUMENT WITH TRIGGER ASSEMBLY FOR GENERATING MULTIPLE ACTUATION MOTIONS, now U.S. Pat. No. 8,789,741;
    • U.S. patent application Ser. No. 13/241,629, entitled SURGICAL INSTRUMENT WITH SELECTIVELY ARTICULATABLE END EFFECTOR, now U.S. Patent Application Publication No. 2012/0074200;
    • U.S. patent application Ser. No. 13/433,096, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF CAPSULES, now U.S. Pat. No. 9,301,752;
    • U.S. patent application Ser. No. 13/433,103, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF LAYERS, now U.S. Pat. No. 9,433,419;
    • U.S. patent application Ser. No. 13/433,098, entitled EXPANDABLE TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,301,753;
    • U.S. patent application Ser. No. 13/433,102, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A RESERVOIR, now U.S. Pat. No. 9,232,941;
    • U.S. patent application Ser. No. 13/433,114, entitled RETAINER ASSEMBLY INCLUDING A TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,386,988;
    • U.S. patent application Ser. No. 13/433,136, entitled TISSUE THICKNESS COMPENSATOR COMPRISING AT LEAST ONE MEDICAMENT, now U.S. Pat. No. 9,839,420;
    • U.S. patent application Ser. No. 13/433,141, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CONTROLLED RELEASE AND EXPANSION, now U.S. Pat. No. 10,123,798;
    • U.S. patent application Ser. No. 13/433,144, entitled TISSUE THICKNESS COMPENSATOR COMPRISING FIBERS TO PRODUCE A RESILIENT LOAD, now U.S. Pat. No. 9,277,919;
    • U.S. patent application Ser. No. 13/433,148, entitled TISSUE THICKNESS COMPENSATOR COMPRISING STRUCTURE TO PRODUCE A RESILIENT LOAD, now U.S. Pat. No. 9,220,500;
    • U.S. patent application Ser. No. 13/433,155, entitled TISSUE THICKNESS COMPENSATOR COMPRISING RESILIENT MEMBERS, now U.S. Pat. No. 9,480,476;
    • U.S. patent application Ser. No. 13/433,163, entitled METHODS FOR FORMING TISSUE THICKNESS COMPENSATOR ARRANGEMENTS FOR SURGICAL STAPLERS, now U.S. Patent Application Publication No. 2012/0248169;
    • U.S. patent application Ser. No. 13/433,167, entitled TISSUE THICKNESS COMPENSATORS, now U.S. Pat. No. 9,220,501;
    • U.S. patent application Ser. No. 13/433,175, entitled LAYERED TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,332,974;
    • U.S. patent application Ser. No. 13/433,179, entitled TISSUE THICKNESS COMPENSATORS FOR CIRCULAR SURGICAL STAPLERS, now U.S. Pat. No. 9,364,233;
    • U.S. patent application Ser. No. 13/763,028, entitled ADHESIVE FILM LAMINATE, now U.S. Pat. No. 9,282,962;
    • U.S. patent application Ser. No. 13/433,115, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CAPSULES DEFINING A LOW PRESSURE ENVIRONMENT, now U.S. Pat. No. 9,204,880;
    • U.S. patent application Ser. No. 13/433,118, entitled TISSUE THICKNESS COMPENSATOR COMPRISED OF A PLURALITY OF MATERIALS, now U.S. Pat. No. 9,414,838;
    • U.S. patent application Ser. No. 13/433,135, entitled MOVABLE MEMBER FOR USE WITH A TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,517,063;
    • U.S. patent application Ser. No. 13/433,140, entitled TISSUE THICKNESS COMPENSATOR AND METHOD FOR MAKING THE SAME, now U.S. Pat. No. 9,241,714;
    • U.S. patent application Ser. No. 13/433,129, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A PLURALITY OF MEDICAMENTS, now U.S. Pat. No. 9,211,120;
    • U.S. patent application Ser. No. 11/216,562, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 7,669,746;
    • U.S. patent application Ser. No. 11/714,049, entitled SURGICAL STAPLING DEVICE WITH ANVIL HAVING STAPLE FORMING POCKETS OF VARYING DEPTHS, now U.S. Patent Application Publication No. 2007/0194082;
    • U.S. patent application Ser. No. 11/711,979, entitled SURGICAL STAPLING DEVICES THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Pat. No. 8,317,070;
    • U.S. patent application Ser. No. 11/711,975, entitled SURGICAL STAPLING DEVICE WITH STAPLE DRIVERS OF DIFFERENT HEIGHT, now U.S. Patent Application Publication No. 2007/0194079;
    • U.S. patent application Ser. No. 11/711,977, entitled SURGICAL STAPLING DEVICE WITH STAPLE DRIVER THAT SUPPORTS MULTIPLE WIRE DIAMETER STAPLES, now U.S. Pat. No. 7,673,781;
    • U.S. patent application Ser. No. 11/712,315, entitled SURGICAL STAPLING DEVICE WITH MULTIPLE STACKED ACTUATOR WEDGE CAMS FOR DRIVING STAPLE DRIVERS, now U.S. Pat. No. 7,500,979;
    • U.S. patent application Ser. No. 12/038,939, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 7,934,630;
    • U.S. patent application Ser. No. 13/020,263, entitled SURGICAL STAPLING SYSTEMS THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Pat. No. 8,636,187;
    • U.S. patent application Ser. No. 13/118,278, entitled ROBOTICALLY-CONTROLLED SURGICAL STAPLING DEVICES THAT PRODUCE FORMED STAPLES HAVING DIFFERENT LENGTHS, now U.S. Pat. No. 9,237,891;
    • U.S. patent application Ser. No. 13/369,629, entitled ROBOTICALLY-CONTROLLED CABLE-BASED SURGICAL END EFFECTORS, now U.S. Pat. No. 8,800,838;
    • U.S. patent application Ser. No. 12/695,359, entitled SURGICAL STAPLING DEVICES FOR FORMING STAPLES WITH DIFFERENT FORMED HEIGHTS, now U.S. Pat. No. 8,464,923;
    • U.S. patent application Ser. No. 13/072,923, entitled STAPLE CARTRIDGES FOR FORMING STAPLES HAVING DIFFERING FORMED STAPLE HEIGHTS, now U.S. Pat. No. 8,567,656;
    • U.S. patent application Ser. No. 13/766,325, entitled LAYER OF MATERIAL FOR A SURGICAL END EFFECTOR, now U.S. Patent Application Publication No. 2013/0256380;
    • U.S. patent application Ser. No. 13/763,078, entitled ANVIL LAYER ATTACHED TO A PROXIMAL END OF AN END EFFECTOR, now U.S. Pat. No. 9,848,875;
    • U.S. patent application Ser. No. 13/763,094, entitled LAYER COMPRISING DEPLOYABLE ATTACHMENT MEMBERS, now U.S. Pat. No. 9,788,834;
    • U.S. patent application Ser. No. 13/763,106, entitled END EFFECTOR COMPRISING A DISTAL TISSUE ABUTMENT MEMBER, now U.S. Pat. No. 9,592,050;
    • U.S. patent application Ser. No. 13/433,147, entitled TISSUE THICKNESS COMPENSATOR COMPRISING CHANNELS, now U.S. Pat. No. 9,351,730;
    • U.S. patent application Ser. No. 13/763,112, entitled SURGICAL STAPLING CARTRIDGE WITH LAYER RETENTION FEATURES, now U.S. Pat. No. 10,405,854;
    • U.S. patent application Ser. No. 13/763,035, entitled ACTUATOR FOR RELEASING A TISSUE THICKNESS COMPENSATOR FROM A FASTENER CARTRIDGE, now U.S. Pat. No. 10,213,198;
    • U.S. patent application Ser. No. 13/763,042, entitled RELEASABLE TISSUE THICKNESS COMPENSATOR AND FASTENER CARTRIDGE HAVING THE SAME, now U.S. Pat. No. 9,861,361;
    • U.S. patent application Ser. No. 13/763,048, entitled FASTENER CARTRIDGE COMPRISING A RELEASABLE TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,700,317;
    • U.S. patent application Ser. No. 13/763,054, entitled FASTENER CARTRIDGE COMPRISING A CUTTING MEMBER FOR RELEASING A TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,272,406;
    • U.S. patent application Ser. No. 13/763,065, entitled FASTENER CARTRIDGE COMPRISING A RELEASABLY ATTACHED TISSUE THICKNESS COMPENSATOR, now U.S. Pat. No. 9,566,061;
    • U.S. patent application Ser. No. 13/763,021, entitled STAPLE CARTRIDGE COMPRISING A RELEASABLE COVER, now U.S. Pat. No. 9,386,984;
    • U.S. patent application Ser. No. 13/763,078, entitled ANVIL LAYER ATTACHED TO A PROXIMAL END OF AN END EFFECTOR, now U.S. Pat. No. 9,848,875;
    • U.S. patent application Ser. No. 13/763,095, entitled LAYER ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES, now U.S. Pat. No. 9,770,245;
    • U.S. patent application Ser. No. 13/763,147, entitled IMPLANTABLE ARRANGEMENTS FOR SURGICAL STAPLE CARTRIDGES, now U.S. Pat. No. 10,390,823;
    • U.S. patent application Ser. No. 13/763,192, entitled MULTIPLE THICKNESS IMPLANTABLE LAYERS FOR SURGICAL STAPLING DEVICES, now U.S. Pat. No. 9,615,826;
    • U.S. patent application Ser. No. 13/763,161, entitled RELEASABLE LAYER OF MATERIAL AND SURGICAL END EFFECTOR HAVING THE SAME, now U.S. Patent Application Publication No. 2013/0153641;
    • U.S. patent application Ser. No. 13/763,177, entitled ACTUATOR FOR RELEASING A LAYER OF MATERIAL FROM A SURGICAL END EFFECTOR, now U.S. Pat. No. 9,585,657;
    • U.S. patent application Ser. No. 13/763,037, entitled STAPLE CARTRIDGE COMPRISING A COMPRESSIBLE PORTION, now U.S. Patent Application Publication No. 2014/0224857;
    • U.S. patent application Ser. No. 13/433,126, entitled TISSUE THICKNESS COMPENSATOR COMPRISING TISSUE INGROWTH FEATURES, now U.S. Pat. No. 9,320,523;
    • U.S. patent application Ser. No. 13/433,132, entitled DEVICES AND METHODS FOR ATTACHING TISSUE THICKNESS COMPENSATING MATERIALS TO SURGICAL STAPLING INSTRUMENTS, now U.S. Patent Application Publication No. 2013/0256373;
    • U.S. patent application Ser. No. 13/851,703, entitled FASTENER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR INCLUDING OPENINGS THEREIN, now U.S. Pat. No. 9,572,577;
    • U.S. patent application Ser. No. 13/851,676, entitled TISSUE THICKNESS COMPENSATOR COMPRISING A CUTTING MEMBER PATH, now U.S. Patent Application Publication No. 2014/0291379;
    • U.S. patent application Ser. No. 13/851,693, entitled FASTENER CARTRIDGE ASSEMBLIES, now U.S. Pat. No. 9,332,984;
    • U.S. patent application Ser. No. 13/851,684, entitled FASTENER CARTRIDGE COMPRISING A TISSUE THICKNESS COMPENSATOR AND A GAP SETTING ELEMENT, now U.S. Pat. No. 9,795,384;
    • U.S. patent application Ser. No. 14/187,387, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166724;
    • U.S. patent application Ser. No. 14/187,395, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166725;
    • U.S. patent application Ser. No. 14/187,400, entitled STAPLE CARTRIDGE INCLUDING A BARBED STAPLE, now U.S. Patent Application Publication No. 2014/0166726;
    • U.S. patent application Ser. No. 14/187,383, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING IMPLANTABLE LAYERS FOR USE WITH SURGICAL FASTENING INSTRUMENTS, now U.S. Pat. No. 9,839,422;
    • U.S. patent application Ser. No. 14/187,386, entitled IMPLANTABLE LAYERS AND METHODS FOR ALTERING ONE OR MORE PROPERTIES OF IMPLANTABLE LAYERS FOR USE WITH FASTENING INSTRUMENTS, now U.S. Pat. No. 9,884,456;
    • U.S. patent application Ser. No. 14/187,390, entitled IMPLANTABLE LAYERS AND METHODS FOR MODIFYING THE SHAPE OF THE IMPLANTABLE LAYERS FOR USE WITH A SURGICAL FASTENING INSTRUMENT, now U.S. Pat. No. 9,839,423;
    • U.S. patent application Ser. No. 14/187,389, entitled IMPLANTABLE LAYER ASSEMBLIES, now U.S. Pat. No. 9,757,124;
    • U.S. patent application Ser. No. 14/187,385, entitled IMPLANTABLE LAYERS COMPRISING A PRESSED REGION, now U.S. Pat. No. 9,693,777;
    • U.S. patent application Ser. No. 14/187,384, entitled FASTENING SYSTEM COMPRISING A FIRING MEMBER LOCKOUT, now U.S. Pat. No. 9,775,608;
    • U.S. patent application Ser. No. 14/827,856, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT, now U.S. Patent Application Publication No. 2017/0049444;
    • U.S. patent application Ser. No. 14/827,907, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT, now U.S. Pat. No. 10,617,418;
    • U.S. patent application Ser. No. 14/827,932, entitled IMPLANTABLE LAYERS FOR A SURGICAL INSTRUMENT, now U.S. Patent Application Publication No. 2017/0049448;
    • U.S. patent application Ser. No. 14/667,874, entitled MALLEABLE BIOABSORBABLE POLYMER ADHESIVE FOR RELEASABLY ATTACHING A STAPLE BUTTRESS TO A SURGICAL STAPLER, now U.S. Pat. No. 10,172,617;
    • U.S. patent application Ser. No. 14/300,954, entitled ADJUNCT MATERIALS AND METHODS OF USING SAME IN SURGICAL METHODS FOR TISSUE SEALING, now U.S. Pat. No. 10,172,611;
    • U.S. patent application Ser. No. 14/840,613, entitled DRUG ELUTING ADJUNCTS AND METHODS OF USING DRUG ELUTING ADJUNCTS, now U.S. Pat. No. 10,569,071;
    • U.S. patent application Ser. No. 14/498,145, entitled METHOD FOR CREATING A FLEXIBLE STAPLE LINE, now U.S. Pat. No. 10,327,764; and
    • U.S. patent application Ser. No. 14/865,306, entitled IMPLANTABLE ADJUNCT SYSTEMS FOR DETERMINING ADJUNCT SKEW, now U.S. Pat. No. 10,299,878.


Numerous specific details are set forth to provide a thorough understanding of the overall structure, function, manufacture, and use of the embodiments as described in the specification and illustrated in the accompanying drawings. Well-known operations, components, and elements have not been described in detail so as not to obscure the embodiments described in the specification. The reader will understand that the embodiments described and illustrated herein are non-limiting examples, and thus it can be appreciated that the specific structural and functional details disclosed herein may be representative and illustrative. Variations and changes thereto may be made without departing from the scope of the claims.


The terms “comprise” (and any form of comprise, such as “comprises” and “comprising”), “have” (and any form of have, such as “has” and “having”), “include” (and any form of include, such as “includes” and “including”) and “contain” (and any form of contain, such as “contains” and “containing”) are open-ended linking verbs. As a result, a surgical system, device, or apparatus that “comprises,” “has,” “includes” or “contains” one or more elements possesses those one or more elements, but is not limited to possessing only those one or more elements. Likewise, an element of a system, device, or apparatus that “comprises,” “has,” “includes” or “contains” one or more features possesses those one or more features, but is not limited to possessing only those one or more features.


The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” referring to the portion closest to the clinician and the term “distal” referring to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.


Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, the reader will readily appreciate that the various methods and devices disclosed herein can be used in numerous surgical procedures and applications including, for example, in connection with open surgical procedures. As the present Detailed Description proceeds, the reader will further appreciate that the various instruments disclosed herein can be inserted into a body in any way, such as through a natural orifice, through an incision or puncture hole formed in tissue, etc. The working portions or end effector portions of the instruments can be inserted directly into a patient's body or can be inserted through an access device that has a working channel through which an end effector and elongated shaft of a surgical instrument can be advanced.


A surgical stapling system can comprise a shaft and an end effector extending from the shaft. The end effector comprises a first jaw and a second jaw. The first jaw comprises a staple cartridge. The staple cartridge is insertable into and removable from the first jaw; however, other embodiments are envisioned in which a staple cartridge is not removable from, or at least readily replaceable from, the first jaw. The second jaw comprises an anvil configured to deform staples ejected from the staple cartridge. The second jaw is pivotable relative to the first jaw about a closure axis; however, other embodiments are envisioned in which the first jaw is pivotable relative to the second jaw. The surgical stapling system further comprises an articulation joint configured to permit the end effector to be rotated, or articulated, relative to the shaft. The end effector is rotatable about an articulation axis extending through the articulation joint. Other embodiments are envisioned which do not include an articulation joint.


The staple cartridge comprises a cartridge body. The cartridge body includes a proximal end, a distal end, and a deck extending between the proximal end and the distal end. In use, the staple cartridge is positioned on a first side of the tissue to be stapled and the anvil is positioned on a second side of the tissue. The anvil is moved toward the staple cartridge to compress and clamp the tissue against the deck. Thereafter, staples removably stored in the cartridge body can be deployed into the tissue. The cartridge body includes staple cavities defined therein wherein staples are removably stored in the staple cavities. The staple cavities are arranged in six longitudinal rows. Three rows of staple cavities are positioned on a first side of a longitudinal slot and three rows of staple cavities are positioned on a second side of the longitudinal slot. Other arrangements of staple cavities and staples may be possible.


The staples are supported by staple drivers in the cartridge body. The drivers are movable between a first, or unfired position, and a second, or fired, position to eject the staples from the staple cavities. The drivers are retained in the cartridge body by a retainer which extends around the bottom of the cartridge body and includes resilient members configured to grip the cartridge body and hold the retainer to the cartridge body. The drivers are movable between their unfired positions and their fired positions by a sled. The sled is movable between a proximal position adjacent the proximal end and a distal position adjacent the distal end. The sled comprises a plurality of ramped surfaces configured to slide under the drivers and lift the drivers, and the staples supported thereon, toward the anvil.


Further to the above, the sled is moved distally by a firing member. The firing member is configured to contact the sled and push the sled toward the distal end. The longitudinal slot defined in the cartridge body is configured to receive the firing member. The anvil also includes a slot configured to receive the firing member. The firing member further comprises a first cam which engages the first jaw and a second cam which engages the second jaw. As the firing member is advanced distally, the first cam and the second cam can control the distance, or tissue gap, between the deck of the staple cartridge and the anvil. The firing member also comprises a knife configured to incise the tissue captured intermediate the staple cartridge and the anvil. It is desirable for the knife to be positioned at least partially proximal to the ramped surfaces such that the staples are ejected ahead of the knife.


The staple cartridge can also include an implantable layer. The implantable layer is configured to be captured within a staple along with tissue when the staple is deployed by the corresponding driver. The implantable layer can comprise a buttress, a tissue thickness compensator, and/or other adjunct material. A tissue thickness compensator is configured to compensate for variations in tissue properties, such as variations in the thickness of tissue, for example, along a staple line. A tissue thickness compensator can be compressible and resilient. In use, a tissue thickness compensator prevents or limits the over-compression of stapled tissue while facilitating adequate tissue compression within and between staples.


The implantable layer of a staple cartridge can be releasably secured to the body of the staple cartridge. For example, the implantable layer can be releasably secured to the deck of the staple cartridge with a releasable adhesive, at least one attachment tab, and/or other attachment features. Additionally or alternatively, an implantable layer can be releasably secured to the first jaw or the second jaw. An implantable layer can be positioned on the cartridge-side of an end effector and/or the anvil-side of the end effector, for example.


An implantable layer can be configured to promote tissue ingrowth. In various instances, it is desirable to promote the ingrowth of tissue into an implantable layer to promote the healing of the treated tissue (e.g. stapled and/or incised tissue) and/or to accelerate the patient's recovery. More specifically, the ingrowth of tissue into an implantable layer may reduce the incidence, extent, and/or duration of inflammation at the surgical site. Tissue ingrowth into and/or around the implantable layer may manage the spread of infections at the surgical site, for example. The ingrowth of blood vessels, especially white blood cells, for example, into and/or around the implantable layer may fight infections in and/or around the implantable layer and the adjacent tissue. Tissue ingrowth may also encourage the acceptance of foreign matter (e.g. the implantable layer and the staples) by the patient's body and may reduce the likelihood of the patient's body rejecting the foreign matter. Rejection of foreign matter may cause infection and/or inflammation at the surgical site.


Turning to the Drawings wherein like numerals denote like components throughout the several views, FIG. 1 illustrates an exemplary surgical stapling and severing instrument 8010 suitable for use with an implantable adjunct such as, for example, a tissue thickness compensator. The surgical stapling and severing instrument 8010 can comprise an anvil 8014 which may be repeatedly opened and closed about its pivotal attachment to an elongate staple channel 8016. A staple applying assembly 8012 may comprise the anvil 8014 and the channel 8016, wherein the assembly 8012 can be proximally attached to an elongate shaft 8018 forming an implement portion 8022. When the staple applying assembly 8012 is closed, or at least substantially closed, the implement portion 8022 can present a sufficiently small cross-section suitable for inserting the staple applying assembly 8012 through a trocar.


In various circumstances, the staple cartridge assembly 8012 is manipulated by a handle 8020 connected to the elongate shaft 8018. The handle 8020 can comprise user controls such as a rotation knob 8030 that rotates the elongate shaft 8018 and the staple applying assembly 8012 about a longitudinal axis of the shaft 8018 and a closure trigger 8026, which can pivot in front of a pistol grip 8036 to close the staple applying assembly 8012. A closure release button 8038 is outwardly presented on the handle 8020 when the closure trigger 8026 is clamped such that the release button 8038 can be depressed to unclamp the closure trigger 8026 and open the staple applying assembly 8012, for example.


A firing trigger 8034, which can pivot in front of the closure trigger 8026, causes the staple applying assembly 8012 to simultaneously sever and staple tissue clamped therein. In various circumstances, multiple firing strokes can be employed using the firing trigger 8034 to reduce the amount of force required to be applied by the surgeon's hand per stroke. In certain embodiments, the handle 8020 can comprise one or more rotatable indicator wheels such as, for example, rotatable indicator wheel 8041 which can indicate the firing progress. A manual firing release lever 8042 can allow the firing system to be retracted before full firing travel has been completed, if desired, and, in addition, the firing release lever 8042 can allow a surgeon, or other clinician, to retract the firing system in the event that the firing system binds and/or fails.


Additional details on the surgical stapling and severing instrument 8010 and other surgical stapling and severing instruments suitable for use with the present disclosure are described, for example, in U.S. patent application Ser. No. 13/851,693, entitled FASTENER CARTRIDGE ASSEMBLY, and filed on Mar. 27, 2013, now U.S. Pat. No. 9,332,984, the entire disclosure of which is incorporated herein by reference. Furthermore, powered surgical stapling and severing instruments can also be utilized with the present disclosure. See, for example, U.S. Patent Application Publication No. 2009/0090763, entitled POWERED SURGICAL STAPLING DEVICE, and filed on Aug. 12, 2008, the entire disclosure of which is incorporated herein by reference.


With reference to FIGS. 2 and 3, a firing assembly such as, for example, firing assembly 9090 can be utilized with the surgical stapling and severing instrument 8010 to advance a wedge sled 9126 which comprises a plurality of wedges 9204 configured to deploy staples from the staple applying assembly 8012 into tissue captured between the anvil 8014 and the elongate staple channel 8016. Furthermore, an E-beam 9102 at a distal portion of the firing assembly 9090 may fire the stales from the staple applying assembly 8012 as well as position the anvil 8014 relative to the elongate staple channel 8016 during firing. The E-beam 9102 includes a pair of top pins 9110, a pair of middle pins 9112 which may follow portion 9218 of the wedge sled 9126, and a bottom pin or foot 9114, as well as a sharp cutting edge 9116 which can be configured to sever the captured tissue as the firing assembly 9090 is advanced distally. In addition, integrally formed and proximally projecting top guide 9118 and middle guide 9120 bracketing each vertical end of the cutting edge 9116 may further define a tissue staging area 9122 assisting in guiding tissue to the sharp cutting edge 9116 prior to being severed. The middle guide 9120 may also serve to engage and fire the staple applying assembly 8012 by abutting a stepped central member 9124 of the wedge sled 9126 (FIG. 2) that effects staple formation by the staple applying assembly 8012.


In various circumstances, a staple cartridge can comprise means for compensating for the thickness of tissue captured within staples deployed from a staple cartridge. Referring to FIG. 4, a staple cartridge, such as staple cartridge 10000, for example, can be utilized with the surgical stapling and severing instrument 8010 and can include a rigid first portion, such as support portion 10010, for example, and a compressible second portion, such as tissue thickness compensator 10020, for example. The support portion 10010 can comprise a cartridge body and a plurality of staple cavities 10012. A staple 10030, for example, can be removably positioned in each staple cavity 10012. Referring primarily to FIGS. 4 and 5, each staple 10030 can comprise a base 10031 and one or more legs 10032 extending from the base 10031. Prior to the staples 10030 being deployed, the bases 10031 of the staples 10030 can be supported by staple drivers positioned within the support portion 10010 and, concurrently, the legs 10032 of the staples 10030 can be at least partially contained within the staple cavities 10012.


In various circumstances, the staples 10030 can be deployed between an unfired position and a fired position such that the legs 10032 move through the tissue thickness compensator 10020, penetrate through a top surface of the tissue thickness compensator 10020, penetrate the tissue T, and contact an anvil positioned opposite the staple cartridge 10000. As the legs 10032 are deformed against the anvil, the legs 10032 of each staple 10030 can capture a portion of the tissue thickness compensator 10020 and a portion of the tissue T within each staple 10030 and apply a compressive force to the tissue. Further to the above, the legs 10032 of each staple 10030 can be deformed downwardly toward the base 10031 of the staple to form a staple entrapment area in which the tissue T and the tissue thickness compensator 10020 can be captured. In various circumstances, the staple entrapment area can be defined between the inner surfaces of the deformed legs 10032 and the inner surface of the base 10031. The size of the entrapment area for a staple can depend on several factors such as the length of the legs, the diameter of the legs, the width of the base, and/or the extent in which the legs are deformed, for example.


In use, further to the above and referring primarily to FIG. 4, an anvil, such as anvil 8014 of the surgical stapling and severing instrument 8010, can be moved into a closed position opposite the staple cartridge 10000 by depressing the closure trigger 8026 to advance the E-beam 9102. The anvil 8014 can position tissue against the tissue thickness compensator 10020 and, in various circumstances, compress the tissue thickness compensator 10020 against the support portion 10010, for example. Once the anvil 8014 has been suitably positioned, the staples 10030 can be deployed, as also illustrated in FIG. 4.


In various circumstances, as mentioned above, a staple-firing sled 10050, which is similar in many respects to the sled 9126 (See FIG. 3), can be moved from a proximal end of the staple cartridge 10000 toward a distal end 10002, as illustrated in FIG. 5. As the firing assembly 9090 is advanced, the sled 10050 can contact the staple drivers 10040 and lift the staple drivers 10040 upwardly within the staple cavities 10012. In at least one example, the sled 10050 and the staple drivers 10040 can each comprise one or more ramps, or inclined surfaces, which can co-operate to move the staple drivers 10040 upwardly from their unfired positions. As the staple drivers 10040 are lifted upwardly within their respective staple cavities 10012, the staple drivers 10040 can lift the staples 10030 upwardly such that the staples 10030 can emerge from their staple cavities 10012. In various circumstances, the sled 10050 can move several staples upwardly at the same time as part of a firing sequence.


Referring to FIG. 5, the staple legs 10032 of the staples 10030 can extend into the compensator 10020 beyond the support portion 10010 when the staples 10030 are in their unfired positions. In various circumstances, the tips of the staple legs 10032, or any other portion of the staple legs 10032, may not protrude through a top tissue-contacting surface 10021 of the tissue thickness compensator 10020 when the staples 10030 are in their unfired positions. In certain circumstances, the tips of the staple legs 10032 can comprise sharp tips which can incise and penetrate the tissue thickness compensator 10020.


Referring to FIG. 6, a staple cartridge assembly 10 is illustrated. The staple cartridge assembly 10 includes a staple cartridge 12 which can be used with the surgical stapling and severing instrument 8010. The staple cartridge 12 is similar in many respects to the staple cartridge 10000. Like the staple cartridge 10000, the staple cartridge 12 includes a plurality of staples 10030 which are housed in a plurality of cavities or pockets defined in the staple cartridge 12. Also, the plurality of staples 10030 of the staple cartridge 12 can be deployed in a firing sequence of the surgical stapling and severing instrument 8010.


The staple cartridge 12 further includes a cartridge deck 16 and a knife slot 37 (FIGS. 14 and 16) that accommodates the cutting edge 9116 as it is advanced to cut tissue captured by the surgical stapling and severing instrument 8010. Advancement of the sled 10050 through the staple cartridge 12 causes the staples 10030 of staple cartridge 12 to be deployed from their respective pockets into tissue in the same, or substantially the same, manner that the staples 10030 are deployed from the staple cartridge 10000, as described above.


Referring again to FIG. 6, the staple cartridge assembly 10 further includes a tissue thickness compensator or compressible adjunct 11 which is similar in many respects to the tissue thickness compensator 10020. The compressible adjunct 11 is positioned against the cartridge deck 16. The compressible adjunct 11 is attached to the cartridge deck 16. For example, the compressible adjunct 11 can be partially melted onto the cartridge deck 16 then resolidified by cooling which causes the compressible adjunct 11 to bond to the cartridge deck 16. Various attachment features can also be employed to attach the compressible adjunct 11 to the cartridge deck 16.


The compressible adjunct 11 includes a first biocompatible layer 14 which is configured to be positioned against and/or attached to the cartridge deck 16 and, in addition, a second biocompatible layer 15 which is configured to be positioned against tissue captured between the anvil 8014 and the staple cartridge 12. The first biocompatible layer 14 and the second biocompatible layer 15 are spaced apart by a plurality of supporting members or pillars 19 extending or standing between the first biocompatible layer 14 and the second biocompatible layer 15, as illustrated in FIG. 6. The pillars 19 maintain an average distance between the first biocompatible layer 14 and the second biocompatible layer 15 defined in part by an average height (H) of the pillars 19.


As illustrated in FIG. 6, the pillars 19 have the same, or at least substantially the same, height (H). Alternatively, in certain instances, the pillars 19 may have different heights. Furthermore, as illustrated in FIG. 6, the pillars 19 have the same, or at least substantially the same, transverse cross-sectional area. Alternatively, the pillars 19 may have different transverse cross-sectional areas. In at least one instance, the transverse cross-sectional areas of a pillar 19 may vary along the height (H) of the pillar 19. For example, a pillar 19 may have a wide intermediate section and narrow end sections. Alternatively, a pillar 19 may have a narrow intermediate section and wide end sections. Alternatively, a pillar 19 may have a wide intermediate section, one wide end section, and one narrow end section. Alternatively, a pillar 19 may have a narrow intermediate section, one narrow end section, and one wide end section.


As illustrated in FIG. 6, the pillars 19 have circular, or at least substantially circular, transverse cross-sectional areas. Alternatively, one or more of the pillars 19 may have non-circular transverse cross-sectional areas. In at least one example, one or more of the pillars 19 may have an oval-shaped, a clover-shaped, a crescent-shaped, or a triangular-shaped transverse cross-sectional area. Other shapes of the transverse cross-sectional areas of the pillars 19 are contemplated by the present disclosure.


Generally, the material composition, the height, and/or the transverse cross-sectional area of a pillar 19 control, at least in part, its stiffness or ability to bend under compression which, in turn, controls, at least in part, the compressibility of the compressible adjunct 11. Accordingly, the pillars 19 can be configured to tune the compressibility of the compressible adjunct 11 to one or more desired values. Various sections of a compressible adjunct 11 may have pillars 19 with different stiff nesses or compressibilities, for example.


The pillars 19 are bendable under compression applied to the compressible adjunct 11 as an anvil 8014 is moved into a closed position opposite the staple cartridge 12. The resilience of the pillars 19 permits the compressible adjunct 11 to accommodate tissue (T) with tissue portions having different tissue thicknesses while maintaining the same, or at least substantially the same, average distance between the anvil 8014 and the staple cartridge 12 during a firing sequence of the surgical stapling and severing instrument 8010.


As illustrated in FIG. 6A, a staple 10030 is fired into a compressible adjunct 11 and tissue (T) comprising a first tissue portion 72 with an average tissue thickness (T1) and a second tissue portion 74 with an average tissue thickness (T2) greater than the tissue thickness (T1). The fired staple 10030 defines a space therein for accommodating the captured compressible adjunct 11 and the captured tissue (T). The space defined by the fired staple 10030 is limited, at least in part, by a height (H3) of the fired staple 10030, as illustrated in FIG. 6A. The sum of the final thickness of the captured tissue (T) and final height of the collapsed compressible adjunct 11 is equal, or at least substantially equal, to the height (H3) of the fired staple 10030. To compensate for the variability in the thickness of the captured tissue (T), the portion of the compressible adjunct 11 positioned against the second tissue portion (T2) is compressed to a final height (H2) which is greater than a final height (H1) of the portion of the compressible adjunct 11 positioned against the first tissue portion (T1). The resilience of the pillars 19 permits the compressible adjunct 11 to be compressed to a greater degree against the second tissue portion 74 than the first tissue portion 72, which permits the compressible adjunct 11 to compensate for the different thicknesses of the tissue portions 72 and 74 within the space defined by the fired staples 10030.


As the anvil 8014 is moved toward its closed position, the anvil 8014 can contact tissue T and apply a compressive force to the tissue T and the compressible adjunct 11. The material composition, porosity, frequency, size, and/or orientation of the pillars 19 can be tailored to control or tune the compressibility of the compressible adjunct 11.


In certain instances, the pillars 19 can be angled or slanted to favor an organized collapse in a first direction such as, for example, a proximal direction (P) in response to the compressive forces. In other instances, however, the pillars 19 can be angled or slanted to favor an organized collapse in a second direction different from the first direction such as, for example, a distal direction (D) in response to the compressive forces. In certain instances, a compressible adjunct 11 may include a first group of the pillars 19 that are angled or slanted to favor bending in a first direction and a second group of the pillars 19 that are angled or slanted to favor bending in a second direction different from the first direction. In such instances, the different bending directions may cause the compressible adjunct 11 to bend in a disorganized manner.


Referring to FIG. 6, the pillars 19 are oriented such that each pillar 19 extends, or at least substantially extends, along a transverse axis intersecting the first biocompatible layer 14 and the second biocompatible layer 15. The pillars 19 are perpendicular, or at least substantially perpendicular, to the first biocompatible layer 14 and the second biocompatible layer 15. Accordingly, the pillars 19 extend in parallel, or at least substantially in parallel, with one another. As illustrated in FIG. 6, the pillars 19 are spaced apart from one another and are arranged in parallel rows.


In certain instances, the pillars 19 are angled or oriented diagonally with respect to the first biocompatible layer 14 and/or the second biocompatible layer 15. In certain instances, the pillars 19 are organized in a predefined pattern such as, for example, in concentric circles. The frequency of the pillars 19 within a certain section of the compressible adjunct 11 can affect, among other things, the compressibility of such section. In certain instances, the pillars can be strategically concentrated in certain sections of the compressible adjunct 11 to provide greater column strength in such sections, for example. In at least one instance, the pillars 19 can be concentrated in sections of the compressible adjunct 11 that are configured to receive staples when the surgical stapling and severing instrument 8010 is fired. Alternatively, the pillars 19 can be concentrated in sections of the compressible adjunct 11 that do not receive staples when the surgical stapling and severing instrument 8010 is fired. In certain instances, the pillars 19 are arranged about an outer perimeter thereby defining side walls of the compressible adjunct 11, as illustrated in FIG. 6.


Each of the pillars 19 includes an intermediate standing portion 22 extending between a first end portion 18 secured to the first biocompatible layer 14 and a second end portion 20 secured to the second biocompatible layer 15. The end portions 18 and 20 can be embedded into the first biocompatible layer 14 and the second biocompatible layer 15, respectively. For example, the end portions 18 and 20 can be knitted or woven into the first biocompatible layer 14 and the second biocompatible layer 15, respectively. In certain instances, the end portions 18 and 20 can be welded onto the first biocompatible layer 14 and the second biocompatible layer 15, respectively, with heat or solvents. In certain instances, the end portions 18 and 20 can be glued, hooked, an/or fastened to the first biocompatible layer 14 and the second biocompatible layer 15, respectively,


As illustrated in FIG. 6, The first biocompatible layer 14 and the second biocompatible layer 15 are woven layers. In certain instances, the first biocompatible layer 14 and/or the second biocompatible layer 15 can be knitted layers. In certain instances, the first biocompatible layer 14 and/or the second biocompatible layer 15 can be foam layers. In certain instances, the first biocompatible layer 14 and/or the second biocompatible layer 15 can be film layers.


Referring to FIG. 6B, a compressible adjunct 61 is stapled with a tissue (T). The compressible adjunct 61 includes a first biocompatible layer 64 which is configured to be positioned against and/or attached to a cartridge deck 16 of a staple cartridge 12. Looping members 69 protrude from the first biocompatible layer 64. The looping members 69 are directly positioned against the tissue captured between an anvil 8014 and the staple cartridge 12. Alternatively, the compressible adjunct 61 may include a second biocompatible layer is present, and the looping members 69 may maintain an average distance or separation between the biocompatible layers. In other words, the looping members 69 may lift or raise the second biocompatible layer over the first biocompatible layer 64.


The first biocompatible layer 64 and/or the second biocompatible layer can be woven layers. In certain instances, the first biocompatible layer 64 and/or the second biocompatible layer can be knitted layers. In certain instances, the first biocompatible layer 64 and/or the second biocompatible layer can be foam layers. In certain instances, the first biocompatible layer 64 and/or the second biocompatible layer can be film layers. One or more elongate flexible members such as, for example, monofilament and/or multifilament fibers can be used to form one or more looping members 69 by various techniques such as, for example, weaving and/or knitting. In at least one instance, an elongate flexible member can be threaded into the first biocompatible layer 64 to form a looping member 69, for example.


As illustrated in FIG. 6B, a looping member 69 includes a first end portion 69a, a second end portion 69b, and an intermediate curved portion 69c that extends between the first end portion 69a and the second end portion 69b. The end portions 69a and 69b are partially embedded and/or attached to the first biocompatible layer 64 while the intermediate curved portion 69c is lifted away or spaced apart from the first biocompatible layer 64 by the first end portion 69a and the second end portion 69b. The looping members 69 may have the same, or at least substantially the same, height. Alternatively, in certain instances, the looping members 69 may have different heights.


When the second biocompatible layer is present, the looping members 69 can be positioned between the first biocompatible layer 64 and the second biocompatible layer, and the intermediate curved portions 69c can be attached to the second biocompatible layer, for example. Various attachment techniques can be employed to secure the second biocompatible layer to the intermediate curved portions 69c such as, for example, using biocompatible glue. In certain instances, the intermediate curved portions 69c can be stitched with the second biocompatible layer.


As illustrated in FIG. 6B, the first biocompatible layer 64 comprises tethering islands 62 that are spaced apart from one another. The tethering islands 62 are arranged in parallel, or at least substantially parallel, rows. Each tethering island 62 is defined by a first end portion 69a and a second end portion 69b of a looping member 69 that intersect at that tethering island 62. In certain instances, the end portions 69a and 69b of a looping member 69 can be received by two tethering islands 62 that are spaced apart from one another, for example. In certain instances, only a single end portion 69a or 69b is received a tethering island 62, for example. Alternatively, a tethering island 62 can be configured to receive three or more of the end portions 69a and/or 69b, for example. A tethering island 62 can be configured to receive one or more of the end portions 69a but none of the end portions 69b, for example.


Further to the above, one or more of the looping members 69 includes a narrow neck portion 63a extending from a tethering island 62 and a wide head portion 63b extending from the narrow neck portion 63a. In certain instances, the head portions 63b can be positioned against the second biocompatible layer. Alternatively, the head portions 63b can be positioned against tissue (T).


As illustrated in FIG. 6B, the looping members 69 protrude from the first biocompatible layer 64 in a generally vertical direction, which causes the looping members 69 to bend in a disorganized manner in response to compressive forces transmitted through tissue (T) that is positioned against the compressible adjunct 61. In certain instances, the looping members 69 can be angled or slanted to favor an organized collapse in a first direction such as, for example, a proximal direction (P) in response to the compressive forces. In other instances, however, the looping members 69 can be angled or slanted to favor an organized collapse in a second direction different from the first direction such as, for example, a distal direction (D) in response to the compressive forces. In certain instances, a compressible adjunct 61 may include a first group of the looping members 69 that are angled or slanted to favor bending in a first direction, and a second group of the looping members 69 that are angled or slanted to favor bending in a second direction different from the first direction. In such instances, the different bending directions may cause the compressible adjunct 69 to bend in a disorganized manner.


Referring to FIG. 7, a compressible adjunct 31 includes a first biocompatible layer 34 and a second biocompatible layer 35 that are perforated film layers, as described below in greater detail. The compressible adjunct 31 is similar in many respects to the compressible adjunct 11. For example, the compressible adjunct 31 comprises a plurality of pillars 39 which are similar in many respects to the pillars 19 of the compressible adjunct 11. Unlike the pillars 19, the pillars 39 are not arranged in parallel rows. The pillars 39 are configured to cross one another which can improve the stability of the compressible adjunct 31 by increasing resistance to collapsing under shear loads and/or compressive loads.


As illustrated in FIG. 7, a pillar 39a is configured to cross a pillar 39b. A first end portion 38a of the pillar 39a is aligned with a second end portion 40b of the pillar 39b such that a first transverse axis defined by the first end portion 38a and the second end portion 40b is perpendicular to the biocompatible layer 34 and a second biocompatible layer 35. Also, a first end portion 38b of the pillar 39b is aligned with a second end portion 40a of the pillar 39a such that a second transverse axis defined by the first end portion 38b and the second end portion 40a is perpendicular to the biocompatible layer 34 and a second biocompatible layer 35. Furthermore, intermediate portions 42a and 42b of the pillars 39a and 39b, respectively, can be attached to one another such as, for example, by welding. Alternatively, the intermediate portions 42a and 42b can be allowed to move freely relative to one another.


In a different arrangement, certain pillars 39 can be configured to share a bonding node or interface. As illustrated in FIG. 7, a pillar 39c and a pillar 39d are attached to the first biocompatible layer 34 at a bonding node 44. The pillars 39c and 39d extend from the bonding node 44 in different directions terminating at two different bonding nodes 46 and 48 on the second biocompatible layer 35. In addition, a pillar 39e extends from the bonding node 48 terminating at a bonding node 49 on the first biocompatible layer 34. Repetition of the arrangement of pillars 39c-39e between the biocompatible layers 34 and 35 can yield a zig-zag pattern therebetween. It should be understood that three or more pillars 39 may extend or emerge from one bonding node.


Further to the above, the perforated films of the biocompatible layers 34 and 35 can be produced by punching holes 50 in the films. The holes 50 may improve tissue ingrowth into the compressible adjunct 31. In certain instances, the holes 50 are created after the films are prepared. For example, a solvent or heat can be employed to remove sections of the films to create the holes 50. In other instances, the films can be prepared with the holes 50 using a mold, for example. As illustrated in FIG. 7, the holes 50 are arranged in rows. In addition, the holes 50 of the first biocompatible layer 34 are aligned with the holes 50 of the second biocompatible layer 35 to provide a path for the tissue growth through the compressible adjunct 31. Alternatively, the holes 50 can be randomly positioned. In at least one instance, the holes 50 are present in only one of the biocompatible layers 34 and 35.


Referring to FIG. 8, a compressible adjunct 51 includes a first biocompatible layer 54 and a second biocompatible layer 55 that are spaced apart from one another by a plurality of support or standing pillars or fibers 59. The compressible adjunct 51 is similar in many respects to the compressible adjuncts 11 and 31. For example, the compressible adjunct 51 can be positioned against the cartridge deck 16 of the staple cartridge 12, as illustrated in FIG. 8. The compressible adjunct 51 comprises a weft knitted double fabric. In certain instances, the compressible adjunct 51 comprises two inter-looping sets of fibers that are configured to yield two tethered layers.


The compressible adjunct 51 includes a plurality of loops 66 running in parallel, or at least substantially in parallel, rows. Each loop 66 is positioned or starts at one of the biocompatible layers 54 and 55 and defines two standing fibers 59 that extend toward the other one of the biocompatible layers 54 and 55. The standing fibers 59 are angled or slanted to favor an organized collapse in a first direction such as, for example, a proximal direction (P) in response to compressive forces applied to the second biocompatible layer 55 through tissue (T) positioned against the second biocompatible layer 55. Alternatively, the standing fibers 59 can be angled or slanted to favor an organized collapse in a second direction opposite the first direction such as, for example, a distal direction (D) in response to the compressive forces. Alternatively, a compressible adjunct may include a first group of the standing fibers 59 that are angled or slanted to favor bending in the first direction and a second group of the standing fibers 59 that are angled or slanted to favor bending in the second direction. The different bending directions may cause the compressible adjunct 51 to bend in a disorganized manner.


As illustrated in FIG. 8, a first loop 66a originating in the second biocompatible layer 55 defines a first pair of standing fibers 59a extending from the second biocompatible layer 55 toward the first biocompatible layer 54. The first loop 66a holds a second pair of standing fibers 59b defined by a second loop 66b also originating in the second biocompatible layer 55. The second loop 66b is positioned at a distal location with respect to the first loop 66a. The second pair of standing fibers 59b also extends toward the first biocompatible layer 54. The described pattern is repeated at regular intervals. Likewise, similar loops 66 originating in the first biocompatible layer 54 define pairs of standing fibers 59 that extend from the first biocompatible layer 54 toward the second biocompatible layer 55.


The spacing between two consecutive pairs of standing fibers 59 can be increased or decreased to increase or decrease, respectively, the compressibility of the compressible adjunct 51. Generally, a greater number of standing fibers 59 at a certain section of the compressible adjunct 51 corresponds to a greater stability of that section of the compressible adjunct 51 under compressive forces.


The loops 66 of the first biocompatible layer 54 are arranged in parallel, or at least substantially parallel, rows 57a and the loops 66 of the second biocompatible layer 55 are arranged in parallel, or at least substantially parallel, rows 57b which are spaced apart from the rows 57a.


Referring to FIG. 9, a staple 10030 is fired into a compressible adjunct 51 and a tissue (T) comprising a first tissue portion 72 with an average tissue thickness (T1) and a second tissue portion 74 with an average tissue thickness (T2) greater than the tissue thickness (T1). The fired staple 10030 defines a space therein for accommodating the captured compressible adjunct 51 and the captured tissue (T). The space defined by the fired staple 10030 is limited, at least in part, by a height (H3) of the fired staple 10030, as illustrated in FIG. 9. The sum of the final thickness of the captured tissue (T) and final height of the collapsed compressible adjunct 51 is equal, or at least substantially equal, to the height (H3) of the fired staple 10030. To compensate for the variability in the thickness of the captured tissue (T), the portion of the compressible adjunct 51 positioned against the second tissue portion (T2) is compressed to a final height (H2) greater than a final height (H1) of the portion of the compressible adjunct 51 positioned against the first tissue portion (T1). The resilience of the standing fibers 59 permits the compressible adjunct 51 to be compressed to a greater degree against the second tissue portion 74 than the first tissue portion 72, which permits the compressible adjunct 51 to compensate for the different thicknesses of the tissue portions 72 and 74 within the space defined by the fired staples 10030. The material composition, porosity, frequency, size, and/or orientation of the standing fibers 59 can be tailored to control or tune the compressibility of the compressible adjunct 51.


Referring to FIGS. 10-12, various compressible adjuncts are positioned against the cartridge deck 16 of the staple cartridge 12. The compressible adjuncts of FIGS. 10-12 are similar in many respects to the compressible adjuncts 11, 31, and 51. The compressible adjuncts of FIGS. 10-12 are further characterized by bonding nodes or interfaces that are interconnected by one or more standing fibers. For example, as illustrated in FIG. 10, a compressible adjunct 81 includes a first series of bonding nodes 84a-84e defined in a first biocompatible layer 84 and a second series of bonding nodes 85a-85e defined in a second biocompatible layer 85 spaced apart from the first biocompatible layer 84. Spacer or standing fibers 89 extend from the first series of bonding nodes 84a-84e and/or the second series of bonding nodes 85a-85e.


The bonding nodes 84a-84e are vertically aligned, or at least substantially aligned, with corresponding bonding nodes 85a-85e. Moreover, the bonding nodes 84a-84e and the bonding nodes 85a-85e are arranged, or at least substantially arranged, in corresponding rows 102 and 103, respectively. Although only one row of bonding nodes is shown in each of the biocompatible layers 84 and 85, the biocompatible layer 84 and/or 85 may each include multiple rows of bonding nodes or interfaces.


As illustrated in FIG. 10, the standing fibers 89 may include a first group of standing fibers 89a and a second group of standing fibers 89b that are interlaced to form a mesh like structure. The standing fibers 89a generally follow parallel, or at least substantially parallel, paths that are angled or slanted in a proximal direction (P) with respect to a vertical axis. On the other hand, the standing fibers 89b generally follow parallel, or at least substantially parallel, paths that are angled or slanted in a distal direction (D) with respect to the vertical axis.


An angle α is defined between the fibers 89a and 89b extending from the a bonding node such as, for example, the bonding node 85e. The angle α is any angle in a range of about 100 to about 160°, for example. In certain instances, the angle α is any angle in a range of about 450 to about 135°, for example. In certain instances, the angle α is any angle in a range of about 600 to about 110°, for example.


As illustrated in FIG. 10, a standing fiber 89b extends in the proximal direction (P) from the bonding node 85a to the bonding node 84d. In other words, the standing fiber 89b connects a bonding node at a first position in the row 102 with a bonding node at a fourth position in the row 103. As a result, the standing fiber 89b crosses four of the standing fibers 89a. In certain instances, the standing fiber 89b can be attached to one or more of the four standing fibers 89a crossed by the standing fiber 89b.


Furthermore, a standing fiber 89a extends in the distal direction (D) from the bonding node 85e to the bonding node 84b. In other words, the standing fiber 89a connects a bonding node at a fifth position in the row 103 with a bonding node at a second position in the row 102. As a result, the standing fiber 89a crosses four of the standing fibers 89b. In certain instances, the standing fiber 89a can be attached to one or more of the four standing fibers 89b crossed by the standing fiber 89a. Crossing the standing fibers 89a and 89b improves the stability of the compressible adjunct 81 under compressive and/or shear forces.


In certain instances, a standing fiber may extend between a bonding node at a first position in a row of bonding nodes on a biocompatible layer and a bonding node at a second position in a row of bonding nodes on a different biocompatible layer. In certain instances, a standing fiber may extend between a bonding node at a first position in a row of bonding nodes on a biocompatible layer and a bonding node at a third position in a row of bonding nodes on a different biocompatible layer. In certain instances, a standing fiber may extend between a bonding node at a first position in a row of bonding nodes on a biocompatible layer and a bonding node at a fifth position in a row of bonding nodes on a different biocompatible layer. Various bonding nodes at various other positions can be connected by the standing fibers 89. In various instances, increasing the distances between the interconnected bonding nodes decreases stiffness of a compressible adjunct 81.


Referring to FIG. 12, the bonding nodes 81 of the biocompatible layer 85 are interconnected via bridging members 92 that extend between the bonding nodes of the biocompatible layer 85. As illustrated in FIG. 12, a bridging member 92 extends between the bonding nodes 85a and 85b. Another bridging member 92 extends between the bonding nodes 85b and 85c. Additional bridging member 92 may extend between various bonding nodes in the same row or different rows of the biocompatible layer 85.


In certain instances, the bonding nodes of at least one of the biocompatible layers 84 and 85 are interconnected via the bridging members 92. In certain instances, the bonding nodes of at least one of the biocompatible layers 84 and 85 are disconnected from one another. As illustrated in FIG. 10, the bonding nodes 84a-84e of the first biocompatible layer 84 are not directly connected to one another.


Referring to FIG. 12, a compressible adjunct 81′ is depicted. The compressible adjunct 81′ is similar in many respects to the compressible adjunct 81. In addition, each pair of vertically aligned bonding nodes of the biocompatible layers 84 and 85 is connected by a pair of standing fibers 94. For example, a pair of standing fibers 94 extends between the bonding node 85a and the bonding node 84a. The standing fibers 94 improve the stability of the compressible adjunct 81′ under compressive and/or shear forces. In certain instances, only one standing fiber 94 extends between the vertically aligned bonding nodes of the biocompatible layers 84 and 85. In certain instances, three or more standing fibers 94 extend between the vertically aligned bonding nodes of the biocompatible layers 84 and 85.


Referring to FIG. 11, a compressible adjunct 100 is depicted. The compressible adjunct 100 is similar in many respects to the compressible adjuncts 81 and 81′. For example, the compressible adjunct 100 includes a first biocompatible layer 84′, which includes bonding nodes 84a and 84b, and a second biocompatible layer 85′, which includes connected bonding nodes 85a and 85b; however, the first biocompatible layer 84′ is offset with the second biocompatible layer 85′ such that the bonding nodes 84a and 84b of the first biocompatible layer 84′ are not vertically aligned with the bonding nodes 85a and 85b of the second biocompatible layer 85′. In an alternative embodiment, however, bonding nodes of the first biocompatible layer 84′ and corresponding bonding nodes of the second biocompatible layer 85′ can be vertically aligned.


As illustrated in FIG. 11, the offset between the first biocompatible layer 84′ and the second biocompatible layer 85′ causes standing fibers 94′, which extend between the bonding nodes 84a and 84b and the bonding nodes 85a 85b, to be angled or slanted to favor bending in a predetermined direction. For example, in the embodiment illustrated in FIG. 11, the first biocompatible layer 84′ lags behind the second biocompatible layer 85′ which causes the bonding node 85a, for example, to be ahead of the bonding node 84a. In result, the standing fibers 94′ extending between the bonding nodes 85a and 84a favor bending in a distal direction (D). The standing fibers 94′ extending between the bonding nodes 84b and 85b are also slanted or angled to favor bending in the distal direction (D). In an alternative embodiment, the standing fibers 94′ can be oriented to favor bending in a proximal direction (P). The pattern is repeated such that the pairs of standing fibers are parallel, or at least substantially, parallel to one another. In at least one embodiment, one or more of the standing fibers 94′ is oriented to favor bending the proximal direction (P) and one or more of the standing fibers 94′ is oriented to favor bending in the distal direction (D). The bending direction of the standing fiber 94′ can be chosen based, in part, on the type, position, and orientation of the treated tissue (T).


Referring again to FIGS. 10 and 12, the outer surfaces of the biocompatible layers 84 and 85 can be tailored to accommodate various staple cartridge decks and tissue surfaces. For example, as illustrated in FIGS. 10-12, the bonding nodes or interfaces of the biocompatible layer 84 are not directly connected to one another, which allows the biocompatible layer 84 additional flexibility to accommodate a stepped cartridge deck, for example. In certain instances, the standing fibers of a compressible adjunct may extend beyond a biocompatible layer to modify an outer surface of the biocompatible layer.


Referring to FIGS. 13 and 14, a compressible adjunct 110 is similar in many respects to the compressible adjuncts 11, 31, 51, 81, 81′, and 100. For example, the compressible adjunct 110 can be positioned against the cartridge deck 16 of the staple cartridge 12. Also, the compressible adjunct 110 includes a first biocompatible layer 114, a second biocompatible layer 115, and spacer or standing fibers 119 that are similar in many respects to the compressible layer 84, the compressible layer 85, and the standing fibers 89, respectively.


The standing fibers 119 are configured to provide structural support for the compressible adjunct 110. Adjacent fiber portions 119a and 119b are configured to cross one another, as illustrated in FIG. 13, to increase the stability of the compressible adjunct 110. Applying Compressive forces to the compressible adjunct 110 may cause the fiber portions 119a and 119b to bend and/or shift relative to one another.


As illustrated in FIG. 13-16, the compressible adjuncts 110 and 130 include building blocks 111 that are positioned at an outer perimeter of the compressible adjunct 110 and/or, in certain instances, at various other central positions. A building block 111 of the compressible adjunct 110 includes a pair of fiber portions 119a that is configured to cross a pair of fiber portions 119b at a plane defined at an intermediate distance between the compressible layers 114 and 115. In addition, four fiber portions 122 define four corners of the building block 111. Each of the four fiber portions 122 extends, or at least substantially extends, along a vertical axis transecting the biocompatible layers 114 and 115. In certain instances, the building blocks 111 do not include vertical fiber portions. Adjacent building blocks 111 share common fiber portions 122.


As illustrated in FIG. 13, Crossing fiber portions 119a and 119b define an angle β which can be any angle in a range of about 10° to about 170°, for example. In certain instances, the angle β can be any angle in a range of about 30° to about 100°, for example. In certain instances, the angle β can be any angle in a range of about 50° to about 70°, for example.


The standing fibers 119 of the compressible adjunct 110 further define gripping features that protrude from the first biocompatible layer 114. The gripping features can be in the form of traction loops 120. As illustrated in FIG. 13, two fiber portions 119a and 119b intersect at a bonding node or interface 105 at an inner surface 116 of the first biocompatible layer 114, and then extend through the first biocompatible layer 114 to form a loop 120 onto an outer surface 118 of the first biocompatible layer 114. A fiber 119 can be passed through the first biocompatible layer 114 to form several loops 120. Alternatively, the loops 120 can be formed onto the outer surface 118 independently of the fiber 119. For example, another fiber can be employed to form the loops 120 onto the first biocompatible layer 114. As illustrated in FIG. 13, the loops 120 are aligned with the bonding nodes or interfaces 105. Alternatively, in certain instances, the loops 120 are not be aligned with the bonding nodes 105.


As illustrated in FIG. 13, the loops 120 are spaced apart and arranged in rows 123. The loops 120 can be positioned at an outer perimeter of the biocompatible layer 114 and/or, in certain instances, at various other positions on the first biocompatible layer 114 to provide traction against a cartridge deck 16 of a staple cartridge 12.


The frequency, position, arrangement, and/or size of the loops 120 at a particular section of the first biocompatible layer 114 can be controlled to achieve a desired degree of traction against the cartridge deck 16 at that section of the first biocompatible layer 114. For example, if additional traction against the cartridge deck 16 is desired at a proximal portion of the first biocompatible layer 114, a greater number of the traction loops 120 can be formed onto the proximal portion of the outer surface 118 of the first biocompatible layer 114 in comparison to the remainder of the outer surface 118.


In addition, the cartridge deck may also include attachment means for releasably holding the traction loops 120 to improve the traction between the compressible adjunct 110 and the cartridge deck 16, for example. Moreover, the first biocompatible layer 114 may be designed to include especially dense section(s) for thermoforming or bonding to the cartridge deck 16.


Like the first biocompatible layer 114, the second biocompatible layer 115 can also include gripping features for providing traction against tissue. For example, as illustrated in FIGS. 15 and 16, a compressible adjunct 130 includes traction loops 140 that are similar in many respects to the traction loops 120. The traction loops 140 are positioned onto an outer surface 138 of a second biocompatible layer 115. Alternatively, the outer surface 138 of the second biocompatible layer 115 can be smooth, or at least substantially smooth, and/or treated to minimize tissue ingrowth and/or adhesion.


In various instances, the gripping features of the biocompatible layers 114 and 115, including the loops 120 and 140, can be knitted or woven directly onto the biocompatible layers 114 and 115, respectively. In at least one instance, the first biocompatible layer 114 and/or the second biocompatible layer 115 may include satin-type weaves with exposed threads that are longer in a first direction and shorter in a second direction crossing the first direction. The satin-type weaves can increase traction by resisting flow in the second direction. In various instances, the biocompatible layers 114 and 115 can be knitted from one or more multifilament fibers while the standing fibers 119 comprise monofilament fibers. The monofilament fibers 119 can be extended beyond the biocompatible layers 114 and 115 to form the loops 120 and 140. The extensions of the standing fibers 119 can be looped between the courses of the knitting pattern of the biocompatible layers 114 and 115, for example.


In various instances, the gripping features of the biocompatible layers 114 and 115, including the loops 120 and 140, can be angled or slanted to improve traction in a predetermined direction. For example, as illustrated in FIGS. 15 and 16, the loops 140 are slightly angled or slanted in a proximal direction (P) to resist flow of adjacent tissue in a distal direction (D). In an alternative embodiment, the loops 140 can be slightly angled or slanted in the distal direction (D) to resist flow of adjacent tissue in the proximal direction (P). In certain instances, some of the loops 140 can angled or slanted in the proximal direction (P) and some of the loops 140 can be angled or slanted in the distal direction (D). In various instances, increasing the height of a loop 140 increases its resistance to the flow of adjacent tissue.


Referring to FIGS. 14 and 16, a knife channel or slot 137 is defined in the body of each of the compressible adjuncts 110 and 130. When the compressible adjunct 110 and 114 are positioned against a staple cartridge 12, the knife slot 137 is aligned, or at least substantially aligned, with a knife slot 37 that is defined in the staple cartridge 12. The knife slots 37 and 137 are configured to accommodate the cutting edge 9116 as it is advanced to cut tissue captured by the surgical stapling and severing instrument 8010.


A compressible adjunct such as, for example, the compressible adjuncts 110 and/or 130 can be fabricated with a knife slot 137. For example, the knife slot 137 can be woven or knitted as a locally thin area with a reduced fiber density in the body of a compressible adjunct. Alternatively, the knife slot 137 can be created in a compressible adjunct after fabrication. For example, the knife slot 137 can be cut into a compressible adjunct using a solvent, a heat operation, a die cutting operation, a laser cutting operation, an ultrasonic cutting operation, or a combination of these techniques. The knife slot 137 helps to minimize the resistance of the compressible adjunct to the advancement of the cutting edge 9116 which, among other things, can improve the life of the cutting edge 9116 and/or reduce the force required to advance the cutting edge 9116.


In certain instances, the knife slot 137 may separate a compressible adjunct into two completely separate portions. Alternatively, as illustrated in FIGS. 17 and 18, a knife slot 137 extending between two portions 150a and 150b of a compressible adjunct 150 can be interrupted by one or more bridging members 152 configured to tether the two portions 150a and 150b. Like the compressible adjuncts 110 and 130, each of the portions 150a and 150b of the compressible adjunct 150 includes a first biocompatible layer 114 positionable against a cartridge deck 16, a second biocompatible layer 115 positionable against the captured tissue, and spacer or standing fibers 179 which are similar in many respects to the standing fibers 119.


Referring to FIGS. 17-19, the standing fibers 179 are configured to provide structural support for the compressible adjunct 150. Adjacent fiber portions 179a and 179b are configured to cross one another, as illustrated in FIGS. 17-19, to increase the stability of the compressible adjunct 150 under compressive and/or shear forces. Applying compressive forces to the compressible adjunct 150 may cause the fiber portions 179a and 179b to bend and or shift relative to one another. Like the compressible adjunct 51 (FIG. 9), the compressible adjunct 150 can accommodate tissue with portions of different thicknesses.


Referring to FIG. 19, the biocompatible layers 114 and 115 of the compressible adjunct 150 extend in parallel, or at least substantially parallel, with each other. Fiber portions 179a, 179b, and 172 extend between the biocompatible layers 114 and 115 to maintain a separation between the biocompatible layers 114 and 115. The fiber portions 179a are parallel, or at least substantially parallel, to one another. A fiber 179a extends, or at least substantially extends, along an axis 171 that intersects the biocompatible layers 114 and 115 at an angle α1. Likewise, the fiber portions 179b are parallel, or at least substantially parallel, to one another. A fiber 179b extends, or at least substantially extends, along an axis 173 that intersects the biocompatible layers 114 and 115 at an angle α2. In certain instances, the angles α1 and α2 are the same, or at least substantially the same.


The angle α1 can be any angle in a range of about 10° to about 170°, for example. In certain instances, the angle α1 can be any angle in a range of about 30° to about 100°, for example. In certain instances, the angle α1 can be any angle in a range of about 50° to about 70°, for example. Other values for the angle α1 are contemplated by the present disclosure.


The angle α2 can be any angle in a range of about 10° to about 170°, for example. In certain instances, the angle α2 can be any angle in a range of about 30° to about 100°, for example. In certain instances, the angle α2 can be any angle in a range of about 50° to about 70°, for example. Other values for the angle α2 are contemplated by the present disclosure.


As illustrated in FIG. 19, the fiber portions 179a and 179b may cross one another defining a plurality of “X-shaped” structures. Bonding nodes or interfaces 175 and 178 are defined in the biocompatible layers 115 and 114, respectively, between the neighboring X-shaped structures. Ends of the fiber portions 179a and 179b intersect at the bonding nodes 175 and 178. An angle β is defined between crossing fiber portions 179a and 179b. The angle β can be any angle in a range of about 10° to about 180°, for example. In certain instances, the angle β can be any angle in a range of about 30° to about 100°, for example. In certain instances, the angle β can be any angle in a range of about 50° to about 70°, for example. In at least one instance, the angle β is equal, or at least substantially equal, to the angle α1 and/or the angle α2, for example.


Furthermore, fiber portions 172, including fiber portions 172a-172e, extend between the biocompatible layers 114 and 115. The fiber portions 172 are perpendicular, or at least substantially perpendicular, to the biocompatible layers 114 and 115. As illustrated in FIG. 19, a fiber portion 172a extends, or at least substantially extends, along an axis 177 that intersects the biocompatible layers 114 and 115 at an angle α3. The angle α3 can be any angle in a range of about 80° to about 100°, for example. In certain instances, the angle α3 can be any angle in a range of about 85° to about 95°, for example. In certain instances, the angle α3 can be any angle in a range of about 87° to about 93°, for example. Other values for the angle α3 are contemplated by the present disclosure.


Moreover, the fiber portions 172 are spaced apart from one another. The fiber portions 172 can be equidistant from one another or arranged in any other suitable configuration. As illustrated in FIG. 19, a fiber portion 172c passes through an intersection point 174 of an X-shaped structure defined by crossing fiber portions 179a and 179b. A fiber portion 172d partially passes through an intersection point 174 of an X-shaped structure defined by crossing fiber portions 179a and 179b. In certain instances, two or more fiber portions 172 can pass, or partially pass, through intersection points of X-shaped structures defined by crossing fiber portions 179a and 179b. In certain instances, bonding nodes or interfaces can be created at one or more of the intersection points 174 by using a biocompatible bonding medium such as, for example, biocompatible glue.


Referring to FIG. 19, a fiber portion 172b is positioned on a side of an X-shaped structure of crossing fiber portions 179a and 179b such that the fiber portion 172b intersects the crossing fiber portions 179a and 179b of such X-shaped structure. In certain instances, two or more fiber portions 172 can positioned like the fiber portion 172b with respect to two or more X-shaped structures.


As illustrated in FIG. 19, the bonding nodes 175 are vertically aligned, or at least substantially aligned, with the bonding nodes 178. In certain instances, fiber portions 172 may extend between the bonding nodes 175 and 178 that are vertically aligned such as, for example, the fiber portion 172e.


Referring to FIGS. 17 and 18, the bridging members 152 are severed by the cutting edge 9116 during advancement of the cutting edge 9116 to cut the tissue captured by the surgical stapling and severing instrument 8010. Alternatively, one or more of the bridging members 152 may be positioned outside the path of the cutting edge 9116, and may continue to tether the portions 150a and 150b after the surgical stapling and severing instrument 8010 is fired.


Referring to FIGS. 20-22, portions 150a and 150b of a compressible adjunct 160 are tethered via bridging members 162. As illustrated in FIG. 20, the bridging members 162 are spaced apart to provide discrete attachment means between the portions 150a and 150b along a length of the knife slot 137. One or more of the bridging members 162 can be severed by the cutting edge 9116 as it is advanced to cut tissue captured by the surgical stapling and severing instrument 8010.


As illustrated in FIGS. 21 and 22, the bridging members 162 are also configured to attach or tether the compressible adjunct 160 to a staple cartridge 12. Segments of the bridging members 162 are extended through cutouts or holes 164 in a bottom portion 17 of the staple cartridge 12 to secure the compressible adjunct 160 to the staple cartridge 12. The bridging members 162 can also passed through the knife slots 37 and 137. The bridging members 162 can be severed to release the portions 150a and 150b from each other and/or the staple cartridge 12 by shearing or cutting actions caused by the passing of the cutting edge 9116 as the cutting edge 9116 is advanced to cut tissue captured by the surgical stapling and severing instrument 8010.


As illustrated in FIGS. 21 and 22, the cutouts 164 are formed at discrete positions on opposite sides of the knife slot 37 of the staple cartridge 12. In certain instances, the bridging members 162 are in the form of sutures, for example, that are threaded through the cutouts 164 to attach the compressible adjunct 160 to the staple cartridge 12. In certain instances, the cutouts 164 can be replaced or used in combination with projections that extend from the bottom portion 17 of the staple cartridge 12. The projections can be configured to hold the segments of the bridging members 162 that attach the compressible adjunct 160 to the staple cartridge 12. Other attachment means can be formed in the staple cartridge 12 to facilitate attachment of the compressible adjunct 160 to the staple cartridge 12 by the bridging member 162.


Referring to FIG. 23, a bridging sheath 182 may extend between two portions of a compressible adjunct 180. In FIG. 23, the bridging sheath 182 has been severed by the cutting edge 9116. Only one portion 150a of the compressible adjunct 180 is shown. Also, a portion of the severed bridging sheath 182 that remained attached to the portion 150a of the compressible adjunct 180 is shown. The cutting edge 9116 is advanced through the knife slots 37 and 137 along a path defined by a longitudinal axis AA to sever the bridging sheath 182.


In certain instances, as illustrated in FIG. 23, the bridging sheath 182 is defined between the portions of the compressible adjunct 180 at the bottom of the knife slot 137. In such instances, the bridging sheath 182 can be a part of the first biocompatible layer 114 that extends between the two portions of the compressible adjunct 180. Also, in such instances, when the compressible adjunct 180 is positioned against the cartridge deck 16 of the staple cartridge 12, the bridging sheath 182 separates, or at least partially separates, the knife slot 137 of the compressible adjunct 180 and the knife slot 37 of the staple cartridge 12.


In other instances, the bridging sheath 182 is defined between the portions of the compressible adjunct 180 at the top of the knife slot 137 of the compressible adjunct 180. In such instances, the bridging sheath 182 can be a part of the second biocompatible layer 115 that extends between the two portions of the compressible adjunct 180. Also, in such instances, when the compressible adjunct 180 is positioned against the cartridge deck 16 of the staple cartridge 12, the bridging sheath 182 does not separate the knife slot 137 of the compressible adjunct 180 from the knife slot 37 of the staple cartridge 12. Instead, the knife slots 137 and 37 are positioned below the bridging sheath 182. In yet other instances, the bridging sheath 182 may extend between the portions of the compressible adjunct 180 through, or at least substantially through, a plane defined between the biocompatible layers 114 and 115 of the compressible adjunct 180, for example.


Referring again to FIG. 23, the compressible adjunct 180 can be attached to the staple cartridge 16 by tethering the bridging sheath 182 to the bottom portion 17 of the staple cartridge 16. For example, attachment means such as sutures can be threaded through the bridging sheath 182 and the cutouts 164 to tether the bridging sheath 182 to the bottom portion of the staple cartridge 12. The sutures can be severed by the cutting edge 9116, for example, to progressively release the compressible adjunct 180 from the staple cartridge 12. Attaching the compressible adjunct 180 to the staple cartridge 16 by passing the sutures only through bridging sheath 182 at the bottom of the knife slot 137 frees the remainder of the compressible adjunct 180 to be compressed without losing attachment tension in the sutures. The same can be achieved by passing the sutures only through the first biocompatible layer 114, for example.


Referring to FIGS. 24 and 25, a compressible adjunct 190 is positioned against a cartridge deck 16 of a staple cartridge 12. The compressible adjunct 190 is similar in many respects to the compressible adjuncts 11, 31, 51, 81, 81′, 100, 110, 130, 150, and/or 180. For example, the compressible adjunct 190 includes a first biocompatible layer 114, a second biocompatible layer 115, and spacer or standing fibers 199 extending between the biocompatible layers 114 and 115.


As illustrated in FIG. 24, the compressible adjunct 190 is secured to the staple cartridge 12 by securing members 191 that include bendable barbs or projections 192 protruding from an elongate support member 194. The bendable projections 192 are shaped like arrow heads that are configured to pierce into a structure with relative ease but resist removal from the structure until sufficient force is applied to bend the bendable projections 192 away from the elongate support member 194.


The bendable projections 192 are arranged on opposite end portions 195 and 196 of the elongate support member 194. In at least one example, as illustrated in FIG. 24, three bendable projections 192 are positioned on each of the opposite end portions 195 and 196. The bendable projections 192 of each of the opposite end portions 195 and 196 are spaced apart with equal distances therebetween. More or less than three bendable projections 192 can be placed on each of the opposite end portions 195 and 196. Other arrangements of the bendable projections 192 with respect to the elongate support member 194 are contemplated by the present disclosure.


Referring to FIG. 24, two securing members 191 are employed to secure at least a portion of the compressible cartridge 190 to the staple cartridge 12. More or less than two securing members 191 can be employed to secure the compressible cartridge 190 to the staple cartridge 12. As illustrated in FIG. 24, end portions 195 of the securing members 191 are inserted through the biocompatible layer 114 while end portions 196 are inserted through the cartridge deck 16 into a staple cavity 197 of the staple cartridge 12. A staple 10030 is positioned in the staple cavity 197. The deployment of the staple 10030 from the staple cavity 197 is blocked, or at least partially blocked, by the end portions 196. As the staple 10030 is deployed from the staple cavity 197, the staple 10030 pushes the end portions 196 out of the staple cavity 197 freeing the securing members 191 from the staple cartridge 12.


End portions 196 of other securing members 191 can be progressively freed from other staple cavities 197 of the staple cartridge 12 during deployment of their respective staples 10030. Since the staples 10030 are progressively released from their respective staple cavities 197 by advancement of the wedge sled 9126 (FIG. 4), a corresponding progressive release of the compressible adjunct 190 is also achieved by the advancement of the wedge sled 9126 during the firing sequence of the surgical stapling and severing instrument 8010. Essentially, a securing member 191 with an end portion 196 that is inserted into a more proximal staple cavity is released before a securing member 191 with an end portion 196 that is inserted into a more distal staple cavity.


The progressive release of the compressible adjunct 190 maintains the relative positioning between the compressible adjunct 190 and staple cartridge 12 at discrete locations on the cartridge deck 16 until the staples 10030 at such locations are fired from their respective staple cavities 197. The securing members 191 also resist bunching of the compressible adjunct 190 that may occur as the cutting edge 9116 is advanced during the firing sequence of the surgical stapling and severing instrument 8010.


Referring to FIG. 24, the securing members 191 at a staple cavity 197 extend in parallel, or at least substantially in parallel, to one another. In at least one instance, the securing members 191 at a staple cavity 197 may cross one another defining an “X” shape, for example.


Referring to FIG. 24, the most exterior bendable projections 192 on each of the opposite end portions 195 and 196 of the elongate support member 194 can define piercing tips for penetrating through a structure. The piercing tips can be especially hardened to facilitate penetration into a structure. Furthermore, the arrow head shape of the bendable projections 192 may improve the stability of the attachment between the securing members 191 and the compressible adjunct 190 by entanglement of the bendable projections 192 with the standing fibers 199, for example.


Referring to FIG. 25, an end portion 196 of an elongate support member 194 of a securing member 191 is inserted into a staple cavity 197 of the staple cartridge 12. The end portion 196 includes four bendable projections 192 that define attachment portions 192a protruding from the elongate support member 194 on a first side of the elongate support member 194 and attachment portions 192b protruding from the elongate support member 194 on a second side of the elongate support member 194 opposite the first side. The attachment portions 192a define an angle α1 with the elongate support member 194 on the first side while the attachment portions 192b define an angle α2 with the elongate support member 194 on the second side.


In certain instances, the angle α1 and/or the angle α2 can be any angle in a range of about 1° to about 90°, for example. In certain instances, the angle α1 and or the angle α2 can be any angle in a range of about 30° to about 70°, for example. In certain instances, the angle α1 and or the angle α2 can be any angle in a range of about 40° to about 60°, for example. In at least one instance, the angle α1 is equal, or at least substantially equal, to the angle α2. In at least one instance, the angle α1 is different from the angle α2.


As illustrated in FIG. 25, the bendable projections 192 each include attachment portions 192a and 192b extending from a same position on the elongate support member 194. Alternatively, a bendable projection 192 may include only one of the attachment portions 192a and 192b. In at least one instance, the attachment portions 192a and 192b of the bendable projections 192 are made from biocompatible fibers that extend from the elongate support member 194. In at least one instance, the elongate support member 194 can also be made from biocompatible fibers.


In various instances, the edges of a compressible adjunct can be configured to improve attachment with a cartridge deck 16 of a staple cartridge 12 and/or improve the structural performance of the compressible adjunct. As illustrated in FIG. 17, edges 151a and 151b of the portions 150a and 150b, respectively, of the compressible adjunct 150 are each formed down to an outer lip 153 which defines an outer perimeter of the compressible adjunct 150, and can be attached to the cartridge deck 16, for example.


In certain instances, an outer lip can be formed after fabrication of a compressible adjunct. For example, the outer perimeters of the biocompatible layers of a compressible adjunct can be subjected to heat and/or pressure to form the outer lips. In certain instances, outer lips can be formed by weaving or knitting, for example, outer perimeters of the biocompatible layers of a compressible adjunct into a united structure that defines the outer lips. As illustrated in FIG. 26, an outer lip 203 of a compressible adjunct 200 is formed by knitting outer perimeters 217 and 218 of the biocompatible layers 114 and 115, respectively, of a compressible adjunct 200 into a united structure that defines the outer lip 203.


Uniting the outer perimeters of the biocompatible layers of a compressible adjunct can help stabilize the compressible adjunct and/or minimize shear collapse during compression. In certain instances, however, it is desirable to maintain the spacing between the outer perimeters of the biocompatible layers of a compressible adjunct to minimize structural and/or other differences between the outer perimeters and the center of a compressible adjunct that may result from the modification.


Referring to FIG. 27, a tapered edge 212 is defined in a compressible adjunct 210. The compressible adjunct 210 includes a first biocompatible layer 214 which extends laterally beyond a second biocompatible layer 215. Alternatively, a compressible adjunct 210 can include a second biocompatible layer 215 that extends laterally beyond the first biocompatible layer 214.


The biocompatible layers 214 and 215 are similar in many respects to the biocompatible layers 114 and 115. For example, the first biocompatible layer 214 is configured to be positioned against and/or attached to the cartridge deck 16 and the second biocompatible layer 215 is configured to be positioned against tissue captured between the anvil 8014 and the staple cartridge 12. In at least one instance, a tapered edge 212 of the compressible adjunct 210 is formed by removing or cutting off a portion of the compressible adjunct 210. The cutting plane can be made at a predetermined angle depending on the desired sharpness of the tapered edge 212.


Referring to FIGS. 28-30, a compressible adjunct 230 is depicted. The compressible adjunct 230 is similar to other compressible adjuncts described in the present disclosure. For example, like the compressible adjunct 51 (FIG. 9), the compressible adjunct 230 can compensate for the variability in the thickness of tissue (T) captured with the compressible adjunct 230 by the staples 10030. As illustrated in FIG. 28, the compressible adjunct 230 is configured to accommodate a tissue (T) with tissue portions 72 and 74 having different tissue thicknesses when the tissue portions 72 and 74 are captured with compressible adjunct 230 by the staples 10030.


Referring to FIG. 28, the compressible adjunct 230 includes a plurality of structural cells 236 positioned between a cartridge contacting surface 234 and a tissue contacting surface 235. One or more of the structural cells 236 can extend longitudinally along, or at least substantially along, an entire length of the compressible adjunct 230. A structural cell 236 is generally surrounded by walls that define an outer perimeter on the structural cell 236. Neighboring structural cells 236 may share one or more walls.


Referring to FIG. 29, a structural cell 236 is defined by six walls and comprises a hexagonal shape. In at least one instance, one or more of the structural cells 236 may each include three or more walls. The structural cells 236 of a compressible adjunct 230 may include the same number of walls. Alternatively, a first group of structural cells 236 may include a first number of walls while a second group of structural cells 236 may include a second number of walls different from the first number of walls, for example. In at least one instance, the structural cells 236 define a honeycomb shape that extends longitudinally along, or at least substantially along, at least a portion of the entire length of the compressible adjunct 230.


The honeycomb shape improves the stability of the compressible adjunct 230 under compressive and/or shear forces. In addition, the honeycomb-shaped structural cells 236 are bendable under compression applied to the compressible adjunct 230 and tissue (T) positioned against the second biocompatible layer 215 as an anvil 8014 is moved into a closed position opposite the staple cartridge 12. As illustrated in FIGS. 29 and 30, the honeycomb-shaped structural cells 236 are configured to experience a reduction in height when compressive forces are applied to the compressible adjunct 230 which permits the compressible adjunct 230 to accommodate tissue (T) with tissue portions 72 and 74 having different tissue thicknesses when the tissue portions 72 and 74 are captured with the compressible adjunct 230 by the staples 10030, as illustrated in FIG. 28.


Referring to FIGS. 29 and 30, a structural cell 236 has experienced a reduction in height from a first height (H1), as illustrated in FIG. 29, to a second height (H2), as illustrated in FIG. 30 in response to the compression forces applied to the compressible adjunct 230 as the anvil 8014 is moved into the closed position opposite the staple cartridge 12. The reduction in height may correspond to the thickness of the captured tissue (T) positioned against the compressible adjunct 230 where the structural cell 236 is located. In other words, the greater the thickness of a tissue portion, the greater the reduction in height of a structural cell 236 located at a portion of the compressible adjunct 230 positioned against that tissue portion.


The ratio of the second height (H2) to the first height (H1) can be any value from about 0.05 to about 0.95, for example. In certain instances, the ratio of the second height (H2) to the first height (H1) can be any value from about 0.2 to about 0.7, for example. In certain instances, the ratio of the second height (H2) to the first height (H1) can be any value from about 0.3 to about 0.6, for example. Other values for the ratio of the second height (H2) to the first height (H1) are contemplated by the present disclosure.


The walls of a structural cell 236 may comprise the same, or at least substantially the same, thickness. Alternatively, as illustrated in FIG. 29, the walls of a structural cell 236 may comprise different thicknesses. A pair of opposite walls 242 may comprise a first thickness (T1), a pair of opposite walls 244 may comprise a second thickness (T2), and a pair of opposite walls 246 may comprise a third thickness (T3), wherein at least two of the first thickness (T1), the second thickness (T2), and/or the third thickness (T3) are different from one another. For example, as illustrated in FIG. 29, the first thickness (T1) of the walls 242 is greater than the second thickness (T2) of the walls 244, and greater than the third thickness (T3) of the walls 246


Referring to FIGS. 28-30, the walls 242 of a structural cell 236 extend in parallel, or at least substantially in parallel, with the first biocompatible layer 234 and the second biocompatible layer 235. In certain instances, a wall 242 of a structural cell 236 may define a portion of the first biocompatible layer 234. In certain instances, a wall 242 of a structural cell 236 may define a portion of the second biocompatible layer 235.


As illustrated in FIG. 28, a building block of a compressible adjunct 230 includes five structural cells 236 that include a central structural cell 236 which shares walls with the other four structural cells 236. A height (H) of a compressible adjunct 230 can be defined by a stack of two structural cells 236 sharing a wall 244, as illustrated in FIG. 29. Alternatively, a height (H) of a compressible adjunct 230 can be defined by a stack of two four-walled structural cells 237 and one structural cell 236 extending between the structural cells 237, as illustrated in FIG. 29. The structural cell 236 shares a wall 242 with each of the structural cells 237. Other geometries and arrangements of the structural walls of a compressible adjunct 230 are contemplated by the present disclosure.


Various attachments can be fixed or secured to a compressible adjunct of the present disclosure. An attachment can be made from the same, or at least substantially the same, material(s) as the compressible adjunct. Alternatively, an attachment can be made from different material(s) than the compressible adjunct. In at least one instance, an attachment can be made from the same material(s) as the compressible adjunct but the material(s) are treated differently to modify one or more of the chemical and/or physical properties, for example, of the attachment.


In at least one instance, a compressible adjunct can be harder or softer than an attachment that is secured to the compressible adjunct. A harder attachment can provide a desirable stiffness for securing the attachment to a cartridge deck, for example. Alternatively, a softer attachment can yield a more delicate interaction with sensitive tissue, for example. In at least one instance, a compressible adjunct may comprise smoother or rougher surfaces than the surfaces of an attachment that is secured to the compressible adjunct. Ultimately, an attachment can be tailored to perform various functions in connection with a compressible adjunct. In various instances, an attachment may be in the form of a side attachment or an end cap for a compressible adjunct.


Referring to FIGS. 28-30, a side attachment 250 is fixed or secured to the compressible adjunct 230. In at least one instance, a side attachment 250 can be secured to the compressible adjunct 230 by welding using heat or a solvent, for example. The side attachment 250 defines a tapered edge 252 of the compressible adjunct 230.


Furthermore, the side attachment 250 can be employed to attach the compressible adjunct 230 to a cartridge deck 16 of a staple cartridge 12, for example. In at least one instance, the side attachment 250 can be welded onto the cartridge deck 16 by using heat or a solvent, for example. Other techniques for securing a side attachment 250 to a compressible adjunct 230 and/or to a cartridge deck 16 are contemplated by the present disclosure. For example, a tether 254 (FIG. 29) of a side attachment 250 can be secured to and/or wrapped around a staple cartridge 12.


A compressible adjunct and/or a side attachment can be configured to facilitate tissue ingrowth. For example, as illustrated in FIGS. 28-30, the compressible adjunct 230 and the side attachment 250 include perforations 254 configured to facilitate tissue ingrowth into the compressible adjunct 230 and the side attachment 250. The perforations 254 can be selectively created through the compressible adjunct 230 and/or the side attachment 250 in areas where tissue ingrowth is desirable.


In various instances, a compressible adjunct 230 and/or a side attachment 250 can be fabricated by various extrusion techniques, for example, and the perforations 254 can be laser drilled, for example, into desired portions of the compressible adjunct 230 and/or the side attachment 250. A side attachment 250 can be attached to a compressible adjunct 230 after extrusion, for example. A tailored compression resistance can be achieved in a compressible adjunct 230 by fabricating the walls of structural cells such as, for example, the structural cells 236 to predetermined thicknesses. Patterns of non-uniform wall thicknesses can be extruded, for example, to tune the flexibility of the structural cells within a compressible adjunct 230 to achieve a desired stiffness regardless of the material(s) used in the fabrication of the compressible adjunct 230.


Referring to FIG. 31, a compressible adjunct 260 is depicted. The compressible adjunct 260 includes a first biocompatible layer 114 positioned against a cartridge deck 16 of a staple cartridge 12. In addition, the compressible adjunct 260 includes a second biocompatible layer 115 positionable against tissue (T). A plurality of standing or spacer walls 262 are defined between the biocompatible layers 114 and 115. The standing walls 262 are configured to maintain a space between the biocompatible layers 114 and 115, as illustrated in FIG. 31. In addition, the standing walls 262 are bendable under compression applied to the compressible adjunct 260 and tissue (T) positioned against the second biocompatible layer 115 as an anvil 8014 is moved into a closed position opposite the staple cartridge 12.


The standing walls 262 are attached to the biocompatible layers 114 and 115, and are spaced apart from one another. Alternatively, the standing walls 262 can be tethered or attached to one another. Some of the standing walls 262 are arranged in parallel, or at least substantially in parallel, to one another. Other standing walls 262, however, extend in intersecting planes.


Furthermore, the standing walls 262 comprise cutouts or gaps 264 that improve the flexibility of the standing walls 262. In at least one instance, one or more of the standing walls 262 can be fabricated with the cutouts 264 by extrusion, for example. Alternatively, the cutouts 264 can be created after fabrication of the standing walls 262 is completed. The cutouts 264 can be strategically positioned to achieve a desired flexibility of the compressible adjunct 260, for example.


Referring to FIG. 32, a compressible adjunct 270 includes a first biocompatible layer 114 positioned against a cartridge deck 16 of a staple cartridge 12. The compressible adjunct 270 lacks a second biocompatible layer. Accordingly, tissue (T) is directly positioned against a plurality of spacer or standing walls 272 of the compressible adjunct 270. Alternatively, the compressible adjunct 270 can include a second biocompatible layer on an opposite side of the standing wall 272. In such instances, tissue (T) can be positioned against the second biocompatible layer. In addition, the standing walls 272 are bendable under compression applied to the compressible adjunct 270 and tissue (T) positioned against the standing walls 272 as an anvil 8014 is moved into a closed position opposite the staple cartridge 12.


The standing walls 272 include longitudinal walls 272a and transverse walls 272b intersecting the longitudinal walls 272a. The standing walls 272 comprise hollow, or at least substantially hollow, frames, as illustrated in FIG. 32. Alternatively, the standing walls 272 may comprise solid frames. In various instances, the standing walls 272 comprise the shape of a triangular prism, for example. The standing walls 272 comprise triangular cross-sectional areas. The standing walls 272 may comprise square-shaped, rectangular, and/or curved cross-sectional areas in addition to or instead of the triangular cross-sectional areas. As illustrated in FIG. 32, the longitudinal walls 272a comprise transverse cross-sectional areas that are triangle shaped and the transverse walls 272b comprise longitudinal cross-sectional areas that are triangle shaped.


A longitudinal wall 272a comprises a base 276a defined by the first biocompatible layer 114 and an apex 274a extending longitudinally in parallel, or at least substantially in parallel, with other apexes 274a of neighboring longitudinal walls 272a. A transverse wall 272b also comprises a base 276b defined by the first biocompatible layer 114 and an apex 274b extending transversely in parallel, or at least substantially in parallel, with other apexes 274b of neighboring transverse walls 272b.


As illustrated in FIG. 32, the compressible adjunct 272 includes structural cells 278 that comprise inverted pyramid shapes. A structural cell 278 is defined between two parallel, or at least substantially parallel, walls 272a and two parallel, or at least substantially parallel, walls 272b intersecting the walls 272a. A base 280 of a structural cell 278 comprises four corners 282 defined by the intersecting walls 272a and 272b. An apex 284 of a structural cell 278 is defined at the first biocompatible layer 114. Each structural cell 278 extends from an apex 284 and terminates at a base 280, as illustrated in FIG. 32.


In various instances, the second biocompatible layer of a compressible adjunct of the present disclosure such as, for example, the second biocompatible layer 115 of the compressible adjunct 110 is visible when the compressible adjunct 110 is positioned against a cartridge deck 16 of a staple cartridge 12. In various instances, certain information can be communicated to an operator through images, words, symbols, and/or colors that are knitted or printed onto the second biocompatible layer. For example, knitting lines can be employed to show knife travel length, which may help an operator to reduce the number of loads used in a procedure. Knitting lines can also be employed to show the positions of staple crowns. Moreover, knitting lines can also be employed to provide information about a staple cartridge employed with the compressible adjunct such as, for example staple heights. Furthermore, knitting lines can also be employed to outline an optimal location for positioning the treated tissue against the compressible adjunct.


A staple cartridge assembly comprising an implantable layer 4000 is depicted in FIG. 33. The staple cartridge assembly further comprises a cartridge body 12 including a deck 16 which supports the layer 4000. The layer 4000 comprises a bottom portion 4004 supported by the deck 16 and, in addition, a top portion 4005. The bottom portion 4004 and the top portion 4005 are connected by walls 4009. The walls 4009 extend laterally across the layer 4000; however, the walls 4009 can extend in any suitable direction, such as longitudinally, for example. In at least one embodiment, the cartridge body 12 comprises a longitudinal slot configured to receive a cutting member and the walls 4009 extend across the longitudinal slot.


The walls 4009 define chambers 4008 therebetween. When a load is applied to the layer 4000, the chambers 4008 permit the walls 4009 to flex, deflect, and/or collapse. The amount in which the walls 4009 deflect is dependent on the thickness of the tissue clamped against the layer 4000. When tissue is pressed downwardly onto the layer 4000, the layer 4000 can adapt to the thickness of the tissue pressed against the layer 4000. Stated another way, the layer 4000 can provide local adaptations to local variations in tissue thickness, as illustrated in FIG. 34. In various instances, the walls 4009 define seams in the layer 4000. The seams can be lateral seams and/or longitudinal seams, for example. The arrangement of the seams can control the deflection of the layer 4000.


Further to the above, the layer 4000 comprises structural fibers 4006 and reinforcement fibers 4007. The structural fibers 4006 are arranged to form the bottom portion 4004, the top portion 4005, and the walls 4009. In at least one instance, as illustrated in FIG. 33, the structural fibers 4006 are arranged in longitudinal rows which form longitudinal seams therebetween. The structural fibers 4006 form columns or pillars which extend between and connect the bottom portion 4004 and the top portion 4005. The reinforcement fibers 4007 are interwoven within the bottom portion 4004, the top portion 4005, and/or the walls 4009. In at least one instance, the reinforcement fibers 4007 are knotted, looped, and/or wrapped around the structural fibers 4006. In various instances, the reinforcement fibers 4007 are interlocked with the structural fibers 4006.


The reinforcement fibers 4007 connect the structural fibers 4006 within the walls 4009. The reinforcement fibers 4007 hold or tie the pillars within the walls 4009 together to provide the walls 4009 with desirable structural properties. For instance, walls 4009 having a higher density of the reinforcement fibers 4007 are stronger than walls 4009 having a lower density. Similarly, the density of the reinforcement fibers 4007 within the bottom portion 4004 and/or the top portion 4006 can affect the strength of the portions 4004 and/or 4006.


As a result of the above, the structural pillars within a wall 4009 can flex and move together. Moreover, the structural fiber pillars 4006 within a wall 4009 are supported by the adjacent structural fiber pillars 2006 owing to the reinforcement fibers 4007. As illustrated in FIG. 33, the reinforcement fibers 4007 within one wall 4009 are not directly connected to the reinforcement fibers 4007 in an adjacent wall 4009; however, the reinforcement fibers 4007 in a first wall 4009 can be connected to the reinforcement fibers 4007 in a second wall 4009 via the bottom portion 4004 and/or the top portion 4006. In various alternative embodiments, reinforcement fibers 4007 can directly span between and connect the adjacent walls 4009.


The structural fibers 4006 and the reinforcement fibers 4007 can be attached to each other at knot interfaces. The knot interfaces can comprise any suitable knot type. The type of knot interfaces that are used can affect the stiffness of the layer 4000. For instance, if loose knots are used, the layer 4000 can be less stiff or have a lower modulus of elasticity. Alternatively, if tight knots are used, the layer 4000 can be stiffer or have a higher modulus of elasticity. The layer 4000 can utilize any suitable type, or types, of knots.


Further to the above, the knots between the structural fibers 4006 and the reinforcement fibers 4007 can be utilized to selectively provide different portions of the layer 4000 with different stiffnesses or moduli of elasticity. For instance, the types of knots and/or the frequency of the knots between the structural fibers 4006 and the reinforcement fibers 4007 can be selected to create a first compression zone and a second compression zone. The first compression zone has a first stiffness and the second compression zone has a second stiffness which is greater than the first stiffness. In at least one instance, the first compression zone is aligned with and positioned over a longitudinal slot defined in the deck 12 which is configured to receive a cutting member and the second compression zone is aligned with and positioned over staple cavities defined in the deck 12. Such an arrangement can facilitate the transection of the layer 4000 while providing desirable tissue thickness compensation properties within the staples 10030 that capture the layer 4000 against the tissue. In certain instances, the first compression zone is aligned with a proximal end of the deck 12 and the second compression zone is positioned distally with respect to the first compression zone. In at least one such instance, another first compression zone is positioned distally with respect to the second compression zone. Such an arrangement can facilitate the transection of the layer 4000 at the beginning and at the end of the cutting stroke of the cutting member.


The structural fibers 4006 comprise a first cross-sectional width, or diameter, and the reinforcement fibers 4007 comprise a second cross-sectional width, or diameter, that is different than the first cross-sectional width. As illustrated in FIGS. 33 and 34, the cross-sectional width of the structural fibers 4006 is wider than the cross-sectional width of the reinforcement fibers 4007. In at least one instance, the cross-sectional width of the structural fibers 4006 is twice as wide as the cross-sectional width of the reinforcement fibers 4007, for example.


The structural fibers 4006 are comprised of a first material and the reinforcement fibers 4007 are comprised of a second material which is different than the first material. In at least one embodiment, the structural fibers 4006 are comprised of a first polymeric material and the reinforcement fibers 4007 are comprised of a second polymeric material which has a lower modulus of elasticity than the modulus of elasticity of the first polymeric material. In an alternative embodiment, the structural fibers 4006 are comprised of a first polymeric material and the reinforcement fibers 4007 are comprised of a second polymeric material which has a higher modulus of elasticity than the modulus of elasticity of the first polymeric material. In certain embodiments, the structural fibers 4006 are comprised of more than one polymeric material and/or the reinforcement fibers 4007 are comprised of more than one polymeric material. In at least one such embodiment, the structural fibers 4006 and the reinforcement fibers 4007 have at least one material in common with one another and at least one material not in common.


Turning now to FIG. 35, an implantable layer 4100 comprises a top portion 4105 and pillar walls 4109 which support the top portion 4105. The top portion 4105 comprises longitudinal structures or fibers 4103 which are interconnected by structural fibers 4106 which comprise the pillar walls 4109. The structural fibers 4106 are looped, wrapped, and/or knotted around the longitudinal fibers 4103 in any suitable manner. FIGS. 38A and 38B disclose two exemplary manners in which the structural fibers 4106 are interconnected to the longitudinal fibers 4103.


Further to the above, FIG. 38A illustrates a double-looping wrap. A structural fiber 4106 is wrapped around a first longitudinal fiber 4103, bridged over to a second longitudinal fiber 4103, and wrapped around the second longitudinal fiber 4103. The double-looped structural fiber 4106 comprises two standing ends which comprise legs, or pillars, that are part of a pillar wall 4109. Both loops of the structural fiber 4106 comprise closed loops and/or at least one turn; however, alternative embodiments are envisioned in which the loops each include a round turn and/or more than one turn around the longitudinal fibers 4103. The double-looping wrap of FIG. 38A can also be referred to as an inner double-loop. More particularly, the pillars of the structural fiber 4106 both pass through a gap defined between the adjacent first and second longitudinal fibers 4103. In various embodiments, an outer double-loop could be utilized.


Further to the above, FIGS. 38B and 39 illustrate a structural fiber 4106 wrapped around a first longitudinal fiber 4103, bridged over to a second longitudinal fiber 4103, and wrapped around the second longitudinal fiber 4103. The wrap around the first longitudinal fiber 4103 comprises an open loop; however, a closed loop and/or or one or more turns could be utilized, for example. The wrap around the second longitudinal fiber 4103 comprises a turn; however, a round turn could be utilized, for example. Similar to the above, the structural fiber 4106 of FIG. 38B comprises two standing ends which comprise legs, or pillars, that are part of a pillar wall 4109. The standing ends of the structural fiber 4106 extend through different gaps between the longitudinal fibers 4103.


Turning now to FIGS. 36 and 37, a layer 4200 comprises longitudinal structures or fibers 4103. The layer 4200 further comprises structural fibers 4206 and reinforcement fibers 4107. The reinforcement fibers 4107 are interweaved laterally within the longitudinal fibers 4103. The structural fibers 4206 are wrapped around a plurality of the longitudinal fibers 4013 to form walls 4209. As illustrated, each structural fiber 4206 is wrapped around four longitudinal fibers 4103, for example, to form a wall 4209. As a result of the above, each structural fiber 4206 forms several closed ended loop pillars which support the top portion 4205 of the layer 4200. The ends of the structural fibers 4206 do not support the top portion 4205; however, alternative embodiments are envisioned in which the ends of the structural fibers 4206 comprise structural pillars.


The embodiments disclosed herein can provide an organized fiber scaffold with compressive and bending properties interwoven with another scaffold in a manner that forms a larger matrix which has compressive and bending properties in multiple orientations. Such compressive and bending properties can be tuned by adjusting one or more of the characteristics disclosed herein. The walls of the matrix can define an array of macro voids. In various instances, the matrix can have a bi-modal nature with the macro voids defined between walls in the matrix and interstitial spaces defined between the fibers comprising the walls. Such macro voids and interstitial spaces can co-operate to encourage tissue ingrowth and integration of the matrix into the body.



FIG. 40 illustrates a tissue thickness compensator or compressible adjunct 2000. The compressible adjunct 2000 can be used with numerous devices. In at least one embodiment, the compressible adjunct 2000 can be employed with a surgical stapling and severing instrument 8010. The compressible adjunct 2000 can be attached to a staple cartridge deck 16 of a staple cartridge. Alternatively, in certain instances, the compressible adjunct 2000 can be attached to an anvil 8014.


Referring to FIG. 40, the compressible adjunct 2000 is shown in at least one embodiment partially compressed by tissue T. Staples 2002, which are similar in many respects to the staples 10030, engage the compressible adjunct 2000 when the staples 2002 are fired and formed by a surgical stapling and severing instrument 8010. The formed staples 2002 have a staple base 2004, first staple leg 2006, and second staple leg 2008. In the present embodiment, the first staple leg 2006 engages with the tissue T and compressible adjunct 2000.


The compressible adjunct 2000 includes a first portion 2012 having a tissue contacting interface 2010. When the compressible adjunct 2000 is engaged by tissue T, the tissue contacting interface 2010 contacts and interacts with tissue T. The compressible adjunct 2000 includes a second portion 2016 having a cartridge interface 2014. In the present embodiment, the cartridge interface 2014 can be releasably attached or positioned on or adjacent a staple cartridge deck 16.


The compressible adjunct 2000 includes a middle portion positioned between the first portion 2012 and the second portion 2016. The middle portion includes a plurality of standing fiber pillars 2018 and a plurality of interconnecting fibers 2024. The standing fiber pillars 2018 engage the first portion 2012 at a first portion/standing fiber pillar interface 2020. The standing fiber pillars 2018 engage the second portion 2016 at a second portion/standing fiber pillar interface 2022. The plurality of interconnecting fibers 2024 engage the plurality of standing fiber pillars 2018 at a standing fiber pillar/interconnecting fiber interface 2026.


The first portion 2012 and second portion 2016 comprise various biocompatible materials. The first and second portions 2012, 2016 can also be impregnated or coated with various agents, such as hemostatic agents, antibacterial agents, or antimicrobial agents, which may assist with the recovery time of a patient. The first portion 2012 can have various thicknesses, and material properties. In at least one embodiment, the first portion 2012 can have various densities and resiliencies to provide a first portion 2012 with desirable adaptive properties. Likewise, the second portion 2016 can have various thicknesses and material properties. In at least one embodiment, the second portion 2016 can have various densities and resiliencies to provide a second portion 2016 with desirable adaptive properties.


The standing fiber pillars 2018 comprise one or more biocompatible materials. A standing fiber pillar 2018 can be a resilient fiber with a suitable tensile strength and resiliency. The standing fiber pillar 2018 can comprise uniform material properties and characteristics; or the material properties and characteristics can be varied to provide a compressible adjunct 2100 with desirable adaptive properties. In at least one embodiment, the standing fiber pillars 2018 may be aligned in rows, and each row may have different material properties. When employed with a surgical stapler, the standing fiber pillars 2018 positioned closest to the knife slot of a surgical stapler or nearest an incision can have greater resiliency and require additional force before the standing fiber pillar 2018 are bent or buckled. This may create an increased pressure near the incision which may be beneficial in the treatment of a patient. Alternatively, in certain instances, the standing fiber pillars 2018 positioned closest to the knife slot of a surgical stapler or nearest an incision can have more elasticity and require less force before the standing fiber pillar 2018 are bent or buckled.


In other embodiments, the material properties of the standing fiber pillars 2018 may be varied proximally to distally to provide desirable adaptive properties for the compressible adjunct 2000. The plurality of standing fiber pillars 2018 can include different densities and cross-sectional areas or diameters. When a standing fiber pillar 2018 includes a relatively denser or greater cross-sectional area or diameter, the force required to affect the desired deflection of the standing fiber pillar 2018 may increase. Similarly, when a standing fiber pillar 2018 includes a relatively less dense or smaller cross-sectional area or diameter, the force required to affect the desired deflection may decrease. In addition, the density and cross-sectional areas or diameters of the standing fiber pillars 2018 can be varied to allow the standing fiber pillars 2018 to have different bending moments as forces increase or the compressible adjunct 2000 encounters tissue T with varying thicknesses. In one such embodiment, a standing pillar fiber 2018 can have a greater density in a portion closer to the second portion 2016 and can be less dense in a portion closer to the first portion 2012. This may permit increased resiliency of the compressible adjunct 2000 as additional compression forces are applied, and the force and compression profiles vary regarding displacement and compression of the compressible adjunct 2000.


The standing fiber pillars 2018 engage the first portion 2012 at first portion/standing fiber pillar interfaces 2020. The first portion/standing fiber pillar interface 2020 can be one of a friction or resistance relationship where the standing fiber pillars 2018 are not fixably attached to the first portion 2012. In other embodiments, the standing fiber pillars 2018 can be fixably or releasably attached to the first portion 2012 at the first portion/standing fiber pillar interface 2020. In at least one embodiment the standing fiber pillars 2018 can be embedded in the first portion 2012. In alternative embodiments, the standing fiber pillars 2018 can be attached, glued, welded, melted, hooked, woven, knitted, or fastened to the first portion 2012.


The standing fiber pillars 2018 engage the second portion 2016 at second portion/standing fiber pillar interfaces 2022. The second portion/standing fiber pillar interfaces 2022 can be one of a friction or resistance relationship where the standing fiber pillars 2018 are not fixably attached to the second portion 2016. In other embodiments, the standing fiber pillars 2018 can be fixably or releasably attached to the second portion 2016 at the second portion/standing fiber pillar interfaces 2022. In at least one embodiment the standing fiber pillars 2018 can be embedded in the second portion 2016. In alternative embodiments, the standing fiber pillars 2018 can be attached, glued, welded, melted, hooked, woven, knitted, or fastened to the second portion 2016.


The plurality of interconnecting fibers 2024 comprise one or more biocompatible materials. An interconnecting fiber 2024 can be a resilient fiber with a suitable tensile strength and resiliency. The interconnecting fibers 2024 can comprise uniform material properties and characteristics; or the material properties and characteristics can be varied to provide desirable adaptive properties for the compressible adjunct 2000.


In at least one embodiment, the interconnecting fibers 2024 may be aligned in rows and columns to form a matrix and each row and/or column may have different material properties. When employed with a surgical stapler, the interconnecting fibers 2024 positioned closest to the knife slot of the surgical stapler or the incision can be more resilient while the interconnecting fibers 2024 further away from the knife slot can be more elastic. This may create and increased pressure near the incision which may be beneficial in the treatment of the patient. Alternatively, in certain instances, the interconnecting fibers 2024 positioned closest to the knife slot of the surgical stapler or the incision can be more elastic while the interconnecting fibers 2024 further away from the knife slot can be more resilient.


In other embodiments, the material properties of the interconnecting fibers 2024 may be varied proximally to distally depending on a patient's needs. The interconnecting fibers 2024 can include different densities and cross-sectional areas or diameters. When an interconnecting fiber 2024 that includes a relatively denser or greater cross-sectional area or diameter is used, the tension required to affect the desired deflection of the interconnecting fiber 2024 increases. Similarly, when an interconnecting fiber 2024 includes a less dense or smaller cross-section area or diameter, a tension required to affect a desired deflection of the interconnecting fiber 2024 decreases. In addition, the density and cross section areas or diameters of the interconnecting fibers 2024 can be varied between a proximal portion of the staple cartridge 12 and a distal portion of the staple cartridge 12 to allow the interconnecting fibers 2024 to have different physical properties and resiliency when the compressible adjunct 2000 encounters tissue T with varying thicknesses.


The standing fiber pillars 2018 and the interconnecting fibers 2024 engage one another at the standing fiber pillar/interconnecting fiber interfaces 2026. The standing fiber pillar/interconnecting fiber interfaces 2026 can be one of a friction or resistance relationship where the standing fiber pillars 2018 are not fixably attached to the interconnecting fibers 2024. In other embodiments, the standing fiber pillar 2018 can be fixably, releasably, or slidably attached to the interconnecting fibers 2024 at the standing fiber pillar/interconnecting fiber interfaces 2026. In at least one embodiment, the standing fiber pillars 2018 can be embedded in the interconnecting fibers 2024. In alternative embodiments, the standing fiber pillars 2018 can be attached, glued, welded, melted, hooked, woven, looped, or fastened to the interconnecting fibers 2024.


The interconnecting fibers 2024 can also create additional stability for each standing fiber pillar 2018 and for the overall compressible adjunct 2000. Referring again to FIG. 40, the interconnecting fibers 2024 are spaced apart between the first portion 2012 and the second portion 2016. Three interconnecting fibers 2024 are engaged with each standing fiber pillar 2018 spaced substantially equidistance from each other; however, any suitable number of interconnecting fibers 2024 can be employed. In other embodiments, the number of interconnecting fibers 2024 can be increased to increase the stability of the standing fiber pillars 2018 or to increase the resiliency and force required to compress the compressible adjunct 2000. In another embodiment, the spacing and the quantity of interconnecting fibers 2024 can be adjusted to provide a compressible adjunct 2000 with desirable adaptive properties. When the interconnecting fibers 2024 are positioned closer to the second portion 2016, the compressible adjunct 2000 has a higher stiffness in the portion of the compressible adjunct 2000 nearest the second portion 2016 and a lesser stiffness in the portion of the compressible adjunct 2000 nearest the first portion 2012.


Referring to FIG. 41, a compressible adjunct 2100 is shown in at least one embodiment partially compressed by tissue T. Staples 2102 engage the compressible adjunct 2100 when the staples 2102 are fired and formed by a surgical stapler. The formed staples 2102 have a staple base 2104, first staple leg 2106, and second staple leg 2108. In the present embodiment, the first staple leg 2106 engages the tissue T and compressible adjunct 2100.


The compressible adjunct 2100 includes a first portion 2112 having a tissue contacting interface 2110. When the compressible adjunct 2100 engages tissue T, the tissue contacting interface 2110 contacts and interacts with tissue T. The compressible adjunct 2100 includes a second portion 2116 having a cartridge interface 2114. The cartridge interface 2114 can be releasably attached or positioned on or adjacent a staple cartridge deck 16.


The compressible adjunct 2100 includes a middle portion positioned between the first portion 2112 and the second portion 2116. The middle portion includes a plurality of standing fiber pillars 2118 and an interconnecting fiber 2124; however any suitable number of interconnecting fibers 2124 can be used. The standing fiber pillars 2118 engage the first portion 2112 at a first portion/standing fiber pillar interface 2120. The standing fiber pillars 2118 engage the second portion 2116 at a second portion/standing fiber pillar interface 2122. The interconnecting fiber 2124 engages the plurality of standing fiber pillars 2118 at a standing fiber pillar/interconnecting fiber interface 2126.


The first portion 2112 and second portion 2116 comprise one or more biocompatible materials. The first and second portions 2112, 2116 can also be impregnated or coated with various agents, such as hemostatic agents, antibacterial agents, or antimicrobial agents, which may assist with the recovery time of a patient. The first portion 2112 can have various thicknesses, and material properties. In at least one embodiment, the first portion 2112 can have various densities and resiliencies to provide a first portion 2112 with desirable adaptive properties. Likewise, the second portion 2116 can have various thicknesses and material properties. In at least one embodiment, the second portion 2116 can have various densities and resiliencies to provide a second portion 2116 with desirable adaptive properties.


The standing fiber pillars 2118 comprise one or more biocompatible materials. A standing fiber pillar 2118 can be a resilient fiber with a suitable tensile strength and resiliency. The standing fiber pillars 2118 can comprise uniform material properties and characteristics; or the material properties and characteristics can be varied to provide a compressible adjunct 2100 with desirable adaptive properties. In at least one embodiment, the standing fiber pillars 2118 may be aligned in rows and each row may have different material properties. When employed with a surgical stapler, the standing fiber pillars 2118 positioned closest to the knife slot of a surgical stapler or nearest an incision can have greater resiliency and require additional force before the standing fiber pillar 2118 are bent or buckled. This may create an increased pressure near the incision which may be beneficial in the treatment of a patient. Alternatively, in certain instances, the standing fiber pillars 2118 positioned closest to the knife slot of a surgical stapler or nearest an incision can have more elasticity and require less force before the standing fiber pillar 2118 are bent or buckled.


In other embodiments, the material properties of the standing fiber pillars 2118 may be varied proximally to distally to provide desirable adaptive properties for the compressible adjunct 2100. The plurality of standing fiber pillars 2118 can include different densities and cross-sectional areas or diameters. When a standing fiber pillar 2118 includes a relatively denser or greater cross-sectional area or diameter, the force required to affect the desired deflection of the standing fiber pillar 2118 may increase. Similarly, when a standing fiber pillar 2118 includes a relatively less dense or smaller cross-sectional area or diameter, the force required to affect the desired deflection may decrease. In addition, the density and cross-sectional areas or diameters of the standing fiber pillars 2118 can be varied to allow the standing fiber pillars 2118 to have different bending moments as forces increase or the compressible adjunct 2100 encounters tissue T with varying thicknesses. In one such embodiment, a standing pillar fiber 2118 can have a greater density in a portion closer to the second portion 2116 and can be less dense in a portion closer to the first portion 2112. This may permit increased resiliency of the compressible adjunct 2100 as additional compression forces are applied, and the force and compression profiles vary regarding displacement and compression of the compressible adjunct 2100.


The standing fiber pillars 2118 engage the first portion 2112 at first portion/standing fiber pillar interfaces 2120. The first portion/standing fiber pillar interface 2120 can be one of a friction or resistance relationship where the standing fiber pillars 2118 are not fixably attached to the first portion 2112. In other embodiments, the standing fiber pillars 2118 can be fixably or releasably attached to the first portion 2112 at the first portion/standing fiber pillar interface 2120. In at least one embodiment the standing fiber pillars 2118 can be embedded in the first portion 2112. In alternative embodiments, the standing fiber pillars 2118 can be attached, glued, welded, melted, hooked, woven, knitted, or fastened to the first portion 2112.


The standing fiber pillars 2118 engage the second portion 2116 at second portion/standing fiber pillar interfaces 2122. The second portion/standing fiber pillar interfaces 2122 can be one of a friction or resistance relationship where the standing fiber pillars 2118 are not fixably attached to the second portion 2116. In other embodiments, the standing fiber pillars 2118 can be fixably or releasably attached to the second portion 2116 at the second portion/standing fiber pillar interfaces 2122. In at least one embodiment the standing fiber pillars 2118 can be embedded in the second portion 2116. In alternative embodiments, the standing fiber pillars 2118 can be attached, glued, welded, melted, hooked, woven, knitted, or fastened to the second portion 2116.


The interconnecting fiber 2124 comprises one or more biocompatible materials. The interconnecting fiber 2124 can be a resilient fiber with a suitable tensile strength and resiliency. The interconnecting fiber 2124 can comprise uniform material properties and characteristics; or the material properties and characteristics can be to provide desirable adaptive properties for the compressible adjunct 2100.


In other embodiments, the material properties of the interconnecting fiber 2124 may be varied proximally to provide desirable adaptive properties. The interconnecting fiber 2124 can include different densities and cross sectional areas.


When an interconnecting fiber 2124 that includes a relatively denser or greater cross-sectional area or diameter is used, the tension required to affect the desired deflection of the interconnecting fiber 2124 increases. Similarly, when an interconnecting fiber 2124 includes a less dense or smaller cross-section area or diameter, a tension required to affect a desired deflection of the interconnecting fiber 2024 decreases. In addition, the density and cross section area or diameter of the interconnecting fiber 2124 can be varied between a proximal portion of the staple cartridge 12 and a distal portion of the staple cartridge 12 to allow the interconnecting fiber 2124 to have different physical properties and resiliency when the compressible adjunct 2100 encounters tissue T with varying thicknesses.


The standing fiber pillars 2118 and the interconnecting fiber 2124 engage one another at the standing fiber pillar/interconnecting fiber interface 2126. The standing fiber pillar/interconnecting fiber interface 2126 can be one of a friction or resistance relationship where the standing fiber pillars 2118 are not fixably attached to the interconnecting fiber 2124. In other embodiments, the standing fiber pillar 2118 can be fixably, releasably, or slidably attached to the interconnecting fiber 2124 at the standing fiber pillar/interconnecting fiber interface 2126. In at least one embodiment, the standing fiber pillars 2118 can be embedded in the interconnecting fiber 2124. In alternative embodiments, the standing fiber pillars 2118 can be attached, glued, welded, melted, hooked, knitted, woven, looped, or fastened to the interconnecting fiber 2124.


The interconnecting fiber 2124 can also create additional stability for the overall compressible adjunct 2100 and for each standing fiber pillar 2118. Referring again to FIG. 41, a single interconnecting fiber 2124 is spaced between the first portion 2112 and the second portion 2116. The single interconnecting fiber 2124 engages each standing fiber pillar 2118 substantially at the midpoint of the standing fiber pillars 2118. In other embodiments, the number of interconnecting fibers 2124 can be increased to increase the stability of the standing fiber pillars 2118 or to increase the resiliency and force required to compress the compressible adjunct 2100. In another embodiment, spacing of interconnecting fiber 2124 can be adjusted to provide a compressible adjunct 2100 with desirable adaptive properties. When the interconnecting fiber 2124 is positioned closer to the second portion 2116, the compressible adjunct 2100 has a higher stiffness in the portion of the compressible adjunct 2100 nearest the second portion 2116 and a lesser stiffness in the portion of the compressible adjunct 2100 nearest the first portion 2112.


Referring to FIG. 41, the interface 2126 can be in the form of slip joints that permit the interconnecting fiber 2124 to slip, move, and/or shift between the standing fiber pillars 2118. This feature allows the standing fiber pillar 2118 to freely bend to different degrees while maintaining a coupling engagement with the other standing fiber pillars 2118 through the slip joint interface defined by the interconnecting fiber 2124.


Referring to FIG. 42, a compressible adjunct 2200 is depicted. The compressible adjunct 2200 is engaged with tissue T having various tissue thicknesses. Tissue T has a first tissue thickness T1 and a second tissue thickness T2. At least one Staple 2202 engages the compressible adjunct 2200. The staple 2202 has a staple base 2204, and a first staple leg 2206 and a second staple leg 2208 extending from the staple base 2204. The staple 2202 is formed and a portion of the first staple leg 2206 and second staple leg 2208 engage tissue T and the compressible adjunct 2200.


The compressible adjunct 2200 includes a tissue contacting interface 2210 configured to interact with adjacent tissue T. The compressible adjunct 2200 can be used with various surgical procedures and can be employed in surgical staplers or staple cartridges. The compressible adjunct 2200 includes a cartridge interface 2214 that can rest or be fixably attached to a deck 16 of a staple cartridge 12. The compressible adjunct 2200 can include a plurality of standing fiber support portions 2214 and a compressible adjunct base portion 2216. The plurality of standing fiber support portions 2214 can extend from the compressible adjunct base portion 2216.


The compressible adjunct 2200 is engaged with tissue T having various thicknesses, T1, T2. In response to the tissue thicknesses, the compressible adjunct 2200 is compressed to a first compressed height H1 and a second compressed height H2. In the present embodiment, the compressible adjunct 2200 is responsive and conforming regarding tissue T having varying thicknesses. The compressible adjunct 2200 comprises one or more biocompatible materials.


The standing fiber support portions 2214 can be adapted and configured to have various material properties. The standing fiber support portions 2214 can have various densities, cross section areas and diameters, and porosities. The standing fiber support portions 2214 can include multiple woven or twisted fibers in each standing fiber support portion 2214. These individual fibers can have various densities, cross section areas and diameters, and porosities. Each standing fiber support portion 2214 contains at least two twisted fibers and is fixably attached to the compressible adjunct base portion 2214. Alternatively, the standing fiber support portions 2214 can be releasably or slidably attached to the compressible adjunct base portion 2216. In at least one embodiment, the standing fiber support portions 2214 can be embedded in the compressible adjunct base portion 2216. In alternative embodiments, the standing fiber support portions 2214 can be attached, glued, welded, melted, hooked, woven, knitted, looped, or fastened to the compressible adjunct base portion 2216.


In at least one embodiment, each standing fiber support portion 2214 can include at least two fibers twisted or mated together. The twisted fibers can be adjusted to affect the desired resiliency and compressibility of the compressible adjunct 2200. In at least one embodiment, the fibers of the standing fiber support portion 2214 can be more tightly twisted or wound at a portion of the standing fiber support portion 2214 near the compressible adjunct base portion 2216. Similarly, the fibers of the standing fiber support portion 2214 can be more loosely twisted or wound at a portion of the standing fiber support portion 2214 near the tissue contacting interface 2210. The variable tightness of the fibers of the standing fiber support portions 2214 permits different compressibility of the compressible adjunct 2200. In another embodiment, the fibers of the standing fiber support portions 2214 can be configured to untwist or unwind when the compressible adjunct 2200 encounters tissue having a greater thickness or the standing fiber support portions 2214 encounter greater resistance.


In another embodiment, the axial strength of the standing fiber support portions 2214 can be adjusted and adapted to provide desirable adaptive properties for the compressible adjunct 2200. The standing fiber support portions 2214 can also create a dynamic system where the fibers of the standing fiber support portions 2214 may unravel closer to the tissue contacting interface 2210 and compress near the compressible adjunct base portion 2216. The dynamic system permits the compressible adjunct 2200 to dynamically interact with tissue having varying thicknesses. When the standing fiber support portions 2214 engage a portion of tissue having a greater thickness, they can adaptively adjust to permit greater compressibility of the compressible adjunct 2200. Where the standing fiber support portions 2214 engage a portion of tissue having a thinner thickness, the compressible adjunct 2200 can remain more rigid to compensate for the varying tissue thickness. The dynamic ability to adjust to tissue having varying thicknesses helps facilitate proper staple formation and compression to secure the engaged tissue T.


Referring to FIG. 43, a fiber 2300 is depicted. The fiber 2300 can have various material and physical properties and can be made to different shapes, sizes and lengths. As illustrated in FIG. 43, the fiber 2300 comprises a cylindrical, or at least substantially cylindrical, shape. In other embodiments, the fiber 2300 may have a square, rectangular, oval, octagonal, or any other transverse cross-sectional shape. The fiber 2300 can be flexible and elastic and can be used in manufacturing various compressible adjuncts of the present disclosure. The fiber 2300 comprises one or more biocompatible materials.


The material composition, height, and/or transverse cross-sectional area of the fiber 2300 affect its stiffness or ability to bend under compression. The stiffness of the fiber 2300 can be adjusted to tune the compressibility of a compressible adjunct to one or more desired values.


Referring to FIG. 44, a fiber 2400 is depicted. The fiber 2400 has undergone a gas sorption process. The gas sorption process impregnates a fiber inner portion 2406 of the fiber 2400 with a plurality of fiber inner pores 2408. An outer fiber surface 2402 of the fiber 2400 can also be transformed through the gas sorption process to include a plurality of outer fiber surface pores 2404.


Batch foaming through a gas sorption process includes selecting a substrate or fiber 2400 to be used. The method further includes forcing gas into the fiber 2400 or substrate at elevated pressures. Then the pressure is dropped and, as a result, the subjected fiber 2400 or substrate may expand. The expanded fiber 2400 or substrate can have an increased porosity, a reduced density, and/or increased cross section surface area and diameter. The gas sorption process may be advantageous over other conventional methods as it permits the adjustment and tuning of the material characteristics such as, for example, the stiffness of a fiber 2400 without requiring chemical solvents.


A gas sorption batch foaming process can be applied to various substrates. In at least one embodiment, the gas sorption batch foaming method may be applied to biocompatible polymer films that can be used as an implantable device or compressible adjunct. Gas at elevated pressures can be forced into the polymer films. Then the polymer films can be expanded into a closed cell construct by dropping the pressure. The polymer film can become a compressible closed cell structure without requiring chemical solvents.


Another desirable substrate for the gas sorption process includes melt-blown non-woven constructs. In various instances, a melt blowing process comprises extruding a molten polymer through orifices, and attenuating the extrudates into fibers by action of a high-temperature/high-speed gas that blows the molten polymer from near the orifices onto a conveyer or a take-up screen to form fibrous non-woven constructs.


The melt-blown non-woven constructs rapidly increase in stiffness as they increase in thickness. In certain instances, a compressible adjunct with a greater thickness is desired without the accompanying increase in stiffness. This presents a limitation of the melt blowing process. In certain instances, a compressible adjunct with a greater thickness and suitable stiffness can be obtained using chemical solvents.


Referring to FIG. 45, a compressible adjunct 2500 comprising a greater thickness and suitable stiffness is produced without resorting to chemical solvents. The compressible adjunct 2500 is made through a melt blowing process that yields a melt-blown non-woven intermediate substrate with a plurality of fibers 2501. The melt-blown non-woven intermediate substrate is further processed by a gas sorption process to yield a suitable stiffness. By further processing the melt-blown non-woven substrate through a gas sorption process, the intermediate substrate can be expanded and the density, compressibility, and/or porosity can be adjusted to desired parameters.


The melt-blown non-woven intermediate substrate is produced using a melt blowing process. Other suitable techniques can be employed to produce a suitable substrate for the gas sorption process. In at least one instance, an electro-spinning process can be used. In at least one instance, a substrate can be produced by knitting, weaving, or any other suitable process.


One or more of the compressible adjuncts of the present disclosure can be modified by a gas sorption process to adjust their densities, compressibilities, and/or porosities to desired parameters. Various pillars, spacer fibers, standing fibers, and/or looping members of the compressible adjuncts of the present disclosure can be modified by a gas sorption process to adjust their densities, compressibilities, and/or porosities to desired parameters.


Referring to FIG. 45, the gas sorption process may cause outer fiber surfaces 2502 to form outer fiber surface pores 2504. In addition, the gas sorption process can impregnate a fiber inner portion 2506 with a plurality of fiber inner pores 2508. Through the gas sorption process, the intermediate substrate can be expanded in volume while decreasing the density and increasing the porosity of the substrate. Some potential benefits of the combination process may include greater tissue ingrowth into a compressible adjunct 2500 due to the greater porosity achieved by combining the melt blowing process and the gas sorption process. The compressible adjunct 2500, as illustrated in FIG. 45, includes a plurality of pores 2510 generated between the fibers 2501 in the melt blowing process in addition to the pores generated by the gas sorption process within the individual fibers 2501.


Once the compressible adjunct 2500 is formed to the desirable characteristics, further processing may be done. In at least one embodiment, multiple compressible adjuncts 2500 may be layered to increase the thickness of the overall construct or add different material characteristics. In at least one embodiment, compressible adjuncts 2500 made of different materials or of different porosities and densities may be used. In one example, the density and porosity nearer a tissue interface may be greater to allow greater tissue ingrowth. Multiple compressible adjuncts can be attached through melting, fastening, gluing, knitting, weaving, hooking, and other attachment techniques.


The compressible adjunct 2500 can be further enhanced through coating or embedding the compressible adjunct 2500 with various substances. In at least one embodiment, it may be beneficial to coat or impregnate the compressible adjunct 2500 with hemostatic agents, antibacterial agents, or antimicrobial agents.


Various embodiments are disclosed including adjuncts attached to and/or positioned on a staple cartridge. It should be understood that such teachings are applicable to embodiments in which an adjunct is attached to and/or positioned on an anvil of a surgical instrument. In fact, embodiments are envisioned in which a first adjunct is attached to and/or positioned on a cartridge and a second adjunct is attached to and/or positioned on an anvil.


The compressible adjuncts of the present disclosure can be positioned against a cartridge deck of a staple cartridge such as, for example, the cartridge deck 16 of the staple cartridge 12. In at least one instance, a compressible adjunct can be positioned against a cartridge deck of a staple cartridge prior to loading the staple cartridge onto a surgical instrument such as, for example, the surgical stapling and severing instrument 8010 (FIG. 1). Alternatively, a compressible adjunct can be positioned against a cartridge deck of a staple cartridge after the staple cartridge has been loaded into the surgical stapling and severing instrument. A loading unit can be employed to deposit a compressible adjunct onto the cartridge deck of the staple cartridge. The loading unit may include various attachment features and/or placement features for manipulating and positioning the compressible adjunct against the cartridge deck. Once the compressible adjunct is correctly positioned against the cartridge deck, the loading unit can release the compressible adjunct.


Further to the above, a compressible adjunct can be positioned against a cartridge deck without attachment to the staple cartridge. Alternatively, a compressible adjunct can be attached to the staple cartridge prior to or after the staple cartridge is loaded into the surgical stapling and severing instrument. For example, the compressible adjunct can be partially melted onto the cartridge deck then resolidified by cooling which causes the compressible adjunct to bond to the cartridge deck. Various attachment features can also be employed to attach a compressible adjunct to a staple cartridge such as, for example, sutures, straps, barbs, and/or other mechanical attachment mechanisms.


EXAMPLES

Example 1—A compressible adjunct for use with a surgical instrument including a staple cartridge, wherein the compressible adjunct comprises a first biocompatible layer, a second biocompatible layer spaced apart from the first biocompatible layer, and a plurality of supporting pillars extending between the first biocompatible layer and the second biocompatible layer.


Example 2—The compressible adjunct of Example 1, wherein each of the supporting pillars comprises a first end portion attached to the first biocompatible layer and a second end portion attached to the second biocompatible layer.


Example 3—The compressible adjunct of Example 2, wherein the first end portion and the second end portion define a transverse axis intersecting the first biocompatible layer and the second biocompatible layer.


Example 4—The compressible adjunct of Example 3, wherein the transverse axis defines a first angle with the first biocompatible layer, wherein the transverse axis defines a second angle with the second biocompatible layer, and wherein the first angle and the second angle are selected from a range of about 800 to a about 100°.


Example 5—The compressible adjunct of Examples 2, 3, or 4, wherein the first end portion is woven into the first biocompatible layer.


Example 6—The compressible adjunct of Examples 2, 3, 4, or 5, wherein the first end portion is welded to the first biocompatible layer.


Example 7—The compressible adjunct of Examples 1, 2, 3, 4, 5, or 6, wherein the plurality of supporting pillars comprises a first supporting pillar and a second supporting pillar crossing the first supporting pillar.


Example 8—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, or 7, wherein at least one of the first biocompatible layer and the second biocompatible layer comprises a woven matrix.


Example 9—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 7 or 8, wherein at least one of the first biocompatible layer and the second biocompatible layer comprises a knitted matrix.


Example 10—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 8 or 9, wherein at least one of the first biocompatible layer and the second biocompatible layer comprises a film.


Example 11—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 8, 9, or 10, wherein the second biocompatible layer comprises an outer surface configured to grip tissue.


Example 12—The compressible adjunct of Example 11, wherein the outer surface comprises a plurality of gripping features, and wherein each of the gripping features defines an acute angle with the outer surface.


Example 13—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, or 12, wherein the first biocompatible layer comprises a greater density than the second biocompatible layer.


Example 14—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, or 13, further comprising a body portion and an outer edge at least partially surrounding the body portion, wherein the body portion comprises a greater thickness than the outer edge.


Example 15—The compressible adjunct of Example 14, wherein the outer edge is tapered.


Example 16—The compressible adjunct of Examples 14 or 15, wherein the outer edge comprises a first outer edge portion extending from the first biocompatible layer and a second outer edge portion extending from the second biocompatible layer, wherein the first outer edge portion and the second outer edge portion are united into a continuous side portion configured to join the first biocompatible layer and the second biocompatible layer.


Example 17—The compressible adjunct of Examples 1, 2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, or 16, further comprising a knife slot configured to receive a knife for cutting tissue captured by the surgical instrument, wherein the knife slot defines two sides, and wherein the knife passes between the two sides.


Example 18—The compressible adjunct of Example 17, further comprising a tether extending between the two sides, wherein the knife is configured to cut the tether to separate the two sides.


Example 19—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck comprising an outer surface. The staple cartridge assembly further comprises a compressible adjunct positionable against the outer surface, wherein the compressible adjunct comprises a tissue-facing biocompatible layer, a deck-facing biocompatible layer positionable against the outer surface, wherein the tissue-facing biocompatible layer is spaced apart from the deck-facing biocompatible layer, and spacer fibers intersecting the tissue-facing biocompatible layer and the deck-facing biocompatible layer, wherein the spacer fibers are configured to lift the tissue-facing biocompatible layer over the deck-facing biocompatible layer.


Example 20—A compressible adjunct for use with a surgical instrument including a staple cartridge, wherein the compressible adjunct comprises a first biocompatible layer, a second biocompatible layer spaced apart from the first biocompatible layer, and an elongate flexible member interconnecting the first biocompatible layer and the second biocompatible layer, wherein the elongate flexible member is configured to form a plurality of supporting structures standing between the first biocompatible layer and the second biocompatible layer.


Example 21—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises a first biocompatible layer comprising a first portion, a second biocompatible layer comprising a second portion, and crossed spacer fibers extending between the first portion and the second portion.


Example 22—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises a tissue-facing layer comprising a first bonding node and a second bonding node arranged in a first row with the first bonding node. The compressible adjunct further comprises a deck-facing layer, wherein the tissue-facing layer is spaced apart from the deck-facing layer, and wherein the deck-facing layer comprises a third bonding node vertically aligned with the first bonding node and a fourth bonding node vertically aligned with the second bonding node, wherein the fourth bonding node is arranged in a second row with the third bonding node. The compressible adjunct further comprises a first spacer fiber extending between the first bonding node and the fourth bonding node and a second spacer fiber extending between the second bonding node and the third bonding node, wherein the first spacer fiber crosses the second spacer fiber.


Example 23—The staple cartridge assembly of Example 22, wherein the first row is parallel to the second row.


Example 24—The staple cartridge assembly of Examples 22 or 23, wherein the first row further comprises a fifth bonding node between the first bonding node and the second bonding node.


Example 25—The staple cartridge assembly of Example 24, further comprising a first fiber portion interconnecting the first bonding node and the fifth bonding node.


Example 26—The staple cartridge assembly of Examples 24 or 25, further comprising a second fiber portion interconnecting the second bonding node and the fifth bonding node.


Example 27—The staple cartridge assembly of Examples 22, 23, 24, 25, or 26, wherein the second row further comprises a sixth bonding node between the third bonding node and the fourth bonding node.


Example 28—The staple cartridge assembly of Example 27, further comprising a third fiber portion interconnecting the third bonding node and the sixth bonding node.


Example 29—The staple cartridge assembly of Examples 27 or 28, further comprising a fourth fiber portion interconnecting the fourth bonding node and the sixth bonding node.


Example 30—The staple cartridge assembly of Examples 27, 28, or 29, wherein the fifth bonding node is vertically aligned with the sixth bonding node.


Example 31—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck defining a proximal end and a distal end. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises a tissue-facing layer comprising a first bonding node and a second bonding node arranged in a first row with the first bonding node. The compressible adjunct further comprises a deck-facing layer, wherein the tissue-facing layer is spaced apart from the deck-facing layer, and wherein the deck-facing layer comprises a third bonding node and a fourth bonding node, wherein the fourth bonding node is arranged in a second row with the third bonding node. The compressible adjunct further comprises a first spacer fiber extending from the first bonding node to the third bonding node, a second spacer fiber extending from the first bonding node toward the deck-facing surface in a proximal direction, and a third spacer fiber extending from the first bonding node toward the deck-facing surface in a distal direction. The compressible adjunct further comprises a fourth spacer fiber extending from the second bonding node to the fourth bonding node.


Example 32—The staple cartridge assembly of Example 31, further comprising a fifth spacer fiber extending from the second bonding node toward the deck-facing surface in the proximal direction.


Example 33—The staple cartridge assembly of Examples 31 or 32, further comprising a sixth spacer fiber extending from the second bonding node toward the deck-facing surface in the distal direction.


Example 34—The staple cartridge assembly of Example 33, wherein the sixth spacer fiber crosses the second spacer fiber.


Example 35—The staple cartridge assembly of Examples 31, 32, 33, or 34, further comprising a seventh spacer fiber extending from the first bonding node to the third bonding node.


Example 36—The staple cartridge assembly of Examples 31, 32, 33, 34, or 35, further comprising an eighth spacer fiber extending from the second bonding node to the fourth bonding node.


Example 37—The staple cartridge assembly of Examples 31, 32, 33, 34, 35, or 36, wherein the first bonding node is vertically aligned with the third bonding node.


Example 38—The staple cartridge assembly of Examples 31, 32, 33, 34, 35, 36, or 37, wherein the second bonding node is vertically aligned with the fourth bonding node.


Example 39—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck defining a proximal end and a distal end. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises a tissue-facing layer and a deck-facing layer, wherein the tissue-facing layer is spaced apart from the deck-facing layer, and wherein the deck-facing layer comprises an outer surface and an inner surface. The compressible adjunct further comprises a first spacer fiber extending from the tissue-facing layer toward the inner surface, a second spacer fiber extending from the tissue-facing layer toward the inner surface, wherein the first spacer fiber and the second spacer fiber extend through the deck-facing layer, and a loop defined by the first spacer fiber and the second spacer fiber on the outer surface.


Example 40—The staple cartridge assembly of Example 39, wherein the first spacer fiber and the second spacer fiber intersect at the deck-facing layer.


Example 41—The staple cartridge assembly of Examples 39 or 40, further comprising a third spacer fiber extending from the tissue-facing layer, wherein the third spacer fiber intersects the first spacer fiber and the second spacer fiber at the deck-facing layer.


Example 42—A compressible adjunct for use with a surgical instrument including a staple cartridge, wherein the compressible adjunct comprises a biocompatible layer and a plurality of biocompatible looping members protruding from the biocompatible layer. Each of the biocompatible looping members comprises a first end portion attached to the biocompatible layer, a second end portion attached to the biocompatible layer, and an intermediate curved portion extending between the first end portion and the second end portion, wherein the intermediate curved portion is further away from the biocompatible layer than the first end portion and the second end portion.


Example 43—The compressible adjunct of Example 42, further comprising another biocompatible layer spaced apart from the biocompatible layer.


Example 44—The compressible adjunct of Example 43, wherein the plurality of biocompatible looping members is positioned between the biocompatible layer and the another biocompatible layer.


Example 45—The compressible adjunct of Examples 43 or 44, wherein the intermediate curved portion is attached to the another biocompatible layer.


Example 46—The compressible adjunct of Examples 43, 44, or 45, wherein the another biocompatible layer comprises a woven layer.


Example 47—The compressible adjunct of Examples 42, 43, 44, 45, or 46, wherein the biocompatible layer comprises a plurality of tethering islands that are spaced apart from one another, and wherein each of the tethering islands is defined by the first end portion and the second end portion of at least one of the biocompatible looping members.


Example 48—The compressible adjunct of Example 47, wherein the tethering islands are arranged in parallel rows.


Example 49—The compressible adjunct of Examples 42, 43, 44, 45, 46, or 47, wherein each of the biocompatible looping members comprises a wide head portion and narrow neck portion extending between the wide head portion and the biocompatible layer.


Example 50—The compressible adjunct of Examples 42, 43, 44, 45, 46, 47, or 48, wherein each of the biocompatible looping members is comprised of a fiber.


Example 51—The compressible adjunct of Example 50, wherein the fiber is a multifilament fiber.


Example 52—The compressible adjunct of Examples 42, 43, 44, 45, 46, 47, 48, 49, 50, or 51, wherein the biocompatible looping members are configured to bend in a disorganized manner in response to a compression force.


Example 53—The compressible adjunct of Examples 42, 43, 44, 45, 46, 47, 48, 49, 50, or 51, wherein the biocompatible looping members are configured to bend in an organized manner in response to a compression force.


Example 54—A compressible adjunct for use with a surgical instrument including a staple cartridge, wherein the compressible adjunct comprises a first biocompatible layer comprising first fiber loops arranged in a plurality of first rows, a second biocompatible layer spaced apart from the first biocompatible layer, wherein the second biocompatible layer comprises second fiber loops arranged in a plurality of second rows spaced apart from the plurality of first rows, and a pair of first fiber portions extending from each of the first fiber loops toward the second biocompatible layer. The compressible adjunct further comprises a pair of second fiber portions extending from each of the second fiber loops toward the first biocompatible layer.


Example 55—The compressible adjunct of Example 54, wherein the first fiber portions are slanted to favor bending in a first direction in response to a compression force.


Example 56—The compressible adjunct of Example 55, wherein the second fiber portions are slanted to favor bending in the first direction in response to the compression force.


Example 57—The compressible adjunct of Examples 54, 55, or 56, wherein the first fiber portions and the second fiber portions are configured to bend in a disorganized manner in response to a compression force.


Example 58—The compressible adjunct of Examples 54, 55, or 56, wherein the first fiber portions and the second fiber portions are configured to bend in an organized manner in response to a compression force.


Example 59—A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises a staple cartridge comprising a plurality of staples and a cartridge deck defining a proximal end and a distal end. The staple cartridge assembly further comprises a compressible adjunct positionable against the cartridge deck, wherein the compressible adjunct comprises a first biocompatible layer and a second biocompatible layer spaced apart from the first biocompatible layer. The second biocompatible layer comprises a first fiber loop, a pair of first fiber portions extending from the first fiber loop toward the first biocompatible layer, a second fiber loop proximal to the first fiber loop, wherein the pair of first fiber portions passes through the second fiber loop, and a pair of second fiber portions extending from the second fiber loop toward the first biocompatible layer.


Example 60—The staple cartridge assembly of Example 59, wherein the second biocompatible layer comprises a third fiber loop proximal to the second fiber loop, wherein the pair of second fiber portions passes through the third fiber loop and a pair of third fiber portions extending from the third fiber loop toward the first biocompatible layer.


Example 61—The staple cartridge assembly of Examples 59 or 60, wherein the second layer is a knitted layer.


Example 62—A staple cartridge assembly comprising a cartridge body comprising a deck and a plurality of staple cavities defined in the deck, a plurality of staples removably stored in the staple cavities, and an implantable layer positioned over the staple cavities, wherein the implantable layer comprises structural fibers weaved into a top surface, a bottom surface, and pillar walls extending between the top surface and the bottom surface and reinforcement fibers interwoven within the pillar walls.


Example 63—The staple cartridge assembly of Example 62, wherein the reinforcement fibers are interwoven within the top surface and the bottom surface.


Example 64—The staple cartridge assembly of Examples 62 or 63, wherein the reinforcement fibers are looped around the structural fibers.


Example 65—The staple cartridge assembly of Examples 62, 63, or 64, wherein the implantable layer comprises a first compression zone comprising a first density of loops between the reinforcement fibers and the structural fibers and a second compression zone comprises a second density of loops between the reinforcement fibers and the structural fibers, wherein the second density is greater than the first density.


Example 66—The staple cartridge assembly of Example 65, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, wherein the first compression zone is aligned with the longitudinal slot, and wherein the second compression zone is aligned with the staple cavities.


Example 67—The staple cartridge assembly of Examples 62, 63, 64, 65, or 66, wherein the cartridge body comprises a proximal end and a distal end, wherein the first compression zone is aligned with the proximal end, and wherein the second compression zone is positioned distally with respect to the first compression zone.


Example 68—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, or 67, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, and wherein the pillar walls extend across the longitudinal slot.


Example 69—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, or 68, wherein each the structural fiber comprises a longitudinal seam that extends between a proximal end and a distal end of the cartridge body.


Example 70—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, 68, or 69, wherein each the reinforcement fiber comprises a lateral seam that extends through a pillar wall.


Example 71—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, 68, 69, or 70, wherein the structural fibers are comprised of a first material, and wherein the reinforcement fibers are comprised of a second material which is different than the first material.


Example 72—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, 68, 69, 70, or 71, wherein the reinforcement fibers are knotted with the structural fibers.


Example 73—The staple cartridge assembly of Examples 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, or 72, wherein the implantable layer comprises a first compression zone comprising a first density of knots between the reinforcement fibers and the structural fibers and a second compression zone comprises a second density of knots between the reinforcement fibers and the structural fibers, wherein the second density is greater than the first density.


Example 74—A staple cartridge assembly comprising a cartridge body comprising a deck and a plurality of staple cavities defined in the deck, a plurality of staples stored in the staple cavities, and an implantable layer positioned over the staple cavities, wherein the implantable layer comprises interconnected structural walls comprised of interwoven fibers and pockets defined between the structural walls.


Example 75—The staple cartridge assembly of Example 74, wherein the structural walls are comprised of structural fibers weaved into a top surface, a bottom surface, and pillar walls extending between the top surface and the bottom surface and reinforcement fibers interwoven within the pillar walls.


Example 76—The staple cartridge assembly of Example 75, wherein the reinforcement fibers are looped around the structural fibers.


Example 77—The staple cartridge assembly of Examples 75 or 76, wherein the implantable layer comprises a first compression zone comprising a first density of loops between the reinforcement fibers and the structural fibers and a second compression zone comprises a second density of loops between the reinforcement fibers and the structural fibers, wherein the second density is greater than the first density.


Example 78—The staple cartridge assembly of Example 77, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, wherein the first compression zone is aligned with the longitudinal slot, and wherein the second compression zone is aligned with the staple cavities.


Example 79—The staple cartridge assembly of Examples 77 or 78, wherein the cartridge body comprises a proximal end and a distal end, wherein the first compression zone is aligned with the proximal end, and wherein the second compression zone is positioned distally with respect to the first compression zone.


Example 80—The staple cartridge assembly of Examples 75, 76, 77, 78, or 79, wherein the structural fibers are comprised of a first material, and wherein the reinforcement fibers are comprised of a second material which is different than the first material.


Example 81—The staple cartridge assembly of Examples 75, 76, 77, 78, 79, or 80, wherein the cartridge body further comprises a longitudinal slot configured to receive a cutting member, and wherein the structural walls extend across the longitudinal slot.


Example 82—The staple cartridge assembly of Examples 75, 76, 77, 78, 79, 80, or 81, wherein the structural walls comprise longitudinal seams that extend between a proximal end and a distal end of the cartridge body.


Example 83—The staple cartridge assembly of Example 82, wherein the structural walls further comprise lateral seams that extend transversely to the longitudinal seams.


Example 84—A staple cartridge assembly comprising a cartridge body comprising a deck and a plurality of staple cavities defined in the deck, a plurality of staples stored in the staple cavities, and an implantable layer positioned over the staple cavities, wherein the implantable layer comprises a top portion, a bottom portion, and walls interwoven between the top portion and the bottom portion.


Example 85—A compressible adjunct comprising a first portion, a second portion, and a middle portion, wherein the middle portion is disposed between the first portion and the second portion, and wherein the middle portion comprises a first pillar, a second pillar, wherein the first pillar and the second pillar extend substantially between the first portion and the second portion, and an interconnecting member, wherein the interconnecting member is configured to engage at least the first pillar and the second pillar, wherein when the compressible adjunct is compressed by a force, the first pillar is configured to deflect a first deflection and the second pillar is configured to deflect a second deflection, and wherein the first deflection differs from the second deflection.


Example 86—The compressible adjunct of Example 85, wherein the interconnecting member fixably engages the first pillar and the second pillar.


Example 87—The compressible adjunct of Examples 85 or 86, wherein the interconnecting member slidingly engages the first pillar and the second pillar.


Example 88—The compressible adjunct of Examples 85, 86, or 87, wherein the first pillar comprises a first cross sectional diameter, wherein the second pillar comprises a second cross sectional diameter, and wherein the first diameter differs from the second diameter.


Example 89—The compressible adjunct of Example 88, wherein the first cross sectional diameter is greater than the second cross sectional diameter, and wherein the second deflection is greater than the first deflection.


Example 90—The compressible adjunct of Examples 85, 86, 87, 88, or 89, wherein the first pillar comprises a first density, wherein the second pillar comprises a second density, and wherein the first density differs from the second density.


Example 91—The compressible adjunct of Example 90, wherein the first density is greater than the second density, and wherein the second deflection is greater than the first deflection.


Example 92—The compressible adjunct of Examples 85, 86, 87, 88, 89, 90, or 91, wherein the first pillar comprises a first cross sectional diameter, wherein the second pillar comprises a second cross sectional diameter, wherein the interconnecting member comprises a third cross sectional diameter, and wherein the first cross sectional diameter and the second cross sectional diameter differ from the third cross sectional diameter.


Example 93—The compressible adjunct of Examples 85, 86, 87, 88, 89, 90, 91, or 92, wherein the first pillar comprises a first density, wherein the second pillar comprises a second density, wherein the interconnecting member comprises a third density, and wherein the first density and the second density differ from the third density.


Example 94—The compressible adjunct of Examples 85, 86, 87, 88, 89, 90, 91, 92, or 93, wherein the first pillar comprises a first end, a second end, and a middle section, wherein the first end engages the first portion, wherein the second end engages the second portion, and wherein the interconnecting member engages the middle section.


Example 95—A compressible adjunct comprising a base portion and a plurality of pillars, wherein the plurality of pillars comprises a first support comprising a first pillar, and a second pillar, wherein the first pillar and the second pillar engage the base portion, and wherein the first pillar and the second pillar are interconnected. The plurality of pillars further comprises a second support comprising a third pillar and a fourth pillar, wherein the third pillar and the fourth pillar engage the base portion, wherein the third pillar and the fourth pillar are interconnected, wherein when the compressible adjunct is compressed by a force, the first support is configured to deflect a first deflection and the second support is configured to deflect a second deflection, and wherein the first deflection differs from the second deflection.


Example 96—The compressible adjunct of Example 95, wherein the first support comprises a first material, and wherein the second support comprises a second material, and wherein the first material differs from the second material.


Example 97—The compressible adjunct of Examples 95 or 96, wherein the first support has a first average density, and wherein the second support has a second average density, and wherein the first average density differs from the second average density.


Example 98—The compressible adjunct of Example 97, wherein the first average density is greater than the second average density, and wherein the second deflection is greater than the first deflection.


Example 99—The compressible adjunct of Examples 95, 96, 97, or 98, wherein the first pillar comprises a first cross sectional diameter, wherein the second pillar comprises a second cross sectional diameter, and wherein the first diameter differs from the second diameter.


Example 100—The compressible adjunct of Examples 95, 96, 97, 98, or 99, wherein the first pillar comprises a first cross sectional diameter, wherein the second pillar comprises a second cross sectional diameter, wherein the third pillar comprises a third cross sectional diameter, and wherein the fourth pillar comprises a fourth cross sectional diameter.


Example 101—The compressible adjunct of Example 100, wherein the first diameter differs from the third diameter, and wherein the second diameter differs from the fourth diameter.


Example 102—The compressible adjunct of Examples 95, 96, 97, 98, 99, 100, or 101, wherein the first support comprises an first average height, wherein the second support comprises an second average height, and wherein the first height differs from the second height.


Example 103—The compressible adjunct of Example 102, wherein the first average height is greater than the second average height and the first deflection is greater than the second deflection.


Example 104—The compressible adjunct of Examples 95, 96, 97, 98, 99, 100, 101, 102, or 103, wherein the first pillar and the second pillar are woven together, and wherein when the compressible adjunct is compressed, the first pillar and the second pillar are configured to partially unwind.


Example 105—A method of producing a fibrous compressible construct with a desired thickness, wherein the method comprises the steps of, one, producing a biocompatible melt-blown non-woven substrate that comprises a thickness lesser than the desired thickness, wherein the biocompatible melt-blown non-woven substrate comprises a plurality of fibers and, two, applying a gas sorption process to the biocompatible melt-blown non-woven substrate to modify the thickness to the desired thickness.


Example 106—The method of Example 105, wherein the step of applying the gas sorption process comprises applying a high pressure gas to the biocompatible melt-blown non-woven substrate.


Example 107—The method of Examples 105 or 106, wherein the step of producing the biocompatible melt-blown non-woven substrate comprises extruding a polymer, attenuating the extrudates into fibers by action of a high-temperature and high-speed gas, and collecting the fibers to form a fibrous non-woven fabric.


Example 108—The method of Examples 105, 106, or 107, wherein the step of applying a gas sorption process comprises, one, applying a high pressure gas to the biocompatible melt-blown non-woven substrate and, two, reducing the pressure of the gas.


In various circumstances, one or more of the compressible adjuncts of the present disclosure is comprised of one or more biocompatible materials. A compressible adjunct may comprise a polymeric composition. The polymeric composition may comprise one or more synthetic polymer and/or one or more non-synthetic polymer. The synthetic polymer may comprise a synthetic absorbable polymer and/or a synthetic non-absorbable polymer. In various circumstances, the polymeric composition may comprise a porous structure with a uniform pore morphology or a gradient pore morphology (i.e. small pores gradually increasing in size to large pores across the thickness of the foam in one direction).


In various circumstances, a compressible adjunct has a porous morphology which exhibits a gradient structure such as, for example, small pores on one surface and larger pores on the other surface. Such morphology could be more optimal for tissue in-growth or hemostatic behavior. Further, the gradient could be also compositional with a varying bio-absorption profile. A short term absorption profile may be preferred to address hemostasis while a long term absorption profile may address better tissue healing without leakages.


In various circumstances, the polymeric composition may comprise a pharmaceutically active agent. The polymeric composition may release a therapeutically effective amount of the pharmaceutically active agent. In various circumstances, the pharmaceutically active agent may be released as the polymeric composition is desorbed/absorbed. In various circumstances, the pharmaceutically active agent may be released into fluid, such as, for example, blood, passing over or through the polymeric composition.


The entire disclosures of:

    • U.S. Pat. No. 5,403,312, entitled ELECTROSURGICAL HEMOSTATIC DEVICE, which issued on Apr. 4, 1995;
    • U.S. Pat. No. 7,000,818, entitled SURGICAL STAPLING INSTRUMENT HAVING SEPARATE DISTINCT CLOSING AND FIRING SYSTEMS, which issued on Feb. 21, 2006;
    • U.S. Pat. No. 7,422,139, entitled MOTOR-DRIVEN SURGICAL CUTTING AND FASTENING INSTRUMENT WITH TACTILE POSITION FEEDBACK, which issued on Sep. 9, 2008;
    • U.S. Pat. No. 7,464,849, entitled ELECTRO-MECHANICAL SURGICAL INSTRUMENT WITH CLOSURE SYSTEM AND ANVIL ALIGNMENT COMPONENTS, which issued on Dec. 16, 2008;
    • U.S. Pat. No. 7,670,334, entitled SURGICAL INSTRUMENT HAVING AN ARTICULATING END EFFECTOR, which issued on Mar. 2, 2010;
    • U.S. Pat. No. 7,753,245, entitled SURGICAL STAPLING INSTRUMENTS, which issued on Jul. 13, 2010;
    • U.S. Pat. No. 8,393,514, entitled SELECTIVELY ORIENTABLE IMPLANTABLE FASTENER CARTRIDGE, which issued on Mar. 12, 2013;
    • U.S. patent application Ser. No. 11/343,803, entitled SURGICAL INSTRUMENT HAVING RECORDING CAPABILITIES, now U.S. Pat. No. 7,845,537;
    • U.S. patent application Ser. No. 12/031,573, entitled SURGICAL CUTTING AND FASTENING INSTRUMENT HAVING RF ELECTRODES, filed Feb. 14, 2008;
    • U.S. patent application Ser. No. 12/031,873, entitled END EFFECTORS FOR A SURGICAL CUTTING AND STAPLING INSTRUMENT, filed Feb. 15, 2008, now U.S. Pat. No. 7,980,443;
    • U.S. patent application Ser. No. 12/235,782, entitled MOTOR-DRIVEN SURGICAL CUTTING INSTRUMENT, now U.S. Pat. No. 8,210,411;
    • U.S. patent application Ser. No. 12/249,117, entitled POWERED SURGICAL CUTTING AND STAPLING APPARATUS WITH MANUALLY RETRACTABLE FIRING SYSTEM, now U.S. Pat. No. 8,608,045;
    • U.S. patent application Ser. No. 12/647,100, entitled MOTOR-DRIVEN SURGICAL CUTTING INSTRUMENT WITH ELECTRIC ACTUATOR DIRECTIONAL CONTROL ASSEMBLY, filed Dec. 24, 2009, now U.S. Pat. No. 8,220,688;
    • U.S. patent application Ser. No. 12/893,461, entitled STAPLE CARTRIDGE, filed Sep. 29, 2012, now U.S. Pat. No. 8,733,613;
    • U.S. patent application Ser. No. 13/036,647, entitled SURGICAL STAPLING INSTRUMENT, filed Feb. 28, 2011, now U.S. Pat. No. 8,561,870;
    • U.S. patent application Ser. No. 13/118,241, entitled SURGICAL STAPLING INSTRUMENTS WITH ROTATABLE STAPLE DEPLOYMENT ARRANGEMENTS, now U.S. Pat. No. 9,072,535;
    • U.S. patent application Ser. No. 13/524,049, entitled ARTICULATABLE SURGICAL INSTRUMENT COMPRISING A FIRING DRIVE, filed on Jun. 15, 2012, now U.S. Pat. No. 9,101,358;
    • U.S. patent application Ser. No. 13/800,025, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, filed on Mar. 13, 2013, now U.S. Pat. No. 9,345,481;
    • U.S. patent application Ser. No. 13/800,067, entitled STAPLE CARTRIDGE TISSUE THICKNESS SENSOR SYSTEM, filed on Mar. 13, 2013, now U.S. Patent Application Publication No. 2014/0263552;
    • U.S. Patent Application Publication No. 2007/0175955, entitled SURGICAL CUTTING AND FASTENING INSTRUMENT WITH CLOSURE TRIGGER LOCKING MECHANISM, filed Jan. 31, 2006; and
    • U.S. Patent Application Publication No. 2010/0264194, entitled SURGICAL STAPLING INSTRUMENT WITH AN ARTICULATABLE END EFFECTOR, filed Apr. 22, 2010, now U.S. Pat. No. 8,308,040, are hereby incorporated by reference herein.


Although the various embodiments of the devices have been described herein in connection with certain disclosed embodiments, many modifications and variations to those embodiments may be implemented. Also, where materials are disclosed for certain components, other materials may be used. Furthermore, according to various embodiments, a single component may be replaced by multiple components, and multiple components may be replaced by a single component, to perform a given function or functions. The foregoing description and following claims are intended to cover all such modification and variations.


The devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. In either case, however, the device can be reconditioned for reuse after at least one use. Reconditioning can include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, the device can be disassembled, and any number of the particular pieces or parts of the device can be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, the device can be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device can utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


By way of example only, aspects described herein may be processed before surgery. First, a new or used instrument may be obtained and when necessary cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container may keep the instrument sterile until it is opened in a medical facility. A device also may be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, plasma peroxide, or steam.


While this invention has been described as having exemplary designs, the present invention may be further modified within the spirit and scope of the disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles.


Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated materials does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

Claims
  • 1. A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises: a staple cartridge, comprising: a plurality of staples; anda cartridge deck; anda compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises: a first biocompatible layer comprising a first portion;a second biocompatible layer comprising a second portion, wherein the first biocompatible layer is spaced apart from the second biocompatible layer; anda plurality of discrete crossed spacer fibers extending between the first portion and the second portion, wherein the plurality of discrete crossed spacer fibers comprises: a first spacer fiber; anda second spacer fiber crossing the first spacer fiber in a space defined and maintained outside the first biocompatible layer and the second biocompatible layer by the plurality of discrete crossed spacer fibers, and wherein each of the first and second spacer fibers comprise: a first end portion directly attached to the first biocompatible layer; anda second end portion directly attached to the second biocompatible layer.
  • 2. A staple cartridge assembly for use with a surgical stapling instrument, wherein the staple cartridge assembly comprises: a staple cartridge, comprising: a plurality of staples; anda cartridge deck; anda compressible adjunct positionable against the cartridge deck, wherein the staples are deployable into tissue captured against the compressible adjunct, and wherein the compressible adjunct comprises: a tissue-facing layer, comprising: a first bonding node; anda second bonding node arranged in a first row with the first bonding node;a deck-facing layer, wherein the tissue-facing layer is spaced apart from the deck-facing layer, and wherein the deck-facing layer comprises: a third bonding node vertically aligned with the first bonding node; anda fourth bonding node vertically aligned with the second bonding node, wherein the fourth bonding node is arranged in a second row with the third bonding node;a first spacer fiber extending between the first bonding node and the fourth bonding node, wherein the first spacer fiber comprises: a first end directly attached to the tissue-facing layer; anda second end directly attached to the deck-facing layer; anda second spacer fiber extending between the second bonding node and the third bonding node, wherein the second spacer fiber comprises: a third end directly attached to the tissue-facing layer; anda fourth end directly attached to the deck-facing layer, and wherein the first spacer fiber crosses the second spacer fiber.
  • 3. The staple cartridge assembly of claim 2, wherein the first row is parallel to the second row.
  • 4. The staple cartridge assembly of claim 3, wherein the first row further comprises a fifth bonding node between the first bonding node and the second bonding node.
  • 5. The staple cartridge assembly of claim 4, further comprising a first fiber portion interconnecting the first bonding node and the fifth bonding node.
  • 6. The staple cartridge assembly of claim 5, further comprising a second fiber portion interconnecting the second bonding node and the fifth bonding node.
  • 7. The staple cartridge assembly of claim 6, wherein the second row further comprises a sixth bonding node between the third bonding node and the fourth bonding node.
  • 8. The staple cartridge assembly of claim 7, further comprising a third fiber portion interconnecting the third bonding node and the sixth bonding node.
  • 9. The staple cartridge assembly of claim 8, further comprising a fourth fiber portion interconnecting the fourth bonding node and the sixth bonding node.
  • 10. The staple cartridge assembly of claim 9, wherein the fifth bonding node is vertically aligned with the sixth bonding node.
  • 11. An adjunct for use with a surgical staple cartridge, wherein the adjunct comprises: a first biocompatible layer;a second biocompatible layer spaced apart from the first biocompatible layer; anda plurality of discrete supporting pillars extending between the first biocompatible layer and the second biocompatible layer, wherein the plurality of discrete supporting pillars comprises: a first supporting pillar; anda second supporting pillar crossing the first supporting pillar in a space defined between the first biocompatible layer and the second biocompatible layer, wherein the first supporting pillar is discrete from the second supporting pillar, and wherein each of the first and second supporting pillars comprises:a first end directly coupled to the first biocompatible layer; anda second end directly coupled to the second biocompatible layer.
  • 12. The adjunct of claim 11, wherein the first end is woven into the first biocompatible layer.
  • 13. The adjunct of claim 11, wherein the first end is welded to the first biocompatible layer.
  • 14. The adjunct of claim 11, wherein the second biocompatible layer comprises an outer surface configured to grip tissue.
  • 15. The adjunct of claim 14, wherein the outer surface comprises a plurality of gripping features.
  • 16. The adjunct of claim 11, further comprising a knife slot defined therein to movably receive a knife therethrough.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 17/061,764, entitled COMPRESSIBLE ADJUNCT WITH CROSSING SPACER FIBERS, filed Oct. 2, 2020, which issued on Dec. 28, 2022 as U.S. Pat. No. 11,553,916, which is a continuation application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 16/229,607, entitled COMPRESSIBLE ADJUNCT WITH CROSSING SPACER FIBERS, filed Dec. 21, 2018, which issued on Mar. 2, 2021 as U.S. Pat. No. 10,932,779, which is a continuation application claiming priority under 35 U.S.C. § 120 to U.S. patent application Ser. No. 14/871,071, entitled COMPRESSIBLE ADJUNCT WITH CROSSING SPACER FIBERS, filed Sep. 30, 2015, which issued on Oct. 8, 2019 as U.S. Pat. No. 10,433,846, the entire disclosures of which are hereby incorporated by reference herein.

US Referenced Citations (8465)
Number Name Date Kind
66052 Smith Jun 1867 A
662587 Blake Nov 1900 A
670748 Weddeler Mar 1901 A
719487 Minor Feb 1903 A
804229 Hutchinson Nov 1905 A
903739 Lesemann Nov 1908 A
951393 Hahn Mar 1910 A
1075556 Fenoughty Oct 1913 A
1082105 Anderson Dec 1913 A
1188721 Bittner Jun 1916 A
1306107 Elliott Jun 1919 A
1314601 McCaskey Sep 1919 A
1466128 Hallenbeck Aug 1923 A
1677337 Grove Jul 1928 A
1794907 Kelly Mar 1931 A
1849427 Hook Mar 1932 A
1912783 Meyer Jun 1933 A
1944116 Stratman Jan 1934 A
1954048 Jeffrey et al. Apr 1934 A
2028635 Wappler Jan 1936 A
2037727 La Chapelle Apr 1936 A
2120951 Hodgman Jun 1938 A
2132295 Hawkins Oct 1938 A
2161632 Nattenheimer Jun 1939 A
D120434 Gold May 1940 S
2211117 Hess Aug 1940 A
2214870 West Sep 1940 A
2224108 Ridgway Dec 1940 A
2224882 Peck Dec 1940 A
2256295 Schmid Sep 1941 A
2318379 Davis et al. May 1943 A
2329440 La Place Sep 1943 A
2377581 Shaffrey Jun 1945 A
2406389 Lee Aug 1946 A
2420552 Morrill May 1947 A
2441096 Happe May 1948 A
2448741 Scott et al. Sep 1948 A
2450527 Smith Oct 1948 A
2491872 Neuman Dec 1949 A
2507872 Unsinger May 1950 A
2526902 Rublee Oct 1950 A
2527256 Jackson Oct 1950 A
2578686 Fish Dec 1951 A
2638901 Sugarbaker May 1953 A
2674149 Benson Apr 1954 A
2701489 Osborn Feb 1955 A
2711461 Happe Jun 1955 A
2724289 Wight Nov 1955 A
2742955 Dominguez Apr 1956 A
2804848 O'Farrell et al. Sep 1957 A
2808482 Zanichkowsky et al. Oct 1957 A
2825178 Hawkins Mar 1958 A
2853074 Olson Sep 1958 A
2856192 Schuster Oct 1958 A
2887004 Stewart May 1959 A
2957353 Lewis Oct 1960 A
2959974 Emrick Nov 1960 A
3026744 Rouse Mar 1962 A
3032769 Palmer May 1962 A
3035256 Egbert May 1962 A
3060972 Sheldon Oct 1962 A
3075062 Iaccarino Jan 1963 A
3078465 Bobrov Feb 1963 A
3079606 Bobrov et al. Mar 1963 A
3080564 Strekopitov et al. Mar 1963 A
3166072 Sullivan, Jr. Jan 1965 A
3180236 Beckett Apr 1965 A
3196869 Scholl Jul 1965 A
3204731 Bent et al. Sep 1965 A
3252643 Strekopytov et al. May 1966 A
3266494 Brownrigg et al. Aug 1966 A
3269630 Fleischer Aug 1966 A
3269631 Takaro Aug 1966 A
3275211 Hirsch et al. Sep 1966 A
3315863 O'Dea Apr 1967 A
3317103 Cullen et al. May 1967 A
3317105 Astafjev et al. May 1967 A
3357296 Lefever Dec 1967 A
3359978 Smith, Jr. Dec 1967 A
3377893 Shorb Apr 1968 A
3480193 Ralston Nov 1969 A
3490675 Green et al. Jan 1970 A
3494533 Green et al. Feb 1970 A
3499591 Green Mar 1970 A
3503396 Pierie et al. Mar 1970 A
3509629 Kidokoro May 1970 A
3551987 Wilkinson Jan 1971 A
3568675 Harvey Mar 1971 A
3572159 Tschanz Mar 1971 A
3583393 Takahashi Jun 1971 A
3589589 Akopov Jun 1971 A
3598943 Barrett Aug 1971 A
3604561 Mallina et al. Sep 1971 A
3608549 Merrill Sep 1971 A
3616278 Jansen Oct 1971 A
3618842 Bryan Nov 1971 A
3635394 Natelson Jan 1972 A
3638652 Kelley Feb 1972 A
3640317 Panfili Feb 1972 A
3643851 Green et al. Feb 1972 A
3650453 Smith, Jr. Mar 1972 A
3661339 Shimizu May 1972 A
3661666 Foster et al. May 1972 A
3662939 Bryan May 1972 A
3685250 Henry et al. Aug 1972 A
3688966 Perkins et al. Sep 1972 A
3692224 Astafiev et al. Sep 1972 A
3695646 Mommsen Oct 1972 A
3709221 Riely Jan 1973 A
3717294 Green Feb 1973 A
3724237 Wood Apr 1973 A
3726755 Shannon Apr 1973 A
3727904 Gabbey Apr 1973 A
3734207 Fishbein May 1973 A
3740994 De Carlo, Jr. Jun 1973 A
3744495 Johnson Jul 1973 A
3746002 Haller Jul 1973 A
3747603 Adler Jul 1973 A
3747692 Davidson Jul 1973 A
3751902 Kingsbury et al. Aug 1973 A
3752161 Bent Aug 1973 A
3797494 Zaffaroni Mar 1974 A
3799151 Fukaumi et al. Mar 1974 A
3808452 Hutchinson Apr 1974 A
3815476 Green et al. Jun 1974 A
3819100 Noiles et al. Jun 1974 A
3821919 Knohl Jul 1974 A
3822818 Strekopytov et al. Jul 1974 A
3825007 Rand Jul 1974 A
3826978 Kelly Jul 1974 A
3836171 Hayashi et al. Sep 1974 A
3837555 Green Sep 1974 A
3841474 Maier Oct 1974 A
3851196 Hinds Nov 1974 A
3863639 Kleaveland Feb 1975 A
3863940 Cummings Feb 1975 A
3883624 McKenzie et al. May 1975 A
3885491 Curtis May 1975 A
3887393 La Rue, Jr. Jun 1975 A
3892228 Mitsui Jul 1975 A
3894174 Cartun Jul 1975 A
3899829 Storm et al. Aug 1975 A
3902247 Fleer et al. Sep 1975 A
3940844 Colby et al. Mar 1976 A
3944163 Hayashi et al. Mar 1976 A
3950686 Randall Apr 1976 A
3952747 Kimmell, Jr. Apr 1976 A
3955581 Spasiano et al. May 1976 A
3959879 Sellers Jun 1976 A
RE28932 Noiles et al. Aug 1976 E
3972734 King Aug 1976 A
3973179 Weber et al. Aug 1976 A
3981051 Brumlik Sep 1976 A
3993072 Zaffaroni Nov 1976 A
3999110 Ramstrom et al. Dec 1976 A
4025216 Hives May 1977 A
4027746 Kine Jun 1977 A
4034143 Sweet Jul 1977 A
4038987 Komiya Aug 1977 A
4047654 Alvarado Sep 1977 A
4054108 Gill Oct 1977 A
4060089 Noiles Nov 1977 A
4066133 Voss Jan 1978 A
4085337 Moeller Apr 1978 A
4100820 Evett Jul 1978 A
4106446 Yamada et al. Aug 1978 A
4106620 Brimmer et al. Aug 1978 A
4108211 Tanaka Aug 1978 A
4111206 Vishnevsky et al. Sep 1978 A
4127227 Green Nov 1978 A
4129059 Van Eck Dec 1978 A
4132146 Uhlig Jan 1979 A
4135517 Reale Jan 1979 A
4149461 Simeth Apr 1979 A
4154122 Severin May 1979 A
4160857 Nardella et al. Jul 1979 A
4169476 Hiltebrandt Oct 1979 A
4169990 Lerdman Oct 1979 A
4180285 Reneau Dec 1979 A
4185701 Boys Jan 1980 A
4190042 Sinnreich Feb 1980 A
4191377 Burnside Mar 1980 A
4198734 Brumlik Apr 1980 A
4198982 Fortner et al. Apr 1980 A
4203444 Bonnell et al. May 1980 A
4207898 Becht Jun 1980 A
4213562 Garrett et al. Jul 1980 A
4226242 Jarvik Oct 1980 A
4239431 Davini Dec 1980 A
4241861 Fleischer Dec 1980 A
4244372 Kapitanov et al. Jan 1981 A
4250436 Weissman Feb 1981 A
4250817 Michel Feb 1981 A
4261244 Becht et al. Apr 1981 A
4272002 Moshofsky Jun 1981 A
4272662 Simpson Jun 1981 A
4274304 Curtiss Jun 1981 A
4274398 Scott, Jr. Jun 1981 A
4275813 Noiles Jun 1981 A
4278091 Borzone Jul 1981 A
4282573 Imai et al. Aug 1981 A
4289131 Mueller Sep 1981 A
4289133 Rothfuss Sep 1981 A
4290542 Fedotov et al. Sep 1981 A
D261356 Robinson Oct 1981 S
4293604 Campbell Oct 1981 A
4296654 Mercer Oct 1981 A
4296881 Lee Oct 1981 A
4304236 Conta et al. Dec 1981 A
4305539 Korolkov et al. Dec 1981 A
4312363 Rothfuss et al. Jan 1982 A
4312685 Riedl Jan 1982 A
4317451 Cerwin et al. Mar 1982 A
4319576 Rothfuss Mar 1982 A
4321002 Froehlich Mar 1982 A
4321746 Grinage Mar 1982 A
4328839 Lyons et al. May 1982 A
4331277 Green May 1982 A
4340331 Savino Jul 1982 A
4347450 Colligan Aug 1982 A
4348603 Huber Sep 1982 A
4349028 Green Sep 1982 A
4350151 Scott Sep 1982 A
4353371 Cosman Oct 1982 A
4357940 Muller Nov 1982 A
4361057 Kochera Nov 1982 A
4366544 Shima et al. Dec 1982 A
4369013 Abildgaard et al. Jan 1983 A
4373147 Carlson, Jr. Feb 1983 A
4376380 Burgess Mar 1983 A
4379457 Gravener et al. Apr 1983 A
4380312 Landrus Apr 1983 A
4382326 Rabuse May 1983 A
4383634 Green May 1983 A
4389963 Pearson Jun 1983 A
4393728 Larson et al. Jul 1983 A
4394613 Cole Jul 1983 A
4396139 Hall et al. Aug 1983 A
4397311 Kanshin et al. Aug 1983 A
4402445 Green Sep 1983 A
4406621 Bailey Sep 1983 A
4408692 Sigel et al. Oct 1983 A
4409057 Molenda et al. Oct 1983 A
4415112 Green Nov 1983 A
4416276 Newton et al. Nov 1983 A
4417890 Dennehey et al. Nov 1983 A
4421264 Arter et al. Dec 1983 A
4423456 Zaidenweber Dec 1983 A
4425915 Ivanov Jan 1984 A
4428376 Mericle Jan 1984 A
4429695 Green Feb 1984 A
4430997 DiGiovanni et al. Feb 1984 A
4434796 Karapetian et al. Mar 1984 A
4438659 Desplats Mar 1984 A
4442964 Becht Apr 1984 A
4448194 DiGiovanni et al. May 1984 A
4451743 Suzuki et al. May 1984 A
4452376 Klieman et al. Jun 1984 A
4454887 Kruger Jun 1984 A
4459519 Erdman Jul 1984 A
4461305 Cibley Jul 1984 A
4467805 Fukuda Aug 1984 A
4468597 Baumard et al. Aug 1984 A
4469481 Kobayashi Sep 1984 A
4470414 Imagawa et al. Sep 1984 A
4471780 Menges et al. Sep 1984 A
4471781 Di Giovanni et al. Sep 1984 A
4473077 Noiles et al. Sep 1984 A
4475679 Fleury, Jr. Oct 1984 A
4476864 Tezel Oct 1984 A
4478220 Di Giovanni et al. Oct 1984 A
4480641 Failla et al. Nov 1984 A
4481458 Lane Nov 1984 A
4483562 Schoolman Nov 1984 A
4485816 Krumme Dec 1984 A
4485817 Swiggett Dec 1984 A
4486928 Tucker et al. Dec 1984 A
4488523 Shichman Dec 1984 A
4489875 Crawford et al. Dec 1984 A
4493983 Taggert Jan 1985 A
4494057 Hotta Jan 1985 A
4499895 Takayama Feb 1985 A
4500024 DiGiovanni et al. Feb 1985 A
D278081 Green Mar 1985 S
4503842 Takayama Mar 1985 A
4505272 Utyamyshev et al. Mar 1985 A
4505273 Braun et al. Mar 1985 A
4505414 Filipi Mar 1985 A
4506671 Green Mar 1985 A
4512038 Alexander et al. Apr 1985 A
4514477 Kobayashi Apr 1985 A
4520817 Green Jun 1985 A
4522327 Korthoff et al. Jun 1985 A
4523707 Blake, III et al. Jun 1985 A
4526174 Froehlich Jul 1985 A
4527724 Chow et al. Jul 1985 A
4530357 Pawloski et al. Jul 1985 A
4530453 Green Jul 1985 A
4531522 Bedi et al. Jul 1985 A
4532927 Miksza, Jr. Aug 1985 A
4540202 Amphoux et al. Sep 1985 A
4548202 Duncan Oct 1985 A
4556058 Green Dec 1985 A
4560915 Soultanian Dec 1985 A
4565109 Tsay Jan 1986 A
4565189 Mabuchi Jan 1986 A
4566620 Green et al. Jan 1986 A
4569346 Poirier Feb 1986 A
4569469 Mongeon et al. Feb 1986 A
4571213 Ishimoto Feb 1986 A
4573468 Conta et al. Mar 1986 A
4573469 Golden et al. Mar 1986 A
4573622 Green et al. Mar 1986 A
4576165 Green et al. Mar 1986 A
4576167 Noiles Mar 1986 A
4580712 Green Apr 1986 A
4585153 Failla et al. Apr 1986 A
4586501 Claracq May 1986 A
4586502 Bedi et al. May 1986 A
4589416 Green May 1986 A
4589582 Bilotti May 1986 A
4589870 Citrin et al. May 1986 A
4591085 Di Giovanni May 1986 A
RE32214 Schramm Jul 1986 E
4597753 Turley Jul 1986 A
4600037 Hatten Jul 1986 A
4604786 Howie, Jr. Aug 1986 A
4605001 Rothfuss et al. Aug 1986 A
4605004 Di Giovanni et al. Aug 1986 A
4606343 Conta et al. Aug 1986 A
4607636 Kula et al. Aug 1986 A
4607638 Crainich Aug 1986 A
4608980 Aihara Sep 1986 A
4608981 Rothfuss et al. Sep 1986 A
4610250 Green Sep 1986 A
4610383 Rothfuss et al. Sep 1986 A
4612933 Brinkerhoff et al. Sep 1986 A
D286180 Korthoff Oct 1986 S
D286442 Korthoff et al. Oct 1986 S
4617893 Donner et al. Oct 1986 A
4617914 Ueda Oct 1986 A
4617935 Cartmell et al. Oct 1986 A
4619262 Taylor Oct 1986 A
4619391 Sharkany et al. Oct 1986 A
4624401 Gassner et al. Nov 1986 A
D287278 Spreckelmeier Dec 1986 S
4628459 Shinohara et al. Dec 1986 A
4628636 Folger Dec 1986 A
4629107 Fedotov et al. Dec 1986 A
4632290 Green et al. Dec 1986 A
4633861 Chow et al. Jan 1987 A
4633874 Chow et al. Jan 1987 A
4634419 Kreizman et al. Jan 1987 A
4635638 Weintraub et al. Jan 1987 A
4641076 Linden Feb 1987 A
4642618 Johnson et al. Feb 1987 A
4642738 Meller Feb 1987 A
4643173 Bell et al. Feb 1987 A
4643731 Eckenhoff Feb 1987 A
4646722 Silverstein et al. Mar 1987 A
4646745 Noiles Mar 1987 A
4651734 Doss et al. Mar 1987 A
4652820 Maresca Mar 1987 A
4654028 Suma Mar 1987 A
4655222 Florez et al. Apr 1987 A
4662555 Thornton May 1987 A
4663874 Sano et al. May 1987 A
4664305 Blake, III et al. May 1987 A
4665916 Green May 1987 A
4667674 Korthoff et al. May 1987 A
4669647 Storace Jun 1987 A
4671278 Chin Jun 1987 A
4671280 Dorband et al. Jun 1987 A
4671445 Barker et al. Jun 1987 A
4672964 Dee et al. Jun 1987 A
4675944 Wells Jun 1987 A
4676245 Fukuda Jun 1987 A
4679460 Yoshigai Jul 1987 A
4679719 Kramer Jul 1987 A
4684051 Akopov et al. Aug 1987 A
4688555 Wardle Aug 1987 A
4691703 Auth et al. Sep 1987 A
4693248 Failla Sep 1987 A
4698579 Richter et al. Oct 1987 A
4700703 Resnick et al. Oct 1987 A
4705038 Sjostrom et al. Nov 1987 A
4708141 Inoue et al. Nov 1987 A
4709120 Pearson Nov 1987 A
4715520 Roehr, Jr. et al. Dec 1987 A
4719917 Barrows et al. Jan 1988 A
4721099 Chikama Jan 1988 A
4722340 Takayama et al. Feb 1988 A
4724840 McVay et al. Feb 1988 A
4726247 Hormann Feb 1988 A
4727308 Huljak et al. Feb 1988 A
4728020 Green et al. Mar 1988 A
4728876 Mongeon et al. Mar 1988 A
4729260 Dudden Mar 1988 A
4730726 Holzwarth Mar 1988 A
4741336 Failla et al. May 1988 A
4743214 Tai-Cheng May 1988 A
4744363 Hasson May 1988 A
4747820 Hornlein et al. May 1988 A
4750902 Wuchinich et al. Jun 1988 A
4752024 Green et al. Jun 1988 A
4754909 Barker et al. Jul 1988 A
4755070 Cerutti Jul 1988 A
4761326 Barnes et al. Aug 1988 A
4763669 Jaeger Aug 1988 A
4767044 Green Aug 1988 A
D297764 Hunt et al. Sep 1988 S
4773420 Green Sep 1988 A
4777780 Holzwarth Oct 1988 A
4781186 Simpson et al. Nov 1988 A
4784137 Kulik et al. Nov 1988 A
4787387 Burbank, III et al. Nov 1988 A
4788485 Kawagishi et al. Nov 1988 A
D298967 Hunt Dec 1988 S
4788978 Strekopytov et al. Dec 1988 A
4790225 Moody et al. Dec 1988 A
4790314 Weaver Dec 1988 A
4805617 Bedi et al. Feb 1989 A
4805823 Rothfuss Feb 1989 A
4807628 Peters et al. Feb 1989 A
4809695 Gwathmey et al. Mar 1989 A
4815460 Porat et al. Mar 1989 A
4817643 Olson Apr 1989 A
4817847 Redtenbacher et al. Apr 1989 A
4819495 Hormann Apr 1989 A
4819853 Green Apr 1989 A
4821939 Green Apr 1989 A
4827552 Bojar et al. May 1989 A
4827911 Broadwin et al. May 1989 A
4828542 Hermann May 1989 A
4828944 Yabe et al. May 1989 A
4830855 Stewart May 1989 A
4832158 Farrar et al. May 1989 A
4833937 Nagano May 1989 A
4834096 Oh et al. May 1989 A
4834720 Blinkhorn May 1989 A
4838859 Strassmann Jun 1989 A
4844068 Arata et al. Jul 1989 A
4848637 Pruitt Jul 1989 A
4856078 Konopka Aug 1989 A
4860644 Kohl et al. Aug 1989 A
4862891 Smith Sep 1989 A
4863423 Wallace Sep 1989 A
4865030 Polyak Sep 1989 A
4868530 Ahs Sep 1989 A
4868958 Suzuki et al. Sep 1989 A
4869414 Green et al. Sep 1989 A
4869415 Fox Sep 1989 A
4870966 Dellon et al. Oct 1989 A
4873977 Avant et al. Oct 1989 A
4875486 Rapoport et al. Oct 1989 A
4880015 Nierman Nov 1989 A
4890613 Golden et al. Jan 1990 A
4892244 Fox et al. Jan 1990 A
4893622 Green et al. Jan 1990 A
4894051 Shiber Jan 1990 A
4896584 Stoll et al. Jan 1990 A
4896678 Ogawa Jan 1990 A
4900303 Lemelson Feb 1990 A
4903697 Resnick et al. Feb 1990 A
4909789 Taguchi et al. Mar 1990 A
4915100 Green Apr 1990 A
4919039 Nutter Apr 1990 A
4919679 Averill et al. Apr 1990 A
4921479 Grayzel May 1990 A
4925082 Kim May 1990 A
4928699 Sasai May 1990 A
4930503 Pruitt Jun 1990 A
4930674 Barak Jun 1990 A
4931047 Broadwin et al. Jun 1990 A
4931737 Hishiki Jun 1990 A
4932960 Green et al. Jun 1990 A
4933800 Yang Jun 1990 A
4933843 Scheller et al. Jun 1990 A
D309350 Sutherland et al. Jul 1990 S
4938408 Bedi et al. Jul 1990 A
4941623 Pruitt Jul 1990 A
4943182 Hoblingre Jul 1990 A
4944443 Oddsen et al. Jul 1990 A
4946067 Kelsall Aug 1990 A
4948327 Crupi, Jr. Aug 1990 A
4949707 Levahn et al. Aug 1990 A
4949927 Madocks et al. Aug 1990 A
4950268 Rink Aug 1990 A
4951860 Peters et al. Aug 1990 A
4951861 Schulze et al. Aug 1990 A
4954960 Lo et al. Sep 1990 A
4955959 Tompkins et al. Sep 1990 A
4957212 Duck et al. Sep 1990 A
4962681 Yang Oct 1990 A
4962877 Hervas Oct 1990 A
4964559 Deniega et al. Oct 1990 A
4964863 Kanshin et al. Oct 1990 A
4965709 Ngo Oct 1990 A
4970656 Lo et al. Nov 1990 A
4973274 Hirukawa Nov 1990 A
4973302 Armour et al. Nov 1990 A
4976173 Yang Dec 1990 A
4978049 Green Dec 1990 A
4978333 Broadwin et al. Dec 1990 A
4979952 Kubota et al. Dec 1990 A
4984564 Yuen Jan 1991 A
4986808 Broadwin et al. Jan 1991 A
4987049 Komamura et al. Jan 1991 A
4988334 Hornlein et al. Jan 1991 A
4995877 Ams et al. Feb 1991 A
4995959 Metzner Feb 1991 A
4996975 Nakamura Mar 1991 A
5001649 Lo et al. Mar 1991 A
5002543 Bradshaw et al. Mar 1991 A
5002553 Shiber Mar 1991 A
5005754 Van Overloop Apr 1991 A
5009222 Her Apr 1991 A
5009661 Michelson Apr 1991 A
5012411 Policastro et al. Apr 1991 A
D316875 Momot et al. May 1991 S
5014898 Heidrich May 1991 A
5014899 Presty et al. May 1991 A
5015227 Broadwin et al. May 1991 A
5018515 Gilman May 1991 A
5018657 Pedlick et al. May 1991 A
5019077 De Bastiani et al. May 1991 A
5024652 Dumenek et al. Jun 1991 A
5024671 Tu et al. Jun 1991 A
5025559 McCullough Jun 1991 A
5027834 Pruitt Jul 1991 A
5030226 Green et al. Jul 1991 A
5031814 Tompkins et al. Jul 1991 A
5033552 Hu Jul 1991 A
5035040 Kerrigan et al. Jul 1991 A
5037018 Matsuda et al. Aug 1991 A
5038109 Goble et al. Aug 1991 A
5038247 Kelley et al. Aug 1991 A
5040715 Green et al. Aug 1991 A
5042707 Taheri Aug 1991 A
5056953 Marot et al. Oct 1991 A
5060658 Dejter, Jr. et al. Oct 1991 A
5061269 Muller Oct 1991 A
5062491 Takeshima et al. Nov 1991 A
5062563 Green et al. Nov 1991 A
5065929 Schulze et al. Nov 1991 A
5071052 Rodak et al. Dec 1991 A
5071430 de Salis et al. Dec 1991 A
5074454 Peters Dec 1991 A
5077506 Krause Dec 1991 A
5079006 Urquhart Jan 1992 A
5080556 Carreno Jan 1992 A
5083695 Foslien et al. Jan 1992 A
5084057 Green et al. Jan 1992 A
5088979 Filipi et al. Feb 1992 A
5088997 Delahuerga et al. Feb 1992 A
5089606 Cole et al. Feb 1992 A
5094247 Hernandez et al. Mar 1992 A
5098004 Kerrigan Mar 1992 A
5098360 Hirota Mar 1992 A
5100042 Gravener et al. Mar 1992 A
5100420 Green et al. Mar 1992 A
5100422 Berguer et al. Mar 1992 A
5104025 Main et al. Apr 1992 A
5104397 Vasconcelos et al. Apr 1992 A
5104400 Berguer et al. Apr 1992 A
5106008 Tompkins et al. Apr 1992 A
5108368 Hammerslag et al. Apr 1992 A
5109722 Hufnagle et al. May 1992 A
5111987 Moeinzadeh et al. May 1992 A
5116349 Aranyi May 1992 A
D327323 Hunt Jun 1992 S
5119009 McCaleb et al. Jun 1992 A
5122156 Granger et al. Jun 1992 A
5124990 Williamson Jun 1992 A
5129570 Schulze et al. Jul 1992 A
5135483 Wagner et al. Aug 1992 A
5137198 Nobis et al. Aug 1992 A
5139513 Segato Aug 1992 A
5141144 Foslien et al. Aug 1992 A
5142932 Moya et al. Sep 1992 A
5151102 Kamiyama et al. Sep 1992 A
5155941 Takahashi et al. Oct 1992 A
5156151 Imran Oct 1992 A
5156315 Green et al. Oct 1992 A
5156609 Nakao et al. Oct 1992 A
5156614 Green et al. Oct 1992 A
5158222 Green et al. Oct 1992 A
5158567 Green Oct 1992 A
D330699 Gill Nov 1992 S
5163598 Peters et al. Nov 1992 A
5163842 Nonomura Nov 1992 A
5164652 Johnson et al. Nov 1992 A
5168605 Bartlett Dec 1992 A
5170925 Madden et al. Dec 1992 A
5171247 Hughett et al. Dec 1992 A
5171249 Stefanchik et al. Dec 1992 A
5171253 Klieman Dec 1992 A
5173053 Swanson et al. Dec 1992 A
5173133 Morin et al. Dec 1992 A
5176677 Wuchinich Jan 1993 A
5176688 Narayan et al. Jan 1993 A
5180375 Feibus Jan 1993 A
5181514 Solomon et al. Jan 1993 A
5187422 Izenbaard et al. Feb 1993 A
5188102 Idemoto et al. Feb 1993 A
5188111 Yates et al. Feb 1993 A
5188126 Fabian et al. Feb 1993 A
5190517 Zieve et al. Mar 1993 A
5190544 Chapman et al. Mar 1993 A
5190560 Woods et al. Mar 1993 A
5190657 Heagle et al. Mar 1993 A
5192288 Thompson et al. Mar 1993 A
5193731 Aranyi Mar 1993 A
5195505 Josefsen Mar 1993 A
5195968 Lundquist et al. Mar 1993 A
5197648 Gingold Mar 1993 A
5197649 Bessler et al. Mar 1993 A
5197966 Sommerkamp Mar 1993 A
5197970 Green et al. Mar 1993 A
5200280 Karasa Apr 1993 A
5201750 Hocherl et al. Apr 1993 A
5205459 Brinkerhoff et al. Apr 1993 A
5207672 Roth et al. May 1993 A
5207697 Carusillo et al. May 1993 A
5209747 Knoepfler May 1993 A
5209756 Seedhom et al. May 1993 A
5211649 Kohler et al. May 1993 A
5211655 Hasson May 1993 A
5217457 Delahuerga et al. Jun 1993 A
5217478 Rexroth Jun 1993 A
5219111 Bilotti et al. Jun 1993 A
5220269 Chen et al. Jun 1993 A
5221036 Takase Jun 1993 A
5221281 Klicek Jun 1993 A
5222945 Basnight Jun 1993 A
5222963 Brinkerhoff et al. Jun 1993 A
5222975 Crainich Jun 1993 A
5222976 Yoon Jun 1993 A
5223675 Taft Jun 1993 A
D337962 Avitan Isaac Aug 1993 S
D338729 Sprecklemeier et al. Aug 1993 S
5234447 Kaster et al. Aug 1993 A
5236269 Handy Aug 1993 A
5236424 Imran Aug 1993 A
5236440 Hlavacek Aug 1993 A
5236629 Mahabadi et al. Aug 1993 A
5239981 Anapliotis Aug 1993 A
5240163 Stein et al. Aug 1993 A
5242456 Nash et al. Sep 1993 A
5242457 Akopov et al. Sep 1993 A
5244462 Delahuerga et al. Sep 1993 A
5246156 Rothfuss et al. Sep 1993 A
5246443 Mai Sep 1993 A
5251801 Ruckdeschel et al. Oct 1993 A
5253793 Green et al. Oct 1993 A
5258007 Spetzler et al. Nov 1993 A
5258008 Wilk Nov 1993 A
5258009 Conners Nov 1993 A
5258010 Green et al. Nov 1993 A
5258012 Luscombe et al. Nov 1993 A
5259366 Reydel et al. Nov 1993 A
5259835 Clark et al. Nov 1993 A
5260637 Pizzi Nov 1993 A
5261135 Mitchell Nov 1993 A
5261877 Fine et al. Nov 1993 A
5261922 Hood Nov 1993 A
5263629 Trumbull et al. Nov 1993 A
5263937 Shipp Nov 1993 A
5263973 Cook Nov 1993 A
5264218 Rogozinski Nov 1993 A
5268622 Philipp Dec 1993 A
5269794 Rexroth Dec 1993 A
5271543 Grant et al. Dec 1993 A
5271544 Fox et al. Dec 1993 A
RE34519 Fox et al. Jan 1994 E
5275322 Brinkerhoff et al. Jan 1994 A
5275323 Schulze et al. Jan 1994 A
5275608 Forman et al. Jan 1994 A
5279416 Malec et al. Jan 1994 A
5281216 Klicek Jan 1994 A
5281400 Berry, Jr. Jan 1994 A
5282806 Haber et al. Feb 1994 A
5282826 Quadri Feb 1994 A
5282829 Hermes Feb 1994 A
5284128 Hart Feb 1994 A
5285381 Iskarous et al. Feb 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5286253 Fucci Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290271 Jernberg Mar 1994 A
5290310 Makower et al. Mar 1994 A
5291133 Gokhale et al. Mar 1994 A
5292053 Bilotti et al. Mar 1994 A
5293024 Sugahara et al. Mar 1994 A
5297714 Kramer Mar 1994 A
5300087 Knoepfler Apr 1994 A
5302148 Heinz Apr 1994 A
5303606 Kokinda Apr 1994 A
5304204 Bregen Apr 1994 A
D347474 Olson May 1994 S
5307976 Olson et al. May 1994 A
5308353 Beurrier May 1994 A
5308358 Bond et al. May 1994 A
5308576 Green et al. May 1994 A
5309387 Mori et al. May 1994 A
5309927 Welch May 1994 A
5312023 Green et al. May 1994 A
5312024 Grant et al. May 1994 A
5312329 Beaty et al. May 1994 A
5313935 Kortenbach et al. May 1994 A
5313967 Lieber et al. May 1994 A
5314424 Nicholas May 1994 A
5314445 Heidmueller et al. May 1994 A
5314466 Stern et al. May 1994 A
5318221 Green et al. Jun 1994 A
5318589 Lichtman Jun 1994 A
5320627 Sorensen et al. Jun 1994 A
D348930 Olson Jul 1994 S
5326013 Green et al. Jul 1994 A
5329923 Lundquist Jul 1994 A
5330486 Wilk Jul 1994 A
5330487 Thornton et al. Jul 1994 A
5330502 Hassler et al. Jul 1994 A
5331971 Bales et al. Jul 1994 A
5332142 Robinson et al. Jul 1994 A
5333422 Warren et al. Aug 1994 A
5333772 Rothfuss et al. Aug 1994 A
5333773 Main et al. Aug 1994 A
5334183 Wuchinich Aug 1994 A
5336130 Ray Aug 1994 A
5336229 Noda Aug 1994 A
5336232 Green et al. Aug 1994 A
5338317 Hasson et al. Aug 1994 A
5339799 Kami et al. Aug 1994 A
5341724 Vatel Aug 1994 A
5341807 Nardella Aug 1994 A
5341810 Dardel Aug 1994 A
5342380 Hood Aug 1994 A
5342381 Tidemand Aug 1994 A
5342385 Norelli et al. Aug 1994 A
5342395 Jarrett et al. Aug 1994 A
5342396 Cook Aug 1994 A
5343382 Hale et al. Aug 1994 A
5343391 Mushabac Aug 1994 A
5344059 Green et al. Sep 1994 A
5344060 Gravener et al. Sep 1994 A
5344454 Clarke et al. Sep 1994 A
5346504 Ortiz et al. Sep 1994 A
5348259 Blanco et al. Sep 1994 A
5350104 Main et al. Sep 1994 A
5350355 Sklar Sep 1994 A
5350388 Epstein Sep 1994 A
5350391 Iacovelli Sep 1994 A
5350400 Esposito et al. Sep 1994 A
5352229 Goble et al. Oct 1994 A
5352235 Koros et al. Oct 1994 A
5352238 Green et al. Oct 1994 A
5353798 Sieben Oct 1994 A
5354215 Viracola Oct 1994 A
5354250 Christensen Oct 1994 A
5354303 Spaeth et al. Oct 1994 A
5355897 Pietrafitta et al. Oct 1994 A
5356006 Alpern et al. Oct 1994 A
5356064 Green et al. Oct 1994 A
5358506 Green et al. Oct 1994 A
5358510 Luscombe et al. Oct 1994 A
5359231 Flowers et al. Oct 1994 A
D352780 Glaeser et al. Nov 1994 S
5359993 Slater et al. Nov 1994 A
5360305 Kerrigan Nov 1994 A
5360428 Hutchinson, Jr. Nov 1994 A
5361902 Abidin et al. Nov 1994 A
5364001 Bryan Nov 1994 A
5364002 Green et al. Nov 1994 A
5364003 Williamson, IV Nov 1994 A
5366133 Geiste Nov 1994 A
5366134 Green et al. Nov 1994 A
5366479 McGarry et al. Nov 1994 A
5368015 Wilk Nov 1994 A
5368592 Stern et al. Nov 1994 A
5368599 Hirsch et al. Nov 1994 A
5369565 Chen et al. Nov 1994 A
5370645 Klicek et al. Dec 1994 A
5372124 Takayama et al. Dec 1994 A
5372596 Klicek et al. Dec 1994 A
5372602 Burke Dec 1994 A
5374277 Hassler Dec 1994 A
5375588 Yoon Dec 1994 A
5376095 Ortiz Dec 1994 A
5379933 Green et al. Jan 1995 A
5381649 Webb Jan 1995 A
5381782 DeLaRama et al. Jan 1995 A
5381943 Allen et al. Jan 1995 A
5382247 Cimino et al. Jan 1995 A
5383460 Jang et al. Jan 1995 A
5383738 Herbermann Jan 1995 A
5383874 Jackson et al. Jan 1995 A
5383880 Hooven Jan 1995 A
5383881 Green et al. Jan 1995 A
5383882 Buess et al. Jan 1995 A
5383888 Zvenyatsky et al. Jan 1995 A
5383895 Holmes et al. Jan 1995 A
5388568 van der Heide Feb 1995 A
5388748 Davignon et al. Feb 1995 A
5389072 Imran Feb 1995 A
5389098 Tsuruta et al. Feb 1995 A
5389102 Green et al. Feb 1995 A
5389104 Hahnen et al. Feb 1995 A
5391180 Tovey et al. Feb 1995 A
5392979 Green et al. Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5395033 Byrne et al. Mar 1995 A
5395034 Allen et al. Mar 1995 A
5395312 Desai Mar 1995 A
5395384 Duthoit et al. Mar 1995 A
5397046 Savage et al. Mar 1995 A
5397324 Carroll et al. Mar 1995 A
5400267 Denen et al. Mar 1995 A
5403276 Schechter et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5404106 Matsuda Apr 1995 A
5404870 Brinkerhoff et al. Apr 1995 A
5404960 Wada et al. Apr 1995 A
5405072 Zlock et al. Apr 1995 A
5405073 Porter Apr 1995 A
5405344 Williamson et al. Apr 1995 A
5405360 Tovey Apr 1995 A
5407293 Crainich Apr 1995 A
5408409 Glassman et al. Apr 1995 A
5409498 Braddock et al. Apr 1995 A
5409703 McAnalley et al. Apr 1995 A
D357981 Green et al. May 1995 S
5411481 Allen et al. May 1995 A
5411508 Bessler et al. May 1995 A
5413107 Oakley et al. May 1995 A
5413267 Solyntjes et al. May 1995 A
5413268 Green et al. May 1995 A
5413272 Green et al. May 1995 A
5413573 Koivukangas May 1995 A
5415334 Williamson et al. May 1995 A
5415335 Knodell, Jr. May 1995 A
5417203 Tovey et al. May 1995 A
5417361 Williamson, IV May 1995 A
5419766 Chang et al. May 1995 A
5421829 Olichney et al. Jun 1995 A
5422567 Matsunaga Jun 1995 A
5423471 Mastri et al. Jun 1995 A
5423809 Klicek Jun 1995 A
5423835 Green et al. Jun 1995 A
5425355 Kulick Jun 1995 A
5425745 Green et al. Jun 1995 A
5427298 Tegtmeier Jun 1995 A
5431322 Green et al. Jul 1995 A
5431323 Smith et al. Jul 1995 A
5431645 Smith et al. Jul 1995 A
5431654 Nic Jul 1995 A
5431666 Sauer et al. Jul 1995 A
5431668 Burbank, III et al. Jul 1995 A
5433721 Hooven et al. Jul 1995 A
5437681 Meade et al. Aug 1995 A
5438302 Goble Aug 1995 A
5438997 Sieben et al. Aug 1995 A
5439155 Viola Aug 1995 A
5439156 Grant et al. Aug 1995 A
5439479 Shichman et al. Aug 1995 A
5441191 Linden Aug 1995 A
5441193 Gravener Aug 1995 A
5441483 Avitall Aug 1995 A
5441494 Ortiz Aug 1995 A
5441499 Fritzsch Aug 1995 A
5443197 Malis et al. Aug 1995 A
5443198 Viola et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5444113 Sinclair et al. Aug 1995 A
5445155 Sieben Aug 1995 A
5445304 Plyley et al. Aug 1995 A
5445604 Lang Aug 1995 A
5445644 Pietrafitta et al. Aug 1995 A
5446646 Miyazaki Aug 1995 A
5447265 Vidal et al. Sep 1995 A
5447417 Kuhl et al. Sep 1995 A
5447513 Davison et al. Sep 1995 A
5449355 Rhum et al. Sep 1995 A
5449365 Green et al. Sep 1995 A
5449370 Vaitekunas Sep 1995 A
5452836 Huitema et al. Sep 1995 A
5452837 Williamson, IV et al. Sep 1995 A
5454378 Palmer et al. Oct 1995 A
5454822 Schob et al. Oct 1995 A
5454824 Fontayne et al. Oct 1995 A
5454827 Aust et al. Oct 1995 A
5456401 Green et al. Oct 1995 A
5456917 Wise et al. Oct 1995 A
5458279 Plyley Oct 1995 A
5458579 Chodorow et al. Oct 1995 A
5462215 Viola et al. Oct 1995 A
5464013 Lemelson Nov 1995 A
5464144 Guy et al. Nov 1995 A
5464300 Crainich Nov 1995 A
5465819 Weilant et al. Nov 1995 A
5465894 Clark et al. Nov 1995 A
5465895 Knodel et al. Nov 1995 A
5465896 Allen et al. Nov 1995 A
5466020 Page et al. Nov 1995 A
5467911 Tsuruta et al. Nov 1995 A
5468253 Bezwada et al. Nov 1995 A
5470006 Rodak Nov 1995 A
5470007 Plyley et al. Nov 1995 A
5470008 Rodak Nov 1995 A
5470009 Rodak Nov 1995 A
5470010 Rothfuss et al. Nov 1995 A
5471129 Mann Nov 1995 A
5472132 Savage et al. Dec 1995 A
5472442 Klicek Dec 1995 A
5473204 Temple Dec 1995 A
5474057 Makower et al. Dec 1995 A
5474223 Viola et al. Dec 1995 A
5474566 Alesi et al. Dec 1995 A
5474570 Kockerling et al. Dec 1995 A
5474738 Nichols et al. Dec 1995 A
5476206 Green et al. Dec 1995 A
5476479 Green et al. Dec 1995 A
5476481 Schondorf Dec 1995 A
5478003 Green et al. Dec 1995 A
5478308 Cartmell et al. Dec 1995 A
5478354 Tovey et al. Dec 1995 A
5480089 Blewett Jan 1996 A
5480409 Riza Jan 1996 A
5482197 Green et al. Jan 1996 A
5483630 Unuma et al. Jan 1996 A
5483952 Aranyi Jan 1996 A
5484095 Green et al. Jan 1996 A
5484398 Stoddard Jan 1996 A
5484451 Akopov et al. Jan 1996 A
5485947 Olson et al. Jan 1996 A
5485952 Fontayne Jan 1996 A
5487377 Smith et al. Jan 1996 A
5487499 Sorrentino et al. Jan 1996 A
5487500 Knodel et al. Jan 1996 A
5489058 Plyley et al. Feb 1996 A
5489256 Adair Feb 1996 A
5489290 Furnish Feb 1996 A
5490819 Nicholas et al. Feb 1996 A
5492671 Krafft Feb 1996 A
5496312 Klicek Mar 1996 A
5496317 Goble et al. Mar 1996 A
5497933 DeFonzo et al. Mar 1996 A
5498164 Ward et al. Mar 1996 A
5498838 Furman Mar 1996 A
5501654 Failla et al. Mar 1996 A
5503320 Webster et al. Apr 1996 A
5503635 Sauer et al. Apr 1996 A
5503638 Cooper et al. Apr 1996 A
5505363 Green et al. Apr 1996 A
5507425 Ziglioli Apr 1996 A
5507426 Young et al. Apr 1996 A
5507773 Huitema et al. Apr 1996 A
5508080 Sorimachi et al. Apr 1996 A
5509596 Green et al. Apr 1996 A
5509916 Taylor Apr 1996 A
5509918 Romano Apr 1996 A
5510138 Sanftleben et al. Apr 1996 A
5511564 Wilk Apr 1996 A
5514129 Smith May 1996 A
5514149 Green et al. May 1996 A
5514157 Nicholas et al. May 1996 A
5518163 Hooven May 1996 A
5518164 Hooven May 1996 A
5520609 Moll et al. May 1996 A
5520634 Fox et al. May 1996 A
5520678 Heckele et al. May 1996 A
5520700 Beyar et al. May 1996 A
5522817 Sander et al. Jun 1996 A
5522831 Sleister et al. Jun 1996 A
5527264 Moll et al. Jun 1996 A
5527320 Carruthers et al. Jun 1996 A
5529235 Boiarski et al. Jun 1996 A
D372086 Grasso et al. Jul 1996 S
5531305 Roberts et al. Jul 1996 A
5531744 Nardella et al. Jul 1996 A
5531856 Moll et al. Jul 1996 A
5533521 Granger Jul 1996 A
5533581 Barth et al. Jul 1996 A
5533661 Main et al. Jul 1996 A
5535934 Boiarski et al. Jul 1996 A
5535935 Vidal et al. Jul 1996 A
5535937 Boiarski et al. Jul 1996 A
5540375 Bolanos et al. Jul 1996 A
5540705 Meade et al. Jul 1996 A
5541376 Ladtkow et al. Jul 1996 A
5541489 Dunstan Jul 1996 A
5542594 McKean et al. Aug 1996 A
5542945 Fritzsch Aug 1996 A
5542949 Yoon Aug 1996 A
5543119 Sutter et al. Aug 1996 A
5543695 Culp et al. Aug 1996 A
5544802 Crainich Aug 1996 A
5547117 Hamblin et al. Aug 1996 A
5549583 Sanford et al. Aug 1996 A
5549621 Bessler et al. Aug 1996 A
5549627 Kieturakis Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5549637 Crainich Aug 1996 A
5551622 Yoon Sep 1996 A
5553624 Francese et al. Sep 1996 A
5553675 Pitzen et al. Sep 1996 A
5553765 Knodel et al. Sep 1996 A
5554148 Aebischer et al. Sep 1996 A
5554169 Green et al. Sep 1996 A
5556020 Hou Sep 1996 A
5556416 Clark et al. Sep 1996 A
5558533 Hashizawa et al. Sep 1996 A
5558665 Kieturakis Sep 1996 A
5558671 Yates Sep 1996 A
5560530 Bolanos et al. Oct 1996 A
5560532 DeFonzo et al. Oct 1996 A
5561881 Klinger et al. Oct 1996 A
5562239 Boiarski et al. Oct 1996 A
5562241 Knodel et al. Oct 1996 A
5562682 Oberlin et al. Oct 1996 A
5562690 Green et al. Oct 1996 A
5562694 Sauer et al. Oct 1996 A
5562701 Huitema et al. Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5563481 Krause Oct 1996 A
5564615 Bishop et al. Oct 1996 A
5569161 Ebling et al. Oct 1996 A
5569270 Weng Oct 1996 A
5569284 Young et al. Oct 1996 A
5571090 Sherts Nov 1996 A
5571100 Goble et al. Nov 1996 A
5571116 Bolanos et al. Nov 1996 A
5571285 Chow et al. Nov 1996 A
5571488 Beerstecher et al. Nov 1996 A
5573169 Green et al. Nov 1996 A
5573543 Akopov et al. Nov 1996 A
5574431 McKeown et al. Nov 1996 A
5575054 Klinzing et al. Nov 1996 A
5575789 Bell et al. Nov 1996 A
5575799 Bolanos et al. Nov 1996 A
5575803 Cooper et al. Nov 1996 A
5575805 Li Nov 1996 A
5577654 Bishop Nov 1996 A
5578052 Koros et al. Nov 1996 A
5579978 Green et al. Dec 1996 A
5580067 Hamblin et al. Dec 1996 A
5582611 Tsuruta et al. Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5582907 Pall Dec 1996 A
5583114 Barrows et al. Dec 1996 A
5584425 Savage et al. Dec 1996 A
5586711 Plyley et al. Dec 1996 A
5588579 Schnut et al. Dec 1996 A
5588580 Paul et al. Dec 1996 A
5588581 Conlon et al. Dec 1996 A
5591170 Spievack et al. Jan 1997 A
5591187 Dekel Jan 1997 A
5597107 Knodel et al. Jan 1997 A
5599151 Daum et al. Feb 1997 A
5599279 Slotman et al. Feb 1997 A
5599344 Paterson Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5599852 Scopelianos et al. Feb 1997 A
5601224 Bishop et al. Feb 1997 A
5601573 Fogelberg et al. Feb 1997 A
5601604 Vincent Feb 1997 A
5602449 Krause et al. Feb 1997 A
5603443 Clark et al. Feb 1997 A
5605272 Witt et al. Feb 1997 A
5605273 Hamblin et al. Feb 1997 A
D378500 Nakai et al. Mar 1997 S
5607094 Clark et al. Mar 1997 A
5607095 Smith et al. Mar 1997 A
5607303 Nakamura Mar 1997 A
5607433 Polla et al. Mar 1997 A
5607436 Pratt et al. Mar 1997 A
5607450 Zvenyatsky et al. Mar 1997 A
5607474 Athanasiou et al. Mar 1997 A
5609285 Grant et al. Mar 1997 A
5609601 Kolesa et al. Mar 1997 A
5611709 McAnulty Mar 1997 A
5611813 Lichtman Mar 1997 A
5613499 Palmer et al. Mar 1997 A
5613937 Garrison et al. Mar 1997 A
5613966 Makower et al. Mar 1997 A
5614887 Buchbinder Mar 1997 A
5615820 Viola Apr 1997 A
5618294 Aust et al. Apr 1997 A
5618303 Marlow et al. Apr 1997 A
5618307 Donlon et al. Apr 1997 A
5619992 Guthrie et al. Apr 1997 A
5620289 Curry Apr 1997 A
5620326 Younker Apr 1997 A
5620415 Lucey et al. Apr 1997 A
5620452 Yoon Apr 1997 A
5624398 Smith et al. Apr 1997 A
5624452 Yates Apr 1997 A
5626587 Bishop et al. May 1997 A
5626595 Sklar et al. May 1997 A
5626979 Mitsui et al. May 1997 A
5628446 Geiste et al. May 1997 A
5628743 Cimino May 1997 A
5628745 Bek May 1997 A
5630539 Plyley et al. May 1997 A
5630540 Blewett May 1997 A
5630541 Williamson, IV et al. May 1997 A
5630782 Adair May 1997 A
5631973 Green May 1997 A
5632432 Schulze et al. May 1997 A
5632433 Grant et al. May 1997 A
5633374 Humphrey et al. May 1997 A
5634584 Okorocha et al. Jun 1997 A
5636779 Palmer Jun 1997 A
5636780 Green et al. Jun 1997 A
5637110 Pennybacker et al. Jun 1997 A
5638582 Klatt et al. Jun 1997 A
5639008 Gallagher et al. Jun 1997 A
D381077 Hunt Jul 1997 S
5643291 Pier et al. Jul 1997 A
5643293 Kogasaka et al. Jul 1997 A
5643294 Tovey et al. Jul 1997 A
5643319 Green et al. Jul 1997 A
5645209 Green et al. Jul 1997 A
5647526 Green et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5649937 Bito et al. Jul 1997 A
5649956 Jensen et al. Jul 1997 A
5651491 Heaton et al. Jul 1997 A
5651762 Bridges Jul 1997 A
5651821 Uchida Jul 1997 A
5653373 Green et al. Aug 1997 A
5653374 Young et al. Aug 1997 A
5653677 Okada et al. Aug 1997 A
5653721 Knodel et al. Aug 1997 A
5653748 Strecker Aug 1997 A
5655698 Yoon Aug 1997 A
5656917 Theobald Aug 1997 A
5657417 Di Troia Aug 1997 A
5657429 Wang et al. Aug 1997 A
5657921 Young et al. Aug 1997 A
5658238 Suzuki et al. Aug 1997 A
5658281 Heard Aug 1997 A
5658298 Vincent et al. Aug 1997 A
5658300 Bito et al. Aug 1997 A
5658307 Exconde Aug 1997 A
5662258 Knodel et al. Sep 1997 A
5662260 Yoon Sep 1997 A
5662662 Bishop et al. Sep 1997 A
5662667 Knodel Sep 1997 A
5664404 Ivanov et al. Sep 1997 A
5665085 Nardella Sep 1997 A
5667517 Hooven Sep 1997 A
5667526 Levin Sep 1997 A
5667527 Cook Sep 1997 A
5667864 Landoll Sep 1997 A
5669544 Schulze et al. Sep 1997 A
5669904 Platt, Jr. et al. Sep 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5669918 Balazs et al. Sep 1997 A
5672945 Krause Sep 1997 A
5673840 Schulze et al. Oct 1997 A
5673841 Schulze et al. Oct 1997 A
5673842 Bittner et al. Oct 1997 A
5674184 Hassler, Jr. Oct 1997 A
5674286 D'Alessio et al. Oct 1997 A
5678748 Plyley et al. Oct 1997 A
5680981 Mililli et al. Oct 1997 A
5680982 Schulze et al. Oct 1997 A
5680983 Plyley et al. Oct 1997 A
5681341 Lunsford et al. Oct 1997 A
5683349 Makower et al. Nov 1997 A
5683432 Goedeke et al. Nov 1997 A
5685474 Seeber Nov 1997 A
5686090 Schilder et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5690269 Bolanos et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5692668 Schulze et al. Dec 1997 A
5693020 Rauh Dec 1997 A
5693042 Boiarski et al. Dec 1997 A
5693051 Schulze et al. Dec 1997 A
5695494 Becker Dec 1997 A
5695502 Pier et al. Dec 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695524 Kelley et al. Dec 1997 A
5697542 Knodel et al. Dec 1997 A
5697543 Burdorff Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697943 Sauer et al. Dec 1997 A
5700265 Romano Dec 1997 A
5700270 Peyser et al. Dec 1997 A
5700276 Benecke Dec 1997 A
5702387 Arts et al. Dec 1997 A
5702408 Wales et al. Dec 1997 A
5702409 Rayburn et al. Dec 1997 A
5704087 Strub Jan 1998 A
5704534 Huitema et al. Jan 1998 A
5704792 Sobhani Jan 1998 A
5706997 Green et al. Jan 1998 A
5706998 Plyley et al. Jan 1998 A
5707392 Kortenbach Jan 1998 A
5709334 Sorrentino et al. Jan 1998 A
5709335 Heck Jan 1998 A
5709680 Yates et al. Jan 1998 A
5709706 Kienzle et al. Jan 1998 A
5711472 Bryan Jan 1998 A
5711960 Shikinami Jan 1998 A
5712460 Carr et al. Jan 1998 A
5713128 Schrenk et al. Feb 1998 A
5713505 Huitema Feb 1998 A
5713895 Lontine et al. Feb 1998 A
5713896 Nardella Feb 1998 A
5713920 Bezwada et al. Feb 1998 A
5715604 Lanzoni Feb 1998 A
5715836 Kliegis et al. Feb 1998 A
5715987 Kelley et al. Feb 1998 A
5715988 Palmer Feb 1998 A
5716352 Viola et al. Feb 1998 A
5716366 Yates Feb 1998 A
5718359 Palmer et al. Feb 1998 A
5718360 Green et al. Feb 1998 A
5718548 Cotellessa Feb 1998 A
5718714 Livneh Feb 1998 A
5720744 Eggleston et al. Feb 1998 A
D393067 Geary et al. Mar 1998 S
5724025 Tavori Mar 1998 A
5725536 Oberlin et al. Mar 1998 A
5725554 Simon et al. Mar 1998 A
5728110 Vidal et al. Mar 1998 A
5728113 Sherts Mar 1998 A
5728121 Bimbo et al. Mar 1998 A
5730758 Allgeyer Mar 1998 A
5732712 Adair Mar 1998 A
5732821 Stone et al. Mar 1998 A
5732871 Clark et al. Mar 1998 A
5732872 Bolduc et al. Mar 1998 A
5733308 Daugherty et al. Mar 1998 A
5735445 Vidal et al. Apr 1998 A
5735848 Yates et al. Apr 1998 A
5735874 Measamer et al. Apr 1998 A
5736271 Cisar et al. Apr 1998 A
5738474 Blewett Apr 1998 A
5738629 Moll et al. Apr 1998 A
5738648 Lands et al. Apr 1998 A
5741271 Nakao et al. Apr 1998 A
5743456 Jones et al. Apr 1998 A
5746770 Zeitels et al. May 1998 A
5747953 Philipp May 1998 A
5749889 Bacich et al. May 1998 A
5749893 Vidal et al. May 1998 A
5749896 Cook May 1998 A
5749968 Melanson et al. May 1998 A
5752644 Bolanos et al. May 1998 A
5752965 Francis et al. May 1998 A
5752970 Yoon May 1998 A
5752973 Kieturakis May 1998 A
5755717 Yates et al. May 1998 A
5755726 Pratt et al. May 1998 A
D395645 Cappa et al. Jun 1998 S
5758814 Gallagher et al. Jun 1998 A
5762255 Chrisman et al. Jun 1998 A
5762256 Mastri et al. Jun 1998 A
5762458 Wang et al. Jun 1998 A
5765565 Adair Jun 1998 A
5766186 Faraz et al. Jun 1998 A
5766188 Igaki Jun 1998 A
5766205 Zvenyatsky et al. Jun 1998 A
5769303 Knodel et al. Jun 1998 A
5769640 Jacobus et al. Jun 1998 A
5769748 Eyerly et al. Jun 1998 A
5769791 Benaron et al. Jun 1998 A
5769892 Kingwell Jun 1998 A
5772099 Gravener Jun 1998 A
5772379 Evensen Jun 1998 A
5772578 Heimberger et al. Jun 1998 A
5772659 Becker et al. Jun 1998 A
5773991 Chen Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5778939 Hok-Yin Jul 1998 A
5779130 Alesi et al. Jul 1998 A
5779131 Knodel et al. Jul 1998 A
5779132 Knodel et al. Jul 1998 A
5782396 Mastri et al. Jul 1998 A
5782397 Koukline Jul 1998 A
5782748 Palmer et al. Jul 1998 A
5782749 Riza Jul 1998 A
5782859 Nicholas et al. Jul 1998 A
5784934 Izumisawa Jul 1998 A
5785232 Vidal et al. Jul 1998 A
5785647 Tompkins et al. Jul 1998 A
5787897 Kieturakis Aug 1998 A
5791231 Cohn et al. Aug 1998 A
5792135 Madhani et al. Aug 1998 A
5792162 Jolly et al. Aug 1998 A
5792165 Klieman et al. Aug 1998 A
5792573 Pitzen et al. Aug 1998 A
5794834 Hamblin et al. Aug 1998 A
5796188 Bays Aug 1998 A
5797536 Smith et al. Aug 1998 A
5797537 Oberlin et al. Aug 1998 A
5797538 Heaton et al. Aug 1998 A
5797637 Ervin Aug 1998 A
5797900 Madhani et al. Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797927 Yoon Aug 1998 A
5797941 Schulze et al. Aug 1998 A
5797959 Castro et al. Aug 1998 A
5798752 Buxton et al. Aug 1998 A
5799857 Robertson et al. Sep 1998 A
5800379 Edwards Sep 1998 A
5800423 Jensen Sep 1998 A
5804726 Geib et al. Sep 1998 A
5804936 Brodsky et al. Sep 1998 A
5806676 Wasgien Sep 1998 A
5807241 Heimberger Sep 1998 A
5807376 Viola et al. Sep 1998 A
5807378 Jensen et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5809441 McKee Sep 1998 A
5810240 Robertson Sep 1998 A
5810721 Mueller et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5810846 Virnich et al. Sep 1998 A
5810855 Rayburn et al. Sep 1998 A
5812188 Adair Sep 1998 A
5813813 Daum et al. Sep 1998 A
5814055 Knodel et al. Sep 1998 A
5814057 Oi et al. Sep 1998 A
5816471 Plyley et al. Oct 1998 A
5817084 Jensen Oct 1998 A
5817091 Nardella et al. Oct 1998 A
5817093 Williamson, IV et al. Oct 1998 A
5817109 McGarry et al. Oct 1998 A
5817119 Klieman et al. Oct 1998 A
5820009 Melling et al. Oct 1998 A
5823066 Huitema et al. Oct 1998 A
5824333 Scopelianos et al. Oct 1998 A
5826776 Schulze et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5827298 Hart et al. Oct 1998 A
5827323 Klieman et al. Oct 1998 A
5829662 Allen et al. Nov 1998 A
5830598 Patterson Nov 1998 A
5833690 Yates et al. Nov 1998 A
5833695 Yoon Nov 1998 A
5833696 Whitfield et al. Nov 1998 A
5836503 Ehrenfels et al. Nov 1998 A
5836960 Kolesa et al. Nov 1998 A
5839369 Chatterjee et al. Nov 1998 A
5839639 Sauer et al. Nov 1998 A
5841284 Takahashi Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843096 Igaki et al. Dec 1998 A
5843097 Mayenberger et al. Dec 1998 A
5843122 Riza Dec 1998 A
5843132 Ilvento Dec 1998 A
5843169 Taheri Dec 1998 A
5846254 Schulze et al. Dec 1998 A
5847566 Marritt et al. Dec 1998 A
5849011 Jones et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5849023 Mericle Dec 1998 A
5851179 Ritson et al. Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5855311 Hamblin et al. Jan 1999 A
5855583 Wang et al. Jan 1999 A
5860581 Robertson et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5865361 Milliman et al. Feb 1999 A
5865638 Trafton Feb 1999 A
5868361 Rinderer Feb 1999 A
5868664 Speier et al. Feb 1999 A
5868760 McGuckin, Jr. Feb 1999 A
5868790 Vincent et al. Feb 1999 A
5871135 Williamson, IV et al. Feb 1999 A
5873885 Weidenbenner Feb 1999 A
5876401 Schulze et al. Mar 1999 A
5878193 Wang et al. Mar 1999 A
5878607 Nunes et al. Mar 1999 A
5878937 Green et al. Mar 1999 A
5878938 Bittner et al. Mar 1999 A
5881777 Bassi et al. Mar 1999 A
5881943 Heck et al. Mar 1999 A
5891094 Masterson et al. Apr 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891558 Bell et al. Apr 1999 A
5893506 Powell Apr 1999 A
5893835 Witt et al. Apr 1999 A
5893855 Jacobs Apr 1999 A
5893863 Yoon Apr 1999 A
5893878 Pierce Apr 1999 A
5894979 Powell Apr 1999 A
5897552 Edwards et al. Apr 1999 A
5897562 Bolanos et al. Apr 1999 A
5899824 Kurtz et al. May 1999 A
5899914 Zirps et al. May 1999 A
5901895 Heaton et al. May 1999 A
5902312 Frater et al. May 1999 A
5903117 Gregory May 1999 A
5904647 Ouchi May 1999 A
5904693 Dicesare et al. May 1999 A
5904702 Ek et al. May 1999 A
5906577 Beane et al. May 1999 A
5906625 Bito et al. May 1999 A
5907211 Hall et al. May 1999 A
5907664 Wang et al. May 1999 A
5908149 Welch et al. Jun 1999 A
5908402 Blythe Jun 1999 A
5908427 McKean et al. Jun 1999 A
5909062 Krietzman Jun 1999 A
5911353 Bolanos et al. Jun 1999 A
5915616 Viola et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5918791 Sorrentino et al. Jul 1999 A
5919198 Graves, Jr. et al. Jul 1999 A
5921956 Grinberg et al. Jul 1999 A
5922001 Yoon Jul 1999 A
5922003 Anctil et al. Jul 1999 A
5924864 Loge et al. Jul 1999 A
5928137 Green Jul 1999 A
5928256 Riza Jul 1999 A
5931847 Bittner et al. Aug 1999 A
5931853 McEwen et al. Aug 1999 A
5937951 Izuchukwu et al. Aug 1999 A
5938667 Peyser et al. Aug 1999 A
5941442 Geiste et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5944172 Hannula Aug 1999 A
5944715 Goble et al. Aug 1999 A
5946978 Yamashita Sep 1999 A
5947984 Whipple Sep 1999 A
5947996 Logeman Sep 1999 A
5948030 Miller et al. Sep 1999 A
5948429 Bell et al. Sep 1999 A
5951301 Younker Sep 1999 A
5951516 Bunyan Sep 1999 A
5951552 Long et al. Sep 1999 A
5951574 Stefanchik et al. Sep 1999 A
5951575 Bolduc et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5954259 Viola et al. Sep 1999 A
5957831 Adair Sep 1999 A
5964394 Robertson Oct 1999 A
5964774 McKean et al. Oct 1999 A
5966126 Szabo Oct 1999 A
5971916 Koren Oct 1999 A
5973221 Collyer et al. Oct 1999 A
D416089 Barton et al. Nov 1999 S
5976122 Madhani et al. Nov 1999 A
5977746 Hershberger et al. Nov 1999 A
5980248 Kusakabe et al. Nov 1999 A
5980569 Scirica Nov 1999 A
5984949 Levin Nov 1999 A
5988479 Palmer Nov 1999 A
5990379 Gregory Nov 1999 A
5993464 Knodel Nov 1999 A
5993466 Yoon Nov 1999 A
5997528 Bisch et al. Dec 1999 A
5997552 Person et al. Dec 1999 A
6001108 Wang et al. Dec 1999 A
6003517 Sheffield et al. Dec 1999 A
6004319 Goble et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6007521 Bidwell et al. Dec 1999 A
6010054 Johnson et al. Jan 2000 A
6010513 Tormala et al. Jan 2000 A
6010520 Pattison Jan 2000 A
6012494 Balazs Jan 2000 A
6013076 Goble et al. Jan 2000 A
6013991 Philipp Jan 2000 A
6015406 Goble et al. Jan 2000 A
6015417 Reynolds, Jr. Jan 2000 A
6017322 Snoke et al. Jan 2000 A
6017354 Culp et al. Jan 2000 A
6017356 Frederick et al. Jan 2000 A
6018227 Kumar et al. Jan 2000 A
6019745 Gray Feb 2000 A
6019780 Lombardo et al. Feb 2000 A
6022352 Vandewalle Feb 2000 A
6023275 Horvitz et al. Feb 2000 A
6023641 Thompson Feb 2000 A
6024708 Bales et al. Feb 2000 A
6024741 Williamson, IV et al. Feb 2000 A
6024748 Manzo et al. Feb 2000 A
6024750 Mastri et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6027501 Goble et al. Feb 2000 A
6030384 Nezhat Feb 2000 A
6031148 Hayes et al. Feb 2000 A
6032849 Mastri et al. Mar 2000 A
6033105 Barker et al. Mar 2000 A
6033378 Lundquist et al. Mar 2000 A
6033399 Gines Mar 2000 A
6033427 Lee Mar 2000 A
6036641 Taylor et al. Mar 2000 A
6036667 Manna et al. Mar 2000 A
6037724 Buss et al. Mar 2000 A
6037927 Rosenberg Mar 2000 A
6039126 Hsieh Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039734 Goble Mar 2000 A
6042601 Smith Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6043626 Snyder et al. Mar 2000 A
D422545 Palalau et al. Apr 2000 S
6045560 McKean et al. Apr 2000 A
6047861 Vidal et al. Apr 2000 A
6049145 Austin et al. Apr 2000 A
6050172 Corves et al. Apr 2000 A
6050472 Shibata Apr 2000 A
6050989 Fox et al. Apr 2000 A
6050990 Tankovich et al. Apr 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053390 Green et al. Apr 2000 A
6053899 Slanda et al. Apr 2000 A
6053922 Krause et al. Apr 2000 A
6054142 Li et al. Apr 2000 A
6055062 Dina et al. Apr 2000 A
RE36720 Green et al. May 2000 E
6056735 Okada et al. May 2000 A
6056746 Goble et al. May 2000 A
6059806 Hoegerle May 2000 A
6062360 Shields May 2000 A
6063020 Jones et al. May 2000 A
6063025 Bridges et al. May 2000 A
6063050 Manna et al. May 2000 A
6063095 Wang et al. May 2000 A
6063097 Oi et al. May 2000 A
6063098 Houser et al. May 2000 A
6065679 Levie et al. May 2000 A
6065919 Peck May 2000 A
6066132 Chen et al. May 2000 A
6066144 Wolf et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6068627 Orszulak et al. May 2000 A
6071233 Ishikawa et al. Jun 2000 A
6072299 Kurle et al. Jun 2000 A
6074386 Goble et al. Jun 2000 A
6074401 Gardiner et al. Jun 2000 A
6075441 Maloney Jun 2000 A
6077280 Fossum Jun 2000 A
6077286 Cuschieri et al. Jun 2000 A
6077290 Marini Jun 2000 A
6079606 Milliman et al. Jun 2000 A
6080181 Jensen et al. Jun 2000 A
6082577 Coates et al. Jul 2000 A
6083191 Rose Jul 2000 A
6083223 Baker Jul 2000 A
6083234 Nicholas et al. Jul 2000 A
6083242 Cook Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6086600 Kortenbach Jul 2000 A
6090106 Goble et al. Jul 2000 A
6090123 Culp et al. Jul 2000 A
6093186 Goble Jul 2000 A
6094021 Noro et al. Jul 2000 A
D429252 Haitani et al. Aug 2000 S
6099537 Sugai et al. Aug 2000 A
6099551 Gabbay Aug 2000 A
6102271 Longo et al. Aug 2000 A
6102926 Tartaglia et al. Aug 2000 A
6104162 Sainsbury et al. Aug 2000 A
6104304 Clark et al. Aug 2000 A
6106511 Jensen Aug 2000 A
6109500 Alli et al. Aug 2000 A
6110187 Donlon Aug 2000 A
6113618 Nic Sep 2000 A
6117148 Ravo et al. Sep 2000 A
6117158 Measamer et al. Sep 2000 A
6119913 Adams et al. Sep 2000 A
6120433 Mizuno et al. Sep 2000 A
6120462 Hibner et al. Sep 2000 A
6123241 Walter et al. Sep 2000 A
6123701 Nezhat Sep 2000 A
H1904 Yates et al. Oct 2000 H
RE36923 Hiroi et al. Oct 2000 E
6126058 Adams et al. Oct 2000 A
6126359 Dittrich et al. Oct 2000 A
6126670 Walker et al. Oct 2000 A
6131789 Schulze et al. Oct 2000 A
6131790 Piraka Oct 2000 A
6132368 Cooper Oct 2000 A
6134962 Sugitani Oct 2000 A
6139546 Koenig et al. Oct 2000 A
6142149 Steen Nov 2000 A
6142933 Longo et al. Nov 2000 A
6147135 Yuan et al. Nov 2000 A
6148979 Roach et al. Nov 2000 A
6149660 Laufer et al. Nov 2000 A
6151323 O'Connell et al. Nov 2000 A
6152935 Kammerer et al. Nov 2000 A
6155083 Goeser et al. Dec 2000 A
6155473 Tompkins et al. Dec 2000 A
6156056 Kearns et al. Dec 2000 A
6157169 Lee Dec 2000 A
6157303 Bodie et al. Dec 2000 A
6159146 El Gazayerli Dec 2000 A
6159200 Verdura et al. Dec 2000 A
6159224 Yoon Dec 2000 A
6162208 Hipps Dec 2000 A
6162220 Nezhat Dec 2000 A
6162537 Martin et al. Dec 2000 A
6165175 Wampler et al. Dec 2000 A
6165184 Verdura et al. Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6167185 Smiley et al. Dec 2000 A
6168605 Measamer et al. Jan 2001 B1
6171305 Sherman Jan 2001 B1
6171316 Kovac et al. Jan 2001 B1
6171330 Benchetrit Jan 2001 B1
6173074 Russo Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6174309 Wrublewski et al. Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6175290 Forsythe et al. Jan 2001 B1
6179195 Adams et al. Jan 2001 B1
6179776 Adams et al. Jan 2001 B1
6181105 Cutolo et al. Jan 2001 B1
6182673 Kindermann et al. Feb 2001 B1
6185356 Parker et al. Feb 2001 B1
6186142 Schmidt et al. Feb 2001 B1
6186957 Milam Feb 2001 B1
6187003 Buysse et al. Feb 2001 B1
6190386 Rydell Feb 2001 B1
6193129 Bittner et al. Feb 2001 B1
6197042 Ginn et al. Mar 2001 B1
6200311 Danek et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6202914 Geiste et al. Mar 2001 B1
6206894 Thompson et al. Mar 2001 B1
6206897 Jamiolkowski et al. Mar 2001 B1
6206903 Ramans Mar 2001 B1
6206904 Ouchi Mar 2001 B1
6209414 Uneme Apr 2001 B1
6210403 Klicek Apr 2001 B1
6211626 Lys et al. Apr 2001 B1
6213999 Platt, Jr. et al. Apr 2001 B1
6214028 Yoon et al. Apr 2001 B1
6220368 Ark et al. Apr 2001 B1
6221007 Green Apr 2001 B1
6221023 Matsuba et al. Apr 2001 B1
6223100 Green Apr 2001 B1
6223835 Habedank et al. May 2001 B1
6224617 Saadat et al. May 2001 B1
6228080 Gines May 2001 B1
6228081 Goble May 2001 B1
6228083 Lands et al. May 2001 B1
6228084 Kirwan, Jr. May 2001 B1
6228089 Wahrburg May 2001 B1
6228098 Kayan et al. May 2001 B1
6231565 Tovey et al. May 2001 B1
6234178 Goble et al. May 2001 B1
6235036 Gardner et al. May 2001 B1
6237604 Burnside et al. May 2001 B1
6238384 Peer May 2001 B1
6241139 Milliman et al. Jun 2001 B1
6241140 Adams et al. Jun 2001 B1
6241723 Heim et al. Jun 2001 B1
6245084 Mark et al. Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6248117 Blatter Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6249105 Andrews et al. Jun 2001 B1
6250532 Green et al. Jun 2001 B1
6251485 Harris et al. Jun 2001 B1
D445745 Norman Jul 2001 S
6254534 Butler et al. Jul 2001 B1
6254619 Garabet et al. Jul 2001 B1
6254642 Taylor Jul 2001 B1
6258107 Balazs et al. Jul 2001 B1
6261246 Pantages et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261679 Chen et al. Jul 2001 B1
6264086 McGuckin, Jr. Jul 2001 B1
6264087 Whitman Jul 2001 B1
6264617 Bales et al. Jul 2001 B1
6269997 Balazs et al. Aug 2001 B1
6270508 Klieman et al. Aug 2001 B1
6270916 Sink et al. Aug 2001 B1
6273252 Mitchell Aug 2001 B1
6273876 Klima et al. Aug 2001 B1
6273897 Dalessandro et al. Aug 2001 B1
6277114 Bullivant et al. Aug 2001 B1
6280407 Manna et al. Aug 2001 B1
6283981 Beaupre Sep 2001 B1
6293927 McGuckin, Jr. Sep 2001 B1
6293942 Goble et al. Sep 2001 B1
6296607 Milbocker Oct 2001 B1
6296640 Wampler et al. Oct 2001 B1
6302311 Adams et al. Oct 2001 B1
6302743 Chiu et al. Oct 2001 B1
6305891 Burlingame Oct 2001 B1
6306134 Goble et al. Oct 2001 B1
6306149 Meade Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6309397 Julian et al. Oct 2001 B1
6309400 Beaupre Oct 2001 B2
6309403 Minor et al. Oct 2001 B1
6312435 Wallace et al. Nov 2001 B1
6315184 Whitman Nov 2001 B1
6317616 Glossop Nov 2001 B1
6319510 Yates Nov 2001 B1
6320123 Reimers Nov 2001 B1
6322494 Bullivant et al. Nov 2001 B1
6324339 Hudson et al. Nov 2001 B1
6325799 Goble Dec 2001 B1
6325805 Ogilvie et al. Dec 2001 B1
6325810 Hamilton et al. Dec 2001 B1
6328498 Mersch Dec 2001 B1
6330965 Milliman et al. Dec 2001 B1
6331181 Tierney et al. Dec 2001 B1
6331761 Kumar et al. Dec 2001 B1
6333029 Vyakarnam et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6334861 Chandler et al. Jan 2002 B1
6336926 Goble Jan 2002 B1
6338737 Toledano Jan 2002 B1
6338738 Bellotti et al. Jan 2002 B1
6343731 Adams et al. Feb 2002 B1
6346077 Taylor et al. Feb 2002 B1
6348061 Whitman Feb 2002 B1
6349868 Mattingly et al. Feb 2002 B1
D454951 Bon Mar 2002 S
6352503 Matsui et al. Mar 2002 B1
6352532 Kramer et al. Mar 2002 B1
6355699 Vyakarnam et al. Mar 2002 B1
6356072 Chass Mar 2002 B1
6358224 Tims et al. Mar 2002 B1
6358263 Mark et al. Mar 2002 B2
6358459 Ziegler et al. Mar 2002 B1
6361542 Dimitriu et al. Mar 2002 B1
6364828 Yeung et al. Apr 2002 B1
6364877 Goble et al. Apr 2002 B1
6364888 Niemeyer et al. Apr 2002 B1
6366441 Ozawa et al. Apr 2002 B1
6370981 Watarai Apr 2002 B2
6371114 Schmidt et al. Apr 2002 B1
6373152 Wang et al. Apr 2002 B1
6377011 Ben-Ur Apr 2002 B1
6383201 Dong May 2002 B1
6387092 Burnside et al. May 2002 B1
6387113 Hawkins et al. May 2002 B1
6387114 Adams May 2002 B2
6391038 Vargas et al. May 2002 B2
6392854 O'Gorman May 2002 B1
6394998 Wallace et al. May 2002 B1
6398779 Buysse et al. Jun 2002 B1
6398781 Goble et al. Jun 2002 B1
6398797 Bombard et al. Jun 2002 B2
6402766 Bowman et al. Jun 2002 B2
6402780 Williamson, IV et al. Jun 2002 B2
6406440 Stefanchik Jun 2002 B1
6406472 Jensen Jun 2002 B1
6409724 Penny et al. Jun 2002 B1
H2037 Yates et al. Jul 2002 H
6412639 Hickey Jul 2002 B1
6413274 Pedros Jul 2002 B1
6415542 Bates et al. Jul 2002 B1
6416486 Wampler Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6419695 Gabbay Jul 2002 B1
6423079 Blake, III Jul 2002 B1
6424885 Niemeyer et al. Jul 2002 B1
RE37814 Allgeyer Aug 2002 E
6428070 Takanashi et al. Aug 2002 B1
6428487 Burdorff et al. Aug 2002 B1
6429611 Li Aug 2002 B1
6430298 Kettl et al. Aug 2002 B1
6432065 Burdorff et al. Aug 2002 B1
6436097 Nardella Aug 2002 B1
6436107 Wang et al. Aug 2002 B1
6436110 Bowman et al. Aug 2002 B2
6436115 Beaupre Aug 2002 B1
6436122 Frank et al. Aug 2002 B1
6439439 Rickard et al. Aug 2002 B1
6439446 Perry et al. Aug 2002 B1
6440146 Nicholas et al. Aug 2002 B2
6441577 Blumenkranz et al. Aug 2002 B2
D462758 Epstein et al. Sep 2002 S
6443973 Whitman Sep 2002 B1
6445530 Baker Sep 2002 B1
6447518 Krause et al. Sep 2002 B1
6447523 Middleman et al. Sep 2002 B1
6447799 Ullman Sep 2002 B1
6447864 Johnson et al. Sep 2002 B2
6450391 Kayan et al. Sep 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6454656 Brissette et al. Sep 2002 B2
6454781 Witt et al. Sep 2002 B1
6457338 Frenken Oct 2002 B1
6457625 Tormala et al. Oct 2002 B1
6458077 Boebel et al. Oct 2002 B1
6458142 Faller et al. Oct 2002 B1
6458147 Cruise et al. Oct 2002 B1
6460627 Below et al. Oct 2002 B1
6463824 Prell et al. Oct 2002 B1
6468275 Wampler et al. Oct 2002 B1
6468286 Mastri et al. Oct 2002 B2
6471106 Reining Oct 2002 B1
6471659 Eggers et al. Oct 2002 B2
6478210 Adams et al. Nov 2002 B2
6482063 Frigard Nov 2002 B1
6482200 Shippert Nov 2002 B2
6482217 Pintor et al. Nov 2002 B1
6485490 Wampler et al. Nov 2002 B2
6485503 Jacobs et al. Nov 2002 B2
6485667 Tan Nov 2002 B1
6486286 McGall et al. Nov 2002 B1
6488196 Fenton, Jr. Dec 2002 B1
6488197 Whitman Dec 2002 B1
6488659 Rosenman Dec 2002 B1
6491201 Whitman Dec 2002 B1
6491690 Goble et al. Dec 2002 B1
6491701 Tierney et al. Dec 2002 B2
6491702 Heilbrun et al. Dec 2002 B2
6492785 Kasten et al. Dec 2002 B1
6494882 Lebouitz et al. Dec 2002 B1
6494885 Dhindsa Dec 2002 B1
6494888 Laufer et al. Dec 2002 B1
6494896 D'Alessio et al. Dec 2002 B1
6498480 Manara Dec 2002 B1
6500176 Truckai et al. Dec 2002 B1
6500189 Lang et al. Dec 2002 B1
6500194 Benderev et al. Dec 2002 B2
D468749 Friedman Jan 2003 S
6503139 Coral Jan 2003 B2
6503257 Grant et al. Jan 2003 B2
6503259 Huxel et al. Jan 2003 B2
6505768 Whitman Jan 2003 B2
6506197 Rollero et al. Jan 2003 B1
6506399 Donovan Jan 2003 B2
6510854 Goble Jan 2003 B2
6511468 Cragg et al. Jan 2003 B1
6512360 Goto et al. Jan 2003 B1
6514252 Nezhat et al. Feb 2003 B2
6516073 Schulz et al. Feb 2003 B1
6517528 Pantages et al. Feb 2003 B1
6517535 Edwards Feb 2003 B2
6517565 Whitman et al. Feb 2003 B1
6517566 Hovland et al. Feb 2003 B1
6520971 Perry et al. Feb 2003 B1
6520972 Peters Feb 2003 B2
6522101 Malackowski Feb 2003 B2
6524180 Simms et al. Feb 2003 B1
6525499 Naganuma Feb 2003 B2
D471206 Buzzard et al. Mar 2003 S
6527782 Hogg et al. Mar 2003 B2
6527785 Sancoff et al. Mar 2003 B2
6530942 Fogarty et al. Mar 2003 B2
6532958 Buan et al. Mar 2003 B1
6533157 Whitman Mar 2003 B1
6533723 Lockery et al. Mar 2003 B1
6533784 Truckai et al. Mar 2003 B2
6535764 Imran et al. Mar 2003 B2
6539297 Weiberle et al. Mar 2003 B2
D473239 Cockerill Apr 2003 S
6539816 Kogiso et al. Apr 2003 B2
6540737 Bacher et al. Apr 2003 B2
6543456 Freeman Apr 2003 B1
6545384 Pelrine et al. Apr 2003 B1
6547786 Goble Apr 2003 B1
6550546 Thurler et al. Apr 2003 B2
6551333 Kuhns et al. Apr 2003 B2
6554844 Lee et al. Apr 2003 B2
6554861 Knox et al. Apr 2003 B2
6555770 Kawase Apr 2003 B2
6558378 Sherman et al. May 2003 B2
6558379 Batchelor et al. May 2003 B1
6558429 Taylor May 2003 B2
6561187 Schmidt et al. May 2003 B2
6565560 Goble et al. May 2003 B1
6566619 Gillman et al. May 2003 B2
6569085 Kortenbach et al. May 2003 B2
6569171 DeGuillebon et al. May 2003 B2
6569173 Blatter et al. May 2003 B1
6572629 Kalloo et al. Jun 2003 B2
6575969 Rittman, III et al. Jun 2003 B1
6578751 Hartwick Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6582427 Goble et al. Jun 2003 B1
6582441 He et al. Jun 2003 B1
6583533 Pelrine et al. Jun 2003 B2
6585144 Adams et al. Jul 2003 B2
6585664 Burdorff et al. Jul 2003 B2
6586898 King et al. Jul 2003 B2
6587750 Gerbi et al. Jul 2003 B2
6588277 Giordano et al. Jul 2003 B2
6588643 Bolduc et al. Jul 2003 B2
6588931 Betzner et al. Jul 2003 B2
6589118 Soma et al. Jul 2003 B1
6589164 Flaherty Jul 2003 B1
6592538 Hotchkiss et al. Jul 2003 B1
6592572 Suzuta Jul 2003 B1
6592597 Grant et al. Jul 2003 B2
6594552 Nowlin et al. Jul 2003 B1
6595914 Kato Jul 2003 B2
6596296 Nelson et al. Jul 2003 B1
6596304 Bayon et al. Jul 2003 B1
6596432 Kawakami et al. Jul 2003 B2
6599295 Tornier et al. Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
D478665 Isaacs et al. Aug 2003 S
D478986 Johnston et al. Aug 2003 S
6601749 Sullivan et al. Aug 2003 B2
6602252 Mollenauer Aug 2003 B2
6602262 Griego et al. Aug 2003 B2
6603050 Heaton Aug 2003 B2
6605078 Adams Aug 2003 B2
6605669 Awokola et al. Aug 2003 B2
6605911 Klesing Aug 2003 B1
6607475 Doyle et al. Aug 2003 B2
6611793 Burnside et al. Aug 2003 B1
6613069 Boyd et al. Sep 2003 B2
6616686 Coleman et al. Sep 2003 B2
6619529 Green et al. Sep 2003 B2
6620111 Stephens et al. Sep 2003 B2
6620161 Schulze et al. Sep 2003 B2
6620166 Wenstrom, Jr. et al. Sep 2003 B1
6623482 Pendekanti et al. Sep 2003 B2
6625517 Bogdanov et al. Sep 2003 B1
6626834 Dunne et al. Sep 2003 B2
6626901 Treat et al. Sep 2003 B1
6626938 Butaric et al. Sep 2003 B1
H2086 Amsler Oct 2003 H
6629630 Adams Oct 2003 B2
6629974 Penny et al. Oct 2003 B2
6629988 Weadock Oct 2003 B2
6635838 Kornelson Oct 2003 B1
6636412 Smith Oct 2003 B2
6638108 Tachi Oct 2003 B2
6638285 Gabbay Oct 2003 B2
6638297 Huitema Oct 2003 B1
RE38335 Aust et al. Nov 2003 E
6641528 Torii Nov 2003 B2
6644532 Green et al. Nov 2003 B2
6645201 Utley et al. Nov 2003 B1
6646307 Yu et al. Nov 2003 B1
6648816 Irion et al. Nov 2003 B2
6648901 Fleischman et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
D484243 Ryan et al. Dec 2003 S
D484595 Ryan et al. Dec 2003 S
D484596 Ryan et al. Dec 2003 S
6656177 Truckai et al. Dec 2003 B2
6656193 Grant et al. Dec 2003 B2
6659940 Adler Dec 2003 B2
6660008 Foerster et al. Dec 2003 B1
6663623 Oyama et al. Dec 2003 B1
6663641 Kovac et al. Dec 2003 B1
6666854 Lange Dec 2003 B1
6666860 Takahashi Dec 2003 B1
6666875 Sakurai et al. Dec 2003 B1
6667825 Lu et al. Dec 2003 B2
6669073 Milliman et al. Dec 2003 B2
6670806 Wendt et al. Dec 2003 B2
6671185 Duval Dec 2003 B2
D484977 Ryan et al. Jan 2004 S
6676660 Wampler et al. Jan 2004 B2
6677687 Ho et al. Jan 2004 B2
6679269 Swanson Jan 2004 B2
6679410 Wursch et al. Jan 2004 B2
6681978 Geiste et al. Jan 2004 B2
6681979 Whitman Jan 2004 B2
6682527 Strul Jan 2004 B2
6682528 Frazier et al. Jan 2004 B2
6682544 Mastri et al. Jan 2004 B2
6685698 Morley et al. Feb 2004 B2
6685727 Fisher et al. Feb 2004 B2
6689153 Skiba Feb 2004 B1
6692507 Pugsley et al. Feb 2004 B2
6692692 Stetzel Feb 2004 B2
6695198 Adams et al. Feb 2004 B2
6695199 Whitman Feb 2004 B2
6695774 Hale et al. Feb 2004 B2
6695849 Michelson Feb 2004 B2
6696814 Henderson et al. Feb 2004 B2
6697048 Rosenberg et al. Feb 2004 B2
6698643 Whitman Mar 2004 B2
6699177 Wang et al. Mar 2004 B1
6699214 Gellman Mar 2004 B2
6699235 Wallace et al. Mar 2004 B2
6704210 Myers Mar 2004 B1
6705503 Pedicini et al. Mar 2004 B1
6709445 Boebel et al. Mar 2004 B2
6712773 Viola Mar 2004 B1
6716215 David et al. Apr 2004 B1
6716223 Leopold et al. Apr 2004 B2
6716232 Vidal et al. Apr 2004 B1
6716233 Whitman Apr 2004 B1
6720734 Norris Apr 2004 B2
6722550 Ricordi et al. Apr 2004 B1
6722552 Fenton, Jr. Apr 2004 B2
6723087 O'Neill et al. Apr 2004 B2
6723091 Goble et al. Apr 2004 B2
6723106 Charles et al. Apr 2004 B1
6723109 Solingen Apr 2004 B2
6726651 Robinson et al. Apr 2004 B1
6726697 Nicholas et al. Apr 2004 B2
6726705 Peterson et al. Apr 2004 B2
6726706 Dominguez Apr 2004 B2
6729119 Schnipke et al. May 2004 B2
6731976 Penn et al. May 2004 B2
6736810 Hoey et al. May 2004 B2
6736825 Blatter et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6740030 Martone et al. May 2004 B2
6743230 Lutze et al. Jun 2004 B2
6744385 Kazuya et al. Jun 2004 B2
6747121 Gogolewski Jun 2004 B2
6747300 Nadd et al. Jun 2004 B2
6749560 Konstorum et al. Jun 2004 B1
6749600 Levy Jun 2004 B1
6752768 Burdorff et al. Jun 2004 B2
6752816 Culp et al. Jun 2004 B2
6754959 Guiette, III et al. Jun 2004 B1
6755195 Lemke et al. Jun 2004 B1
6755338 Hahnen et al. Jun 2004 B2
6755825 Shoenman et al. Jun 2004 B2
6755843 Chung et al. Jun 2004 B2
6756705 Pulford, Jr. Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6761685 Adams et al. Jul 2004 B2
6762339 Klun et al. Jul 2004 B1
6763307 Berg et al. Jul 2004 B2
6764445 Ramans et al. Jul 2004 B2
6766957 Matsuura et al. Jul 2004 B2
6767352 Field et al. Jul 2004 B2
6767356 Kanner et al. Jul 2004 B2
6769590 Vresh et al. Aug 2004 B2
6769594 Orban, III Aug 2004 B2
6770027 Banik et al. Aug 2004 B2
6770070 Balbierz Aug 2004 B1
6770072 Truckai et al. Aug 2004 B1
6770078 Bonutti Aug 2004 B2
6773409 Truckai et al. Aug 2004 B2
6773437 Ogilvie et al. Aug 2004 B2
6773438 Knodel et al. Aug 2004 B1
6773458 Brauker et al. Aug 2004 B1
6775575 Bommannan et al. Aug 2004 B2
6777838 Miekka et al. Aug 2004 B2
6778846 Martinez et al. Aug 2004 B1
6780151 Grabover et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6783524 Anderson et al. Aug 2004 B2
6784775 Mandell et al. Aug 2004 B2
6786382 Hoffman Sep 2004 B1
6786864 Matsuura et al. Sep 2004 B2
6786896 Madhani et al. Sep 2004 B1
6788018 Blumenkranz Sep 2004 B1
6790173 Saadat et al. Sep 2004 B2
6793652 Whitman et al. Sep 2004 B1
6793661 Hamilton et al. Sep 2004 B2
6793663 Kneifel et al. Sep 2004 B2
6793669 Nakamura et al. Sep 2004 B2
6796921 Buck et al. Sep 2004 B1
6799669 Fukumura et al. Oct 2004 B2
6801009 Makaran et al. Oct 2004 B2
6802822 Dodge Oct 2004 B1
6802843 Truckai et al. Oct 2004 B2
6802844 Ferree Oct 2004 B2
6805273 Bilotti et al. Oct 2004 B2
6806808 Watters et al. Oct 2004 B1
6806867 Arruda et al. Oct 2004 B1
6808525 Latterell et al. Oct 2004 B2
6810359 Sakaguchi Oct 2004 B2
6814154 Chou Nov 2004 B2
6814741 Bowman et al. Nov 2004 B2
6817508 Racenet et al. Nov 2004 B1
6817509 Geiste et al. Nov 2004 B2
6817974 Cooper et al. Nov 2004 B2
6818018 Sawhney Nov 2004 B1
6819269 Flick Nov 2004 B2
6820791 Adams Nov 2004 B2
6821273 Mollenauer Nov 2004 B2
6821282 Perry et al. Nov 2004 B2
6821284 Sturtz et al. Nov 2004 B2
6827246 Sullivan et al. Dec 2004 B2
6827712 Tovey et al. Dec 2004 B2
6827725 Batchelor et al. Dec 2004 B2
6828902 Casden Dec 2004 B2
6830174 Hillstead et al. Dec 2004 B2
6831629 Nishino et al. Dec 2004 B2
6832998 Goble Dec 2004 B2
6834001 Myono Dec 2004 B2
6835173 Couvillon, Jr. Dec 2004 B2
6835199 McGuckin, Jr. et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6836611 Popovic et al. Dec 2004 B2
6837846 Jaffe et al. Jan 2005 B2
6837883 Moll et al. Jan 2005 B2
6838493 Williams et al. Jan 2005 B2
6840423 Adams et al. Jan 2005 B2
6840938 Morley et al. Jan 2005 B1
6841967 Kim et al. Jan 2005 B2
6843403 Whitman Jan 2005 B2
6843789 Goble Jan 2005 B2
6843793 Brock et al. Jan 2005 B2
6846307 Whitman et al. Jan 2005 B2
6846308 Whitman et al. Jan 2005 B2
6846309 Whitman et al. Jan 2005 B2
6847190 Schaefer et al. Jan 2005 B2
6849071 Whitman et al. Feb 2005 B2
6850817 Green Feb 2005 B1
6852122 Rush Feb 2005 B2
6852330 Bowman et al. Feb 2005 B2
6853879 Sunaoshi Feb 2005 B2
6858005 Ohline et al. Feb 2005 B2
6859882 Fung Feb 2005 B2
RE38708 Bolanos et al. Mar 2005 E
D502994 Blake, III Mar 2005 S
6860169 Shinozaki Mar 2005 B2
6861142 Wilkie et al. Mar 2005 B1
6861954 Levin Mar 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6863694 Boyce et al. Mar 2005 B1
6863924 Ranganathan et al. Mar 2005 B2
6866178 Adams et al. Mar 2005 B2
6866668 Giannetti et al. Mar 2005 B2
6866671 Tierney et al. Mar 2005 B2
6867248 Martin et al. Mar 2005 B1
6869430 Balbierz et al. Mar 2005 B2
6869435 Blake, III Mar 2005 B2
6872214 Sonnenschein et al. Mar 2005 B2
6874669 Adams et al. Apr 2005 B2
6876850 Maeshima et al. Apr 2005 B2
6877647 Green et al. Apr 2005 B2
6878106 Herrmann Apr 2005 B1
6882127 Konigbauer Apr 2005 B2
6883199 Lundell et al. Apr 2005 B1
6884392 Malkin et al. Apr 2005 B2
6884428 Binette et al. Apr 2005 B2
6886730 Fujisawa et al. May 2005 B2
6887244 Walker et al. May 2005 B1
6887710 Call et al. May 2005 B2
6889116 Jinno May 2005 B2
6893435 Goble May 2005 B2
6894140 Roby May 2005 B2
6895176 Archer et al. May 2005 B2
6899538 Matoba May 2005 B2
6899593 Moeller et al. May 2005 B1
6899705 Niemeyer May 2005 B2
6899915 Yelick et al. May 2005 B2
6905057 Swayze et al. Jun 2005 B2
6905497 Truckai et al. Jun 2005 B2
6905498 Hooven Jun 2005 B2
6908472 Wiener et al. Jun 2005 B2
6911033 de Guillebon et al. Jun 2005 B2
6911916 Wang et al. Jun 2005 B1
6913579 Truckai et al. Jul 2005 B2
6913608 Liddicoat et al. Jul 2005 B2
6913613 Schwarz et al. Jul 2005 B2
6921397 Corcoran et al. Jul 2005 B2
6921412 Black et al. Jul 2005 B1
6923093 Ullah Aug 2005 B2
6923803 Goble Aug 2005 B2
6923819 Meade et al. Aug 2005 B2
6925849 Jairam Aug 2005 B2
6926716 Baker et al. Aug 2005 B2
6927315 Heinecke et al. Aug 2005 B1
6928902 Eyssallenne Aug 2005 B1
6929641 Goble et al. Aug 2005 B2
6929644 Truckai et al. Aug 2005 B2
6931830 Liao Aug 2005 B2
6932218 Kosann et al. Aug 2005 B2
6932810 Ryan Aug 2005 B2
6936042 Wallace et al. Aug 2005 B2
6936948 Bell et al. Aug 2005 B2
D509297 Wells Sep 2005 S
D509589 Wells Sep 2005 S
6938706 Ng Sep 2005 B2
6939358 Palacios et al. Sep 2005 B2
6942662 Goble et al. Sep 2005 B2
6942674 Belef et al. Sep 2005 B2
6945444 Gresham et al. Sep 2005 B2
6945981 Donofrio et al. Sep 2005 B2
6949196 Schmitz et al. Sep 2005 B2
6951562 Zwirnmann Oct 2005 B2
6953138 Dworak et al. Oct 2005 B1
6953139 Milliman et al. Oct 2005 B2
6953461 McClurken et al. Oct 2005 B2
6957758 Aranyi Oct 2005 B2
6958035 Friedman et al. Oct 2005 B2
6958070 Witt et al. Oct 2005 B2
D511525 Hernandez et al. Nov 2005 S
6959851 Heinrich Nov 2005 B2
6959852 Shelton, IV et al. Nov 2005 B2
6960107 Schaub et al. Nov 2005 B1
6960163 Ewers et al. Nov 2005 B2
6960220 Marino et al. Nov 2005 B2
6962587 Johnson et al. Nov 2005 B2
6963792 Green Nov 2005 B1
6964363 Wales et al. Nov 2005 B2
6966907 Goble Nov 2005 B2
6966909 Marshall et al. Nov 2005 B2
6968908 Tokunaga et al. Nov 2005 B2
6969385 Moreyra Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6971988 Orban, III Dec 2005 B2
6972199 Lebouitz et al. Dec 2005 B2
6974435 Daw et al. Dec 2005 B2
6974462 Sater Dec 2005 B2
6978921 Shelton, IV et al. Dec 2005 B2
6978922 Bilotti et al. Dec 2005 B2
6981628 Wales Jan 2006 B2
6981941 Whitman et al. Jan 2006 B2
6981978 Gannoe Jan 2006 B2
6984203 Tartaglia et al. Jan 2006 B2
6984231 Goble et al. Jan 2006 B2
6986451 Mastri et al. Jan 2006 B1
6988649 Shelton, IV et al. Jan 2006 B2
6988650 Schwemberger et al. Jan 2006 B2
6989034 Hammer et al. Jan 2006 B2
6990731 Haytayan Jan 2006 B2
6990796 Schnipke et al. Jan 2006 B2
6991146 Sinisi et al. Jan 2006 B2
6993200 Tastl et al. Jan 2006 B2
6993413 Sunaoshi Jan 2006 B2
6994708 Manzo Feb 2006 B2
6995729 Govari et al. Feb 2006 B2
6996433 Burbank et al. Feb 2006 B2
6997931 Sauer et al. Feb 2006 B2
6997935 Anderson et al. Feb 2006 B2
6998736 Lee et al. Feb 2006 B2
6998816 Wieck et al. Feb 2006 B2
6999821 Jenney et al. Feb 2006 B2
7000818 Shelton, IV et al. Feb 2006 B2
7000819 Swayze et al. Feb 2006 B2
7000911 McCormick et al. Feb 2006 B2
7001380 Goble Feb 2006 B2
7001408 Knodel et al. Feb 2006 B2
7004174 Eggers et al. Feb 2006 B2
7005828 Karikomi Feb 2006 B2
7007176 Goodfellow et al. Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7008435 Cummins Mar 2006 B2
7009039 Yayon et al. Mar 2006 B2
7011213 Clark et al. Mar 2006 B2
7011657 Truckai et al. Mar 2006 B2
7014640 Kemppainen et al. Mar 2006 B2
7018357 Emmons Mar 2006 B2
7018390 Turovskiy et al. Mar 2006 B2
7021399 Driessen Apr 2006 B2
7021669 Lindermeir et al. Apr 2006 B1
7022131 Derowe et al. Apr 2006 B1
7023159 Gorti et al. Apr 2006 B2
7025064 Wang et al. Apr 2006 B2
7025732 Thompson et al. Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7025774 Freeman et al. Apr 2006 B2
7025775 Gadberry et al. Apr 2006 B2
7028570 Ohta et al. Apr 2006 B2
7029435 Nakao Apr 2006 B2
7029439 Roberts et al. Apr 2006 B2
7030904 Adair et al. Apr 2006 B2
7032798 Whitman et al. Apr 2006 B2
7032799 Viola et al. Apr 2006 B2
7033356 Latterell et al. Apr 2006 B2
7033378 Smith et al. Apr 2006 B2
7035716 Harris et al. Apr 2006 B2
7035762 Menard et al. Apr 2006 B2
7036680 Flannery May 2006 B1
7037314 Armstrong May 2006 B2
7037344 Kagan et al. May 2006 B2
7038421 Trifilo May 2006 B2
7041088 Nawrocki et al. May 2006 B2
7041102 Truckai et al. May 2006 B2
7041868 Greene et al. May 2006 B2
7043852 Hayashida et al. May 2006 B2
7044350 Kameyama et al. May 2006 B2
7044352 Shelton, IV et al. May 2006 B2
7044353 Mastri et al. May 2006 B2
7046082 Komiya et al. May 2006 B2
7048165 Haramiishi May 2006 B2
7048687 Reuss et al. May 2006 B1
7048716 Kucharczyk et al. May 2006 B1
7048745 Tierney et al. May 2006 B2
7052454 Taylor May 2006 B2
7052494 Goble et al. May 2006 B2
7052499 Steger et al. May 2006 B2
7055730 Ehrenfels et al. Jun 2006 B2
7055731 Shelton, IV et al. Jun 2006 B2
7056123 Gregorio et al. Jun 2006 B2
7056284 Martone et al. Jun 2006 B2
7056330 Gayton Jun 2006 B2
7059331 Adams et al. Jun 2006 B2
7059508 Shelton, IV et al. Jun 2006 B2
7063671 Couvillon, Jr. Jun 2006 B2
7063712 Vargas et al. Jun 2006 B2
7064509 Fu et al. Jun 2006 B1
7066879 Fowler et al. Jun 2006 B2
7066944 Laufer et al. Jun 2006 B2
7067038 Trokhan et al. Jun 2006 B2
7070083 Jankowski Jul 2006 B2
7070559 Adams et al. Jul 2006 B2
7070597 Truckai et al. Jul 2006 B2
7071287 Rhine et al. Jul 2006 B2
7075412 Reynolds et al. Jul 2006 B1
7075770 Smith Jul 2006 B1
7077856 Whitman Jul 2006 B2
7080769 Vresh et al. Jul 2006 B2
7081114 Rashidi Jul 2006 B2
7081318 Lee et al. Jul 2006 B2
7083073 Yoshie et al. Aug 2006 B2
7083075 Swayze et al. Aug 2006 B2
7083571 Wang et al. Aug 2006 B2
7083615 Peterson et al. Aug 2006 B2
7083619 Truckai et al. Aug 2006 B2
7083620 Jahns et al. Aug 2006 B2
7083626 Hart et al. Aug 2006 B2
7086267 Dworak et al. Aug 2006 B2
7087049 Nowlin et al. Aug 2006 B2
7087054 Truckai et al. Aug 2006 B2
7087071 Nicholas et al. Aug 2006 B2
7090637 Danitz et al. Aug 2006 B2
7090673 Dycus et al. Aug 2006 B2
7090683 Brock et al. Aug 2006 B2
7090684 McGuckin, Jr. et al. Aug 2006 B2
7091191 Laredo et al. Aug 2006 B2
7091412 Wang et al. Aug 2006 B2
7093492 Treiber et al. Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094247 Monassevitch et al. Aug 2006 B2
7094916 DeLuca et al. Aug 2006 B2
7096972 Orozco, Jr. Aug 2006 B2
7097089 Marczyk Aug 2006 B2
7097644 Long Aug 2006 B2
7097650 Weller et al. Aug 2006 B2
7098794 Lindsay et al. Aug 2006 B2
7100949 Williams et al. Sep 2006 B2
7101187 Deconinck et al. Sep 2006 B1
7101363 Nishizawa et al. Sep 2006 B2
7101371 Dycus et al. Sep 2006 B2
7101394 Hamm et al. Sep 2006 B2
7104741 Krohn Sep 2006 B2
7108695 Witt et al. Sep 2006 B2
7108701 Evens et al. Sep 2006 B2
7108709 Cummins Sep 2006 B2
7111768 Cummins et al. Sep 2006 B2
7111769 Wales et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7112214 Peterson et al. Sep 2006 B2
RE39358 Goble Oct 2006 E
D530339 Hernandez et al. Oct 2006 S
7114642 Whitman Oct 2006 B2
7116100 Mock et al. Oct 2006 B1
7118020 Lee et al. Oct 2006 B2
7118528 Piskun Oct 2006 B1
7118563 Weckwerth et al. Oct 2006 B2
7118582 Wang et al. Oct 2006 B1
7119534 Butzmann Oct 2006 B2
7121446 Arad et al. Oct 2006 B2
7121773 Mikiya et al. Oct 2006 B2
7122028 Looper et al. Oct 2006 B2
7125403 Julian et al. Oct 2006 B2
7125409 Truckai et al. Oct 2006 B2
7126303 Farritor et al. Oct 2006 B2
7126879 Snyder Oct 2006 B2
7128253 Mastri et al. Oct 2006 B2
7128254 Shelton, IV et al. Oct 2006 B2
7128748 Mooradian et al. Oct 2006 B2
7131445 Amoah Nov 2006 B2
7133601 Phillips et al. Nov 2006 B2
7134364 Kageler et al. Nov 2006 B2
7134587 Schwemberger et al. Nov 2006 B2
7135027 Delmotte Nov 2006 B2
7137980 Buysse et al. Nov 2006 B2
7137981 Long Nov 2006 B2
7139016 Squilla et al. Nov 2006 B2
7140527 Ehrenfels et al. Nov 2006 B2
7140528 Shelton, IV Nov 2006 B2
7141055 Abrams et al. Nov 2006 B2
7143923 Shelton, IV et al. Dec 2006 B2
7143924 Scirica et al. Dec 2006 B2
7143925 Shelton, IV et al. Dec 2006 B2
7143926 Shelton, IV et al. Dec 2006 B2
7146191 Kerner et al. Dec 2006 B2
7147138 Shelton, IV Dec 2006 B2
7147139 Schwemberger et al. Dec 2006 B2
7147140 Wukusick et al. Dec 2006 B2
7147637 Goble Dec 2006 B2
7147648 Lin Dec 2006 B2
7147650 Lee Dec 2006 B2
7150748 Ebbutt et al. Dec 2006 B2
7153300 Goble Dec 2006 B2
7153314 Laufer et al. Dec 2006 B2
7155316 Sutherland et al. Dec 2006 B2
7156846 Dycus et al. Jan 2007 B2
7156863 Sonnenschein et al. Jan 2007 B2
7159750 Racenet et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7160299 Baily Jan 2007 B2
7160311 Blatter et al. Jan 2007 B2
7161036 Oikawa et al. Jan 2007 B2
7161580 Bailey et al. Jan 2007 B2
7162758 Skinner Jan 2007 B2
7163563 Schwartz et al. Jan 2007 B2
7166117 Hellenkamp Jan 2007 B2
7166133 Evans et al. Jan 2007 B2
7168604 Milliman et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7170910 Chen et al. Jan 2007 B2
7171279 Buckingham et al. Jan 2007 B2